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The role of diet in pregnancy  
An adequate and healthy diet is needed to ensure optimal foetal development, birth outcomes and 
health later in life [1-3]. The maternal diet must provide sufficient energy, macro- and micronutrients 
to meet the mother’s usual requirements, as well as the needs of the growing foetus, and supporting 
tissues [4]. Undernutrition during pregnancy can have lasting negative consequences for the 
offspring’s health and in this way, many chronic diseases including cardiovascular disease and diabetes 
may originate in the womb [5]. The hypothesis for the underlying mechanism of these associations is 
called foetal programming and was first introduced by Hales and Barker in their developmental origins 
of health and disease (DOHaD) hypothesis [6]. It assumes that metabolic changes in the mother during 
pregnancy can lead to structural and functional adaptations during the development of the foetus, 
with potential consequences for growth and metabolism in the child’s later life. 
Historically, the DOHaD hypothesis focused on the effects of maternal undernutrition. Nowadays, 
besides maternal undernutrition, maternal overnutrition poses a major public health challenge [7]. 
Maternal obesity has been associated with both intrauterine growth restriction and large-for-
gestational age foetuses and is contributing to the epidemic of childhood obesity and metabolic 
syndrome [8].  
Dietary recommendations for pregnant women are quite similar to those for other adults with the 
main recommendation to follow a healthy and balanced diet [9-13]. Most national guidelines, including 
Dutch guidelines, recommend an additional energy intake of 150-500 kcal/d in the second and third 
trimester. Although most pregnant women did not meet this recommendation [14, 15], it is unlikely 
that women are in energy deficit during pregnancy, despite energy intakes below recommendations, 
as there is an increasing prevalence of overweight and excessive gestational weight gain during 
pregnancy in developed countries [16-18]. A plausible reason for the observed discrepancy could be 
that pregnant women compensate for the increased energy need by reducing their physical activities 
[19]. 
Adequate micronutrient intake is critical for foetal development. Micronutrients may affect pregnancy 
outcomes and foetal development through alterations in maternal and foetal metabolism owing to 
their role in enzyme activity, signal transduction and transcription pathways, biological functions and 
oxidative stress [2]. However, the biological mechanisms underlying these associations are not 
completely understood. The most well-known example is that adequate folate intake in the 
periconceptional period reduces the risk of neural tube defects [20]. Furthermore, methyl-donor 
nutrients such as folate, vitamin B6 and vitamin B12 have been positively associated with brain growth 
and cognitive development in the offspring [21, 22]. In addition, zinc, iron and n-3 fatty acids have 
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been related to foetal brain development, as deficiencies were associated with higher risk of preterm 
birth and poorer attention, learning and memory [23-25]. Sufficient iron intake is also needed to 
accommodate the increased production of haemoglobin, as blood volume expands by approximately 
1500 ml, with a 200-250 ml increase in red blood cell mass during pregnancy [26]. Vitamin D 
requirements are increased to support foetal skeletal growth, and vitamin D deficiency has also been 
linked to low birth weight, increased risk of small for gestational age infants [27] and immune function 
[28]. A meta-analysis examined adherence of pregnant women to micronutrient recommendations in 
developed countries and observed that most women do not meet micronutrient recommendations. In 
particular, suboptimal intakes of folate and vitamin D were observed in a large proportion of the 
pregnant women [29]. 
Supplement use 
The gap between recommended and actual dietary intake can be partly bridged by taking supplements. 
The World Health Organization (WHO) recommends folic acid supplements to reduce risk of neural 
tube defects and iron supplements for pregnant women at risk of developing anaemia [30]. 
Furthermore, some countries, including the Netherlands, recommend vitamin D supplementation for 
pregnant women as vitamin D deficiency is common in pregnant populations [26, 31]. However, the 
WHO advises against other supplements including multivitamins as there has been no proven 
additional benefit of other supplements [30] and it may even lead to consumption of micronutrients 
above the recommended upper level of intake [32]. 
Nutrient status 
Adequate dietary intake is needed to ensure adequate nutrient stores to support the developing foetus 
without depleting the mother. Intake and status are both part of the DISH model (Figure 1.1), a 
theoretical model linking behaviour via intake and status to health outcomes. Although intake and 
status are correlated, they do not necessarily reflect the same. Intake is determined by the diet 
consumed, whereas status is affected by absorption, distribution, metabolism and excretion [33]. 
Nutrient status is a measure of the amount of nutrient available to the body and the link between 
intake and disease development. Nutrient status can thus provide information on the mechanism 
underlying a diet-disease association [34]. For example, vitamin D status is dependent on both intake 
of vitamin D and production of vitamin D in the skin under influence of sunlight [35]. The biological 
effect of vitamin D intake on health outcomes will be mediated by vitamin D status [36]. In short, intake 
and status provide complementary information. However, studies examining both dietary intake and 
nutrient status during pregnancy are limited, with studies reporting either only dietary intakes [32, 37, 
38] or nutrient status markers [39-41].  
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Figure 1.1: The DISH model representing the link between diet and health through determinants, intake and 
status [42].  
 
Gestational diabetes 
Definition and prevalence  
Gestational diabetes mellitus (GDM) is one of the most common metabolic complications during 
pregnancy [43]. GDM is defined as carbohydrate intolerance or hyperglycaemia (high blood glucose 
concentration) with first onset or recognition during pregnancy [44]. In 2015, globally, one in eight 
births was affected by GDM according to the International Diabetes Federation estimates [45]. 
However, a lack of consensus regarding the appropriate diagnostic criteria, and the selective one-step 
or universal two-step screening (Box 1.1) have hampered accurate prevalence rates of GDM [46, 47]. 
Depending on the population studied and the diagnostic criteria used, GDM prevalence estimates 
range from 1-18% of all pregnancies [46, 48]. Across Europe, including the Netherlands, prevalence of 
GDM is estimated to be around 2-5% of all pregnancies [46], with prevalence going up to 25% in high-
risk groups [49, 50]. The risk of developing GDM is increased in women with the following risk factors: 
high BMI, age >25 years, non-Caucasian ethnicity, family history of diabetes, GDM in a previous 
pregnancy, chronic hypertension, large abdominal circumference, high fasting glycaemia in the first 
trimester of pregnancy, and the presence of polycystic ovary syndrome [51, 52]. With the increasing 
burden of obesity among women of reproductive age, the prevalence of GDM is increasing [53]. In the 
USA, prevalence of GDM has increased from 0.3% in 1979-1980 to 5.8% in 2008-2010 [54], affecting 
over 110,000 women every year [55]. Increasing rates of GDM have also been observed in Europe, 
Australia and Asia [56-60].  
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Adverse health effects associated with GDM  
GDM has been related to significant short-term and long-term adverse health outcomes for both 
mothers and offspring [65-68]. In 2008 the results from the landmark Hyperglycaemia and Adverse 
Pregnancy Outcome (HAPO) study were published and showed that glucose levels during pregnancy 
are linearly related to risk of adverse pregnancy outcomes including birth weight >90th percentile, 
primary Caesarean section, shoulder dystocia, neonatal hyperbilirubinemia and neonatal 
hypoglycaemia [69]. Women with a history of GDM are seven times more likely to develop type 2 
diabetes mellitus (T2DM) than women without GDM and the onset of T2DM after GDM occurs already 
within five to ten years after the GDM pregnancy [70, 71]. Furthermore, women with a history of GDM 
have a 30-40% higher risk of cardiovascular events, for women who develop T2DM after GDM the risk 
of cardiovascular events is even three-fold higher compared to women without a history of GDM [72, 
73].  
Box 1.1: Screening and diagnosis of gestational diabetes (GDM) 
Screening for GDM is done at 24-28 weeks of gestation using either a universal two-step diagnosis 
strategy or a selective one-step diagnosis strategy.  
Selective one-step diagnosis strategy: Pregnant women with one or more risk factors for GDM 
undergo a 100 grams or 75 grams oral glucose tolerance test (OGTT) after an overnight fast.  
Universal two-step diagnosis strategy: All pregnant women undergo a non-fasting 50 grams glucose 
challenge test. After one hour a blood sample is drawn. Women with a one-hour glucose value ≥7.8 
mmol/L undergo a 100 grams or 75 grams OGTT after an overnight fast.  
A positive GDM diagnosis is given using one of the diagnostic criteria sets displayed below. 
Commonly used diagnostic criteria for GDM after an OGTT 
 NDDG (1979) [61] ADA (1997) [62] WHO (1999) [63] IADPSG1 (2010) [64] 
 100-g OGTTa 100-g OGTTa 75-g OGTTb 75-g OGTTc 75-g OGTTc 
Fasting glucose ≥ 5.8 mmol/L ≥ 5.3 mmol/L ≥ 5.3 mmol/L ≥ 6.1 mmol/L ≥ 5.1 mmol/L 
1 hour glucose ≥ 10.5 mmol/L ≥ 10.0 mmol/L ≥ 10.0 mmol/L - ≥ 10.0 mmol/L 
2 hour glucose ≥ 9.1 mmol/L ≥ 8.6 mmol/L ≥ 8.6 mmol/L ≥ 7.8 mmol/L ≥ 8.5 mmol/L 
3 hour glucose ≥ 8.0 mmol/L ≥ 7.8 mmol/L - - - 
NDDG, National Diabetes Data Group; ADA, American Diabetes Association; WHO, World Health Organization;  
IADPSG, International Association of Diabetes and Pregnancy Study Group; OGTT, oral glucose tolerance test 
1 After publication of IADPSG diagnostic criteria, ADA and WHO endorse the use of the IADPSG criteria. 
a Glucose tolerance test with 100 g of oral glucose: two abnormal values at any time of the curve indicate GDM. 
b Glucose tolerance test with 75 g of oral glucose: two abnormal values at any time of the curve indicate GDM.  
Although diagnostic criteria for the 75-g OGTT are defined, the ADA recommends the use of the 100-g OGTT. 
c Glucose tolerance test with 75 g of oral glucose: one or more abnormal values indicate GDM. 
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Children born to mothers with GDM have an increased risk of developing overweight, the metabolic 
syndrome and T2DM during childhood, adolescence, and adulthood [74, 75]. Uncontrolled GDM leads 
to a hyperglycaemic intra-uterine environment, as glucose can cross the placenta and insulin cannot. 
This may lead to overstimulation of foetal beta cells, accelerating foetal growth and fat disposition and 
is also known as the Pedersen’s hypothesis [76]. Furthermore, epigenetic changes in response to the 
hyperglycaemic intra-uterine environment are thought to be a likely mechanism by which the 
intrauterine environment affects health and disease of the offspring of GDM mothers [77, 78]. 
Pathophysiology of GDM 
Over the course of normal pregnancy, insulin sensitivity decreases by 50-60% [79]. The decrease in 
insulin sensitivity during normal pregnancy is thought to be the result of increased maternal adiposity, 
production of insulin desensitizing hormones by the placenta, subclinical inflammation, and reduced 
adiponectin secretion [80]. The proposed key cellular mechanism is the post-receptor insulin-signalling 
cascade including the insulin receptor substrate 1 tyrosine phosphorylation [80, 81]. GDM results from 
an imbalance between decreased insulin sensitivity and the capacity of pancreatic beta cells to 
compensate by increasing insulin production. Most women who develop GDM have subclinical 
metabolic dysfunction, including impaired insulin response, already prior to conception [81].  
Treatment and prevention  
After GDM diagnosis, women receive treatment from medical care providers. The primary approach 
for GDM treatment is dietary advice in combination with self-monitoring of blood glucose levels [82]. 
Main aim of the treatment is to achieve optimal glycaemic control, i.e. regulation and maintenance of 
blood glucose levels within the normal range. Although there are no specific guidelines for diet in GDM, 
dietary advice mostly includes carbohydrate distribution and a reduction in rapidly digestible sugars. 
Seventy to 85% of the women with GDM achieve glycaemic control by adjustments to their diet [82]. 
Women who fail to maintain glycaemic control within 1-2 weeks generally receive additional insulin 
therapy.  
Two large randomized controlled trials showed that treatment of GDM consisting of dietary 
counselling, self-monitoring of blood glucose and, if needed, insulin therapy is effective in reducing 
adverse pregnancy outcomes, including shoulder dystocia, bone fracture, nerve palsy, Caesarean 
delivery and foetal overgrowth [83, 84]. Although treatment is effective in reducing adverse pregnancy 
outcomes, it is not yet clear whether risk of adverse pregnancy outcomes for treated GDM is similar 
to risk of women with normal glucose tolerance.  
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Prevention of GDM is desirable as this might reduce long-term adverse health outcomes of mother 
and offspring and puts less burden on health care systems and costs than GDM treatment [85, 86]. As 
BMI is one of the most important risk factors for development of GDM, prevention of GDM has focused 
on modifiable factors including diet, exercise and weight [87, 88]. As diet plays a central role in GDM 
treatment and there is substantial evidence relating dietary factors to glucose homeostasis [89, 90], 
the potential role of diet in GDM prevention has increasingly received attention [91, 92].  
Diet and GDM prevention 
A few intervention studies have investigated a dietary intervention, or lifestyle intervention with a 
dietary component, to prevent GDM development [93, 94]. Several have found a reduced incidence of 
GDM in the intervention group. One RCT included 50 Danish obese pregnant women, and the 
intervention group receiving 10 one-hour consultations with a dietician had significantly less 
deterioration in glucose homeostasis than the control group [95]. One non-randomized trial including 
185 Finnish mothers at risk of GDM receiving diet and physical activity counselling, starting at the end 
of the first trimester, reported a 50% reduction in GDM incidence compared with the control group 
[96]. The largest RCT in 400 Finnish women with at least one risk factor for GDM receiving intensive 
individual counselling on diet and physical activity showed a 39% reduction in GDM prevalence 
compared to standard care [97]. However, others, including a large European multicentre trial in 
overweight and obese pregnant women, did not find a reduction in GDM prevalence after lifestyle or 
dietary counselling [98-101]. Differences in dietary intervention (e.g. focus on macronutrient 
composition, low glycaemic (GI) index, healthy dietary pattern), intensity of the intervention, start of 
the intervention (e.g. first trimester, second trimester) and study population (e.g. obese pregnant 
women, women who had GDM in a previous pregnancy) might account for differences in effect. Thus, 
no definite conclusion on the role of diet in GDM prevention can be drawn from these intervention 
studies.  
Most evidence on the associations between diet and GDM comes from observational studies, and has 
been summarized by two recent reviews [91, 93]. These reviews give a comprehensive overview of 
studies investigating dietary factors and the development of GDM. A summary of their results is 
presented in Table 1.1. A wide range of dietary factors has been investigated, but results per dietary 
factor are limited to only a few studies and, together with the observational nature of the studies, the 
associations between individual dietary factors and GDM development remain inconclusive. Several 
observational studies have investigated dietary patterns in relation to GDM risk. Most studies observed 
a lower risk of GDM when adhering to a healthy dietary pattern, e.g. Mediterranean diet, prudent 
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dietary pattern [102-111]. These healthy dietary patterns are often characterized by a high intake of 
fruit, vegetables, whole grain products and a low intake of animal and processed food products.  
Only a few studies have investigated nutrient status of different micronutrients and the association 
with GDM development. A high folate status [112] and vitamin D deficiency [113] have been linked to 
a higher risk of GDM, whereas a lower risk of GDM was observed with higher levels of vitamin B12 
[112, 114, 115], vitamin C [116], zinc and selenium [117].  
Current evidence from observational studies is dominated by findings from the Nurses’ Health Study 
II, which may not be representative for other populations and incomplete adjustment or clustering of 
health behaviours may confound reported associations [91]. Furthermore, detailed dietary 
assessments and blood samples are lacking and GDM diagnosis relies on self-report of participants. 
Furthermore, dietary assessment is done either before pregnancy or once during pregnancy, missing 
potential changes in dietary intake occurring due to getting pregnant. The role of nutrient status in the 
preconception period as well as the influence of changes in dietary intake from preconception to GDM 
diagnosis remain to be investigated.  
 
Table 1.1: Summary of associations between dietary intake and gestational diabetes mellitus reported in 
observational studies, stratified for study design. Adapted from Schoenaker et al. [91] and Donazar et al. [93]. 
 
  Study design  
 # 
 
Prospective 
Cross-
sectional Case-control References  
Energy and macronutrients       
Total energy 14  xxxxx ↑xxx xxxxx [117-130] 
Protein 11  xxxx ↑xx xxxx [118, 120, 121, 123-125, 128-132] 
Carbohydrates 12  xxxx↓ ↑x↓ xxx↓ [118, 120, 121, 123-125, 127-130, 132, 133] 
Dietary fibre 10  xx↓ ↑xxx x↓↓ [119-122, 124-127, 130, 133] 
Total fat 13  ↑↑↑xxx ↑↑x xxx↓ [118-121, 123-125, 127-130, 132, 134] 
Saturated fat 10  xx xxx ↑↑↑xx [120-122, 124, 126-128, 130, 132, 134] 
Monounsaturated fat 9  xx xx ↑xxx↓ [120, 121, 124, 126-128, 130, 132, 134] 
Polyunsaturated fat 9  xx ↑x ↑x↓↓↓ [120, 121, 124, 126-128, 130, 132, 134] 
Omega-3 fatty acids 4  ↑x  ↑ [126, 127, 134] 
Omega-6 fatty acids 3  xx   [127, 134] 
Trans fat 5  xx xx ↑ [121, 124, 127, 130, 134] 
PUFA:SAFA ratio 5  xx xx ↓ [121, 124, 127, 130, 134] 
Cholesterol 9  ↑↑ ↑x ↑x [121, 124, 126, 128, 134] 
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Micronutrients  
 
    
Iron 3  xx ↑  [122, 135, 136] 
Zinc 2  x  ↓ [117, 135] 
Selenium 1    ↓ [117] 
Vitamin A 1    x [117] 
Vitamin E 3   x xx [117, 126, 137] 
Vitamin C 4  x  x↓↓ [116, 117, 126, 138] 
Magnesium 2  x  x [128, 133] 
  
 
    
Dietary patterns  
 
    
Mediterranean diet 3  ↓↓  ↓ [104, 105, 109] 
DASH diet 2  ↓  ↓ [104, 109] 
Healthy Eating Index 2  ↓x   [109, 110] 
Prudent 5  ↓↓↓↓x   [102, 103, 107, 110, 111] 
Western  5  ↑↑↑x ↑  [102, 103, 107, 108, 111] 
Low-Carbohydrate Diet 1  ↑   [139] 
  
 
    
Foods  
 
    
Fruits and vegetables 1  x   [140] 
Fruit 3  xx  ↓ [123, 126, 141] 
Fruit juice 2  xx   [118, 141] 
Vegetables 2  x  x [123, 126] 
Potato 2  ↑↓   [123, 142] 
Legumes 2  xx   [123, 131] 
Dairy products 3  xx  x [123, 126, 131] 
Cheese 1  ↑   [123] 
Red meat 4  ↑↑x  ↑ [111, 126, 127, 131] 
Processed meat 4  ↑↑x  ↑ [111, 126, 127, 131] 
Poultry 1  x   [131] 
Fish 3  xx x  [123, 131, 143] 
Eggs 3  x↑  ↑ [126, 131] 
Nuts 1  ↓   [131] 
Whole grains 2  x  x [126, 127] 
Cereal 1  ↓   [123] 
Fried foods 2  ↑↑   [119, 144] 
Sugar-sweetened cola 1  ↑   [145] 
Sugar-sweetened 
beverages (not cola) 1  x   [145] 
Diet cola 1  x   [145] 
Other diet beverages (not 
cola) 1 
 
x   [145] 
Coffee 1  x   [146] 
Tea 1  x   [146] 
Olive oil 1  ↑   [123] 
PUFA, polyunsaturated fatty acids; SAFA, saturated fatty acids; DASH, dietary approaches to stop hypertension  
↑ Significant positive association between dietary intake and risk of gestational diabetes mellitus (P <0.05) 
↓ Significant inverse association between dietary intake and risk of gestational diabetes mellitus (P <0.05) 
x No statistically significant association between dietary intake and gestational diabetes mellitus 
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Dietary assessment issues 
To study dietary intakes during pregnancy and the association between diet and GDM development 
dietary assessment is essential. However, there are some obstacles in dietary assessment. The concept 
of diet is complex as dietary intake can be expressed as intake of single nutrients, food items, food 
groups or dietary patterns. Foods and nutrients are consumed in combinations, which can induce 
interactions and synergies between dietary components. Therefore, dietary pattern analysis is 
assumed a more appropriate approach for investigating diet-disease associations than focusing on a 
single food or nutrient [147]. Furthermore, a dietary pattern represents a single summary measure of 
one’s diet. Dietary guidelines represent the current state of scientific knowledge and are designed to 
prevent nutrient deficiencies and chronic diseases. A dietary pattern index score assessing adherence 
to dietary guidelines can be used as a measure of diet quality [148]. However, dietary guidelines may 
differ between countries and index scores need to be properly designed and evaluated before they 
can be used in research.  
A second issue in dietary assessment is the measurement error present in dietary intake estimates. 
Food-frequency questionnaires (FFQ) and 24-hour recalls (24hR) are commonly used dietary 
assessment methods. These methods both have their strengths and limitations [34]. The FFQ is, for 
example, relatively cheap and easy to administer, but relies on memory and can lead to social desirable 
answers, while a limited set of aggregated food items leads to loss of precision, and portion sizes are 
difficult to assess accurately. The 24hR assesses all foods consumed on a single day, but also relies on 
memory and can lead to social desirable answers. Furthermore, multiple recalls are necessary to 
capture individual habitual intake. Altogether, dietary intake estimates assessed with the FFQ or 24hR 
are known to be biased due to random and systematic measurement error, which can lead to biased 
associations and reduced power [149, 150]. Statistical methods can partly correct the bias in diet-
health associations introduced by measurement errors, but require intake estimates from a second 
(superior) assessment method, i.e. a reference method.  
 
Aim and outline of the thesis 
This thesis aims to provide more insight into dietary intake and nutrient status before and during 
pregnancy and into the association of dietary intake and nutrient status with development of GDM. To 
achieve this overall aim, one objective and four research questions were defined: 
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- Develop an index to assess adherence to the Dutch dietary guidelines of 2015 
- Does combining dietary data of a FFQ with dietary data of 24hR reduce bias in diet-disease 
associations?  
- Are women with GDM who receive treatment at increased risk of common adverse pregnancy 
outcomes? 
- What is the association between dietary intake, nutrient status and development of GDM? 
- How do dietary intake, supplement use and nutrient status change during pregnancy? 
The first part of the thesis focusses on two methodological issues of nutrition research. In chapter 2, 
the development and evaluation of the Dutch Healthy Diet index 2015 (DHD15 index) score assessing 
adherence to the Dutch dietary guidelines of 2015 is described. Chapter 3 describes the impact of 
combining 24hR and FFQ estimates using (enhanced) regression calibration on diet-disease 
associations. In both chapters data from the NQplus study is used, see box 1.2 for details of the study. 
The next chapter, chapter 4, focusses on adverse pregnancy outcomes related to GDM, by comparing 
adverse pregnancy outcomes of women who develop GDM and receive treatment to pregnant women 
with untreated borderline GDM and pregnant women with normal glucose tolerance. For this chapter, 
data from medical records (GLIMP study) is used, see box 1.2. In the next chapters, the association of 
pre-pregnancy dietary intake and the development of GDM is examined. Chapter 5 focusses on the 
association between pre-pregnancy carbohydrate intake and development of GDM and in chapter 6, 
the association between pre-pregnancy micronutrient intake and development of GDM is described. 
Data from the prospective cohort study Australian Longitudinal Study on Women’s Health (ALSWH) is 
used in chapters 5 and 6, see box 1.2. Dietary intake and supplement use might change over the course 
of the pregnancy, and consequently influence nutrient status. This is described in chapter 7, as well as 
the association of diet quality, micronutrient intake and status with glucose tolerance markers 
measured in the preconception period, at the end of the first trimester and the end of the second 
trimester. In the final part of this thesis, focus lies on dietary intakes in the preconception period. In 
chapter 8, dietary intake in the preconception period is examined in more detail with a description of 
supplement use and dietary sources of folate, vitamin D, and n-3 fatty acids and the correlation 
between supplemental and dietary intake with blood levels is examined. Chapter 7 and 8 use data from 
the small-scale GLIMP2 study, see box 1.2. In the final chapter of this thesis, chapter 9, the main 
findings of the studies are summarized and discussed. This general discussion puts the findings into 
perspective and gives implications for practice and further suggestions for future research.  
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  Box 1.2: Characteristics of the studies used in this thesis. 
 
Nutrition Questionnaires plus (NQplus) [151] 
Study design  Cross-sectional 
Study population 2,048 Dutch adults aged 20-80 year 
Data collection period  2011-2013 
Dietary assessment Food frequency questionnaire, multiple 24-hour recalls, urinary biomarkers 
GDM assessment - 
Other measures  Anthropometric measurements 
 
GLIMP 
Study design  Database with data from medical file records 
Study population 2,239 Dutch women who gave birth in hospital Gelderse Vallei  
Data collection period  2010-2014 
Dietary assessment - 
GDM assessment Glucose tolerance test results 
Other measures  Pregnancy and delivery information 
Australian Longitudinal Study on Women’s Health (ALSWH) [152] 
Study design  Longitudinal prospective cohort study, with survey once in three years 
Study population 40,395 Australian women aged 18-75 years 
Data collection period 1996-2017 
Dietary assessment Food frequency questionnaire administered in 2003 and 2009  
GDM assessment Self-reported GDM diagnosis 
Other measures  Self-reported anthropometrics 
 
GLIMP2 
Study design Longitudinal prospective study, measurements at preconception, 12 weeks 
pregnant, 24 weeks pregnant, and 6-12 weeks after delivery 
Study population 115 Dutch women aged 18-40 with either a wish to get pregnant within one 
year or those less than 24 weeks pregnant  
Data collection period  2015-2017 
Dietary assessment Food frequency questionnaire, multiple 24-hour recalls, nutrient status 
markers 
GDM assessment Glucose tolerance test results 
Other measures  Anthropometrics, supplement use 
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Abstract 
Objective: To update the Dutch Healthy Diet index, a measure of diet quality, to reflect adherence to 
the Dutch dietary guidelines 2015 and to evaluate against participants’ characteristics and nutrient 
intakes with the score based on 24 hour recall (24hR) data and FFQ data. 
Design: The Dutch Healthy Diet index 2015 (DHD15-index) consists of 15 components representing the 
15 food-based Dutch dietary guidelines of 2015. Per component the score ranges between zero and 
ten, resulting in a total score between zero (no adherence) and 150 (complete adherence). 
Setting: Wageningen area, the Netherlands, 2011-2013 
Subjects: Data of 885 men and women, aged 20-70 years, participating in the longitudinal NQplus 
study, who filled out two 24hR and one FFQ was used.  
Results: The mean±SD score of the DHD15-index was 68.7±16.1 for men and 79.4±16.0 for women. 
Significant inverse trends were found between the DHD15-index and BMI, smoking, and intakes of 
energy, total fat, and saturated fat. A positive trend was seen across the sex-specific quintiles of the 
DHD15-index score with energy-adjusted micronutrient intakes. Mean DHD15-index score of the FFQ 
data was 15.5 points higher compared to 24hR data, with a correlation coefficient of 0.56 between the 
scores. Observed trends of the DHD15-index based on FFQ with participant characteristics, 
macronutrient intake and energy-adjusted micronutrients were similar to those with the DHD15-index 
based on 24hR.  
Conclusions: The DHD15-index score assesses adherence to the Dutch dietary guidelines 2015 and 
indicates diet quality. The DHD15-index score can be based on 24hR data and on FFQ data.  
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Introduction 
The Dutch Healthy Diet (DHD) index is a measure of diet quality as it assesses adherence to the Dutch 
dietary guidelines published in 2006 by the Health Council of the Netherlands [1]. The DHD-index has 
been used in a variety of applications, including intervention monitoring and epidemiological research 
[2-4]. A higher DHD-index score has been associated with more nutrient-dense diets [5]and lower risk 
of mortality[6], but not with cardiovascular disease [7] or quality adjusted life years [8]. 
In 2015, the Health Council of the Netherlands published an updated version of the Dutch dietary 
guidelines, based upon the latest scientific evidence [9]. Where the Dutch dietary guidelines of 2006 
consisted of food-based and nutrient-based guidelines (e.g. vegetables, fruit, fibre and saturated fat), 
the 2015 guidelines are completely food-based (e.g. whole grain products, red and processed meat, 
and fats and oils) [10]. Due to this revision of the Dutch Dietary Guidelines the DHD-index needed to 
be updated. Therefore, we developed the Dutch Healthy Diet 2015 (DHD15) index as a tool to measure 
adherence to the Dutch dietary guidelines of 2015. In this paper we describe the development of this 
new score and examine associations between the DHD15-index with participants’ characteristics, and 
energy, macro- and micronutrient intakes based on 24 hour recall (24hR) data. Additionally, the 
DHD15-index score derived from FFQ data was compared to the DHD15-index score derived from the 
24hR data to assess comparability of the index when based on different dietary assessment 
instruments.  
 
Methods 
Study design and population  
The Nutrition Questionnaires plus (NQplus) study is a longitudinal study on diet and health in the 
general Dutch population. The NQplus study has been described elsewhere [11]. Briefly, between May 
2011 and December 2013, a total of 2,048 men and women were included, all randomly selected 
inhabitants of the cities Wageningen, Renkum, Ede, Arnhem, and Veenendaal which are located in the 
central part of the Netherlands. Inclusion criteria were age between 20-70 years and being able to 
speak and write Dutch.  
Baseline measurements consisted of dietary assessment (including supplement use) with multiple 
24hR and FFQ, anthropometric measurements (including height and body weight measurements), a 
venepuncture, a 24-hour urine collection and general questionnaires (including age, sex, highest 
achieved education level (low: primary school, vocational or lower general secondary education, 
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moderate: higher secondary education or intermediate vocational training, high: higher vocational 
education or university) and smoking (yes/no)). Participants with data of least two telephone 
administered 24hR and a baseline FFQ (n=885) were included for the current analysis. 
Dietary assessment 
24 hour recalls 
The 24hR was administered by means of a telephone interview by trained dietitians of the Division of 
Human Nutrition of Wageningen University. The dietitian made an unannounced phone call to the 
participant and asked about the foods and drinks consumed the previous day according to a 
standardized protocol based on the five-step multiple-pass method [12]. Recalls were at least one 
month apart and the first two completed 24hR were used for the present analyses. Energy and nutrient 
intakes were estimated using the 2011 Dutch food composition table [13].  
Food frequency questionnaire (FFQ) 
A 180-item semi–quantitative FFQ was used to assess usual dietary intake and was previously 
evaluated for energy intake, macronutrients, dietary fibre and selected vitamins [14, 15]. Answer 
categories for frequency questions ranged between ‘not in this month’ to ‘6–7 days/week’, and portion 
sizes were estimated using natural portions (bread shapes) and commonly used household measures 
(e.g. spoon and cup). Average daily nutrient intakes were calculated by multiplying frequency of 
consumption by portion size and nutrient content per gram using the 2011 Dutch food composition 
table [13]. We estimated the same micronutrient intakes as for the 24hR, except for iron and 
magnesium as the FFQ was not developed to estimate these intakes. The FFQ was administered online 
using the open-source survey tool Limesurvey.  
Development of the DHD15-index 
In Table 2.1 an overview of the components and their cut-off and threshold values can be found. For 
all 15 components a maximum of ten points could be allotted, resulting in a total score ranging from 
zero to 150 points. The components vegetables, fruit, legumes, nuts, fish, and tea are adequacy 
components, and the components red meat, processed meat, sweetened beverages and fruit juices, 
sodium and alcohol are moderation components. The component dairy is an optimum component with 
an optimal range of intakes, whereas the fats and oils component is defined as a ratio component to 
reflect replacement of intake of less desired foods with healthier options in that food group. The coffee 
component is defined as a qualitative component based on type of coffee. The component wholegrain 
is scored based on two subcomponents as there are two guidelines for grain products: an adequacy 
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component for wholegrain consumption and a ratio component to reflect replacement of refined grain 
products by wholegrain products.  
Cut-off values represent the minimum (for adequacy components) and maximum (for moderation 
components) required amount of consumption awarded with ten points. The threshold values 
represent the lowest level of intake awarded with zero points (for moderation components only). For 
adequacy components, no intake is awarded with zero points. Intakes between the cut-off and 
threshold value are scored proportionally. In the text below, for each guideline/component the 
included food groups, explanation of cut-off and threshold values and adaptations for estimation with 
an FFQ are discussed, if applicable. This is followed by an explanation of the scoring per type of 
component.  
Vegetables 
The first component is based on the recommendation to consume at least 200 grams of vegetables 
per day. Foods for this component are vegetables including frozen and canned vegetables, peas, and 
salads, but not legumes or potatoes. The cut-off was set at 200 grams as quantified in the guideline.  
Fruit 
The second component is based on the recommendation to consume at least 200 grams of fruit a day. 
Fresh fruit intake was included for this component, but not dried fruit as this has a relatively high 
energy and sugar content compared to fresh fruit [16]. In contrast to the previous DHD-index, fruit 
juices are no longer included. The cut-off was set at 200 grams as quantified in the guideline. 
Wholegrain products  
The third component was based on two guidelines regarding wholegrain foods and therefore scored 
with two subcomponents. The first subcomponent was based on the recommendation to consume at 
least 90 grams of wholegrain products per day. The cut-off was set at 90 grams as quantified in the 
guideline. The second subcomponent is based on the recommendation to replace refined cereal 
products by wholegrains products and is scored as a ratio component obtained by dividing intake of 
wholegrain products by intake of refined cereal products. There was no quantitative recommendation, 
nor information about the level of intake of refined cereal products associated with adverse health 
effects to base the cut-off or threshold value on. Therefore, we used the 15th percentile of the intake 
distribution of the Dutch reference population based on two day averages (Dutch National Food 
Consumption Survey 2007-2010 [17]) as (arbitrary) cut-off value. The threshold value was equal to the 
85th percentile as we also did for the DHD-index. The maximum score for both subcomponents is five 
points. By adding the scores of the two subcomponents the score for wholegrain products is obtained. 
Included food groups were cereal products used as staple component of the diet (e.g. bread products, 
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bread replacement products, muesli, pasta and rice), but no snacks made of cereal products such as 
biscuits. Foods were categorized as wholegrain product if they contained at least 25 per cent whole-
grain flour; otherwise they were categorized as refined grain product.  
Legumes 
The fourth component is based on the recommendation to consume legumes weekly. As intakes in the 
score are expressed per day, one portion of legumes (60 grams [16]) was divided by seven and rounded 
to 10 g/day to obtain the cut-off value. Included food groups are pulses, lentils, beans and chickpeas, 
but not peas and peanuts [18].  
Nuts 
The fifth component assesses unsalted nut consumption and is based on the recommendation to 
consume at least 15 grams of unsalted nuts a day. The cut-off was set at 15 grams as quantified in the 
guideline. As stated in the guideline, only unsalted nuts were included in this component. However, 
the FFQ did not distinguish between unsalted and salted nuts. Therefore, total nut consumption was 
included for this component for the FFQ based DHD15-index score.  
Dairy 
The sixth component, dairy, is based on the recommendation to consume a few portions of dairy a day 
including milk and yoghurt. Included food groups are milk, milk products, yoghurt, cheese, cream, 
custard, and porridge prepared with dairy. This component was interpreted as an optimum 
component. Two to three portions a day, with a portion size of 150g per portion (Netherlands Nutrition 
Centre), resulted in the optimum range of intake (300-450g/day) and a score of ten points. An intake 
of more than two times the average recommended amount was set as threshold value. Cheese intake 
was also included in total dairy intake, but limited to a maximum of 40g (as set by the Netherlands 
Nutrition Centre) to account for differences in portion sizes between milk and cheese. Furthermore, a 
limitation in cheese intake ensures that the maximum score for dairy can only be obtained when milk 
or yoghurt products are consumed, as specified in the recommendation of the Health Council of the 
Netherlands. 
Fish  
The seventh component, fish, is based on the recommendation to consume one portion of fish a week, 
preferably oily fish. One portion of fish (100 grams [16]) was divided by seven and rounded to obtain 
the cut-off value of 15 g/d for fish. As the recommendation favours intake of oily fish, a maximum of 
4g/d of lean fish was included. This maximum was derived from the ratio three times oily fish and one 
time lean fish (per month) as set by the Netherlands Nutrition Centre.  
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Tea 
The eighth component is based on the recommendation to consume three cups of black or green tea 
a day. Portion sizes set by the Netherlands Nutrition Centre were used to arrive at a cut-off value of 
450g/day (equal to 450ml/day). As the FFQ does not distinguish between types of tea, total tea 
consumption was used for this component for the FFQ based DHD15-index score. 
Fats and oils 
The ninth component is a ratio component based on the recommendation for fats and oils. The ratio 
is obtained by dividing intake of soft margarines, liquid cooking fats and vegetable oils by intake of 
butter, hard margarines and cooking fats. Similar to the ratio subcomponent whole grains, cut-off and 
threshold values were derived from the 15th percentile and 85th percentile of the intake distribution 
of the Dutch reference population [17].  
Coffee 
The tenth component, coffee, is a quality component, based on type of coffee (filtered or unfiltered). 
Scoring for this component is, contrary to the other components, dichotomous. No consumption of 
unfiltered coffee or no consumption of coffee at all, was set as criterion for the maximum score of ten 
points, whereas any consumption of unfiltered coffee is awarded with zero points. Because both the 
24hR and FFQ do not distinguish between types of coffee consumed, the component score for coffee 
could not be assessed in this study.  
Red meat 
The eleventh component, red meat, is based on the recommendation to limit red meat consumption. 
Included food products for this component are beef, pork, duck, pheasant, offal, and game products. 
The Netherlands Nutrition Centre advices to consume less than 300 grams of red meat per week (about 
45 g/day). The cut-off value was thus set at an intake of 45g/day. The Health Council of the Netherlands 
indicated that with a consumption of 100 g/day or more negative health effects were observed [19]. 
Consequently, the threshold value was set at an intake of 100g/day.  
Processed meat 
The twelfth component, processed meat, is based on the recommendation to limit consumption of 
processed meat. Both processed red meat and processed white meat are food groups included in this 
component. As the Health Council of the Netherlands indicated that especially consumption of 
processed meat should be limited, the cut-off value was set at no consumption. The Health Council of 
the Netherlands indicated that negative health effects of processed meat are observed at intakes of 
50 g/day or more [19], and therefore this was set as threshold value.  
 
Development and evaluation DHD15-index 
35 
Sweetened beverages and fruit juices 
The thirteenth component was based on the recommendation to limit consumption of sweetened 
beverages and fruit juices. For this component, sugar-sweetened soft drinks, sugar-sweetened dairy 
drinks and fruit juices were included. No consumption was set as cut-off value and a consumption of 
250 g/day as threshold value, as consumption of more than 250 grams per day was found to be 
associated with weight gain [20]. 
Alcohol 
The fourteenth component, alcohol, is based on the recommendation to limit consumption to one 
Dutch unit (10 gram ethanol a day), if alcohol is consumed at all. This 10 gram ethanol per day was set 
as cut-off value. Negative health effects occur at different intakes for men and women [21], therefore 
the threshold value was differentiated by sex. For women an intake of 20 gram ethanol a day was 
associated with negative health effects, and thus this intake was used as threshold value, whereas for 
men this was set at 30 gram ethanol a day.  
Salt 
The last component, salt, is based on the recommendation to consume less than 6 grams of table salt 
a day. This corresponds to a recommended consumption of 2.4 grams of sodium per day or less. For 
this component the sodium content of all consumed foods was summed to obtain sodium intake per 
day. Ideally, salt consumption is assessed with sodium content based on a 24h urine collection. 
However, this was not available for the Dutch reference population. Therefore, the threshold value is 
based on the intake distribution of the Dutch reference population assessed with two 24hR. With 
sodium intakes based on 24hR and especially FFQ, salt added during cooking and at the dinner table is 
not taken into account. The contribution of these sources is assumed to be on average 20% of total 
sodium intake in the Netherlands [22]. In most studies there is no data available on the amount of salt 
added during cooking and at the dinner table. Therefore we adjusted the cut-off value, representing 
the recommended maximum sodium intake, by 20% to compensate for this.  
Scoring 
For the adequacy components vegetables, fruit, nuts, legumes, nuts, fish, and tea the minimum score 
was given when there was no consumption of this component. Intakes equal to the cut-off value or 
higher were given the maximum score of ten points. The scores for the intake between zero and the 
cut-off value were calculated by dividing the reported intake by the cut-off value and subsequently 
multiplying the obtained ratio by ten (Figure 2.1a). For the moderation components red meat, 
processed meat, sweetened beverages and fruit juices, sodium and alcohol zero points were assigned 
if intake was above the threshold value. Ten points were assigned if intake was equal to or lower than 
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the cut-off value. The scores for intake between threshold value and cut-off value were calculated by 
dividing the difference between the intake and the cut-off value by the difference between the 
threshold value and the cut-off value. This ratio was subsequently multiplied by ten. The obtained 
score was subtracted from ten to obtain the component score, as the score for moderation 
components has to decrease when intake increases (Figure 2.1b). The maximum score for the optimum 
component dairy was assigned if intake was within the given range. No consumption was scored with 
the minimum score of zero points. Intakes lower than the cut-off value were scored by dividing the 
reported intake by the lower cut-off value of the range and subsequently multiplying the obtained 
ratio by ten. Intakes between the higher cut-off value of the range and the threshold value were scored 
by dividing the difference between the intake and the cut-off value by the difference between the 
threshold value and the cut-off value. This ratio was subsequently multiplied by ten. The obtained 
score was subtracted from ten to ensure that the score decreases when intake increases. For intakes 
above the threshold value the minimum score of zero points was given (Figure 2.1c). Cut-off values 
and threshold values for the ratio components were set for the calculated ratios, instead of intakes. 
The maximum score of ten points was assigned if the ratio was higher than the cut-off value. The 
minimum score of zero points was assigned if the ratio was lower than the threshold value. Intakes 
between the cut-off and threshold value were calculated by diving the difference between the ratio 
and the threshold value by the difference between the cut-off and threshold value (Figure 2.1d). 
Statistical analysis 
All food, energy and nutrient intakes assessed by 24hR were averaged over two days before being used 
to score individual dietary intakes. DHD15-index scores reported in this paper are based on 24hR unless 
stated otherwise. Means across sex-specific quintiles of the DHD15-index score were tested using P 
for trend calculated with general linear models. Macro- and micronutrient intakes are reported with 
and without energy adjustment. Adjusted macronutrient intakes are presented as energy percentage 
(E%) and adjusted micronutrient intakes are presented as mean intakes per 4.2MJ.  
Concordance of ranking of participants with the DHD15-index scores based on 24hR data and FFQ data 
was studied by analysing correlations between the scores and cross-classification of quintiles. Partial 
correlation coefficients were calculated for the DHD15-index score and its components based on the 
24hR data and the FFQ data, adjusting for energy intake assessed by the 24hR. Pearson correlations 
were used for normally distributed variables and Spearman correlations for skewed variables. The 95% 
confidence intervals (95% CI) were calculated using Fisher’s Z-transformation. The Wilcoxon signed-
rank test was used to test differences between medians. Cross-classification and Kendall’s τ-b 
coefficient were used to assess agreement of participants’ ranking for the DHD15-index score based  
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Figure 2.1: Graphic presentation of scoring for the DHD15-index for the different type of components: 
adequacy component (A), moderation component (B), optimum component (D), and ratio component (D). 
 
on 24hR data and on FFQ data. All statistical analyses were performed using SAS 9.3 (SAS Institute Inc.) 
and a P value of <0.05 was considered statistically significant. 
 
Results 
Mean ± SD age of the population was 54.0±11.7 years and mean BMI was 25.9±4.0 kg/m2. Fifty-three 
percent of the population was men. Men were significantly older (56.4±10.8y) than women 
(51.4±12.1y) and their BMI was significantly higher (26.4±3.5 kg/m2) than that of the women (25.4±4.5 
kg/m2). More than 60% of the population completed a level of higher education and less than 10% of 
the population was current smoker, this did not differ between men and women. 
The mean ± SD DHD15-index score for the total population based on 24hR data was 73.7±16.9 points 
(Table 2.2). The total DHD15-index score was significantly higher for women than for men (mean 
difference of 10.7 points). The total DHD15-index score was normally distributed and ranged from 24.3 
to 126.2 points. The highest mean component score was that for the component red meat followed 
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by alcohol, whereas the lowest mean component score was observed for the component legumes 
followed by fish. Women had significantly higher (i.e. better) scores for the components vegetables, 
fruit, nuts, tea, red meat, processed meat, sweetened beverages and juices, alcohol and salt. Men 
scored significantly higher on the component wholegrain products. The DHD15-index score was 
positively correlated with the DHD-index based on the dietary guidelines of 2006 (ρ=0.62; p<0.001).  
BMI and smoking were inversely associated with the DHD15-index (Table 2.3). Age and supplement 
use were positively associated with the DHD15-index score, whereas education was not associated 
with the index score. Participants with a higher DHD15-index score had s lower energy intake. Of the 
macronutrients, animal protein, added sugar, total fat and saturated fat were inversely associated 
whereas dietary fibre and vegetable protein were positively associated with the DHD15-index score, 
and these trends remained significant after energy adjustment (p<0.05). For the micronutrients 
calcium, folate, iron, magnesium, potassium, vitamin B6 and vitamin C significant positive trends were 
observed across quintiles of the DHD15-score, both crude and after energy adjustment. Thiamine was 
inversely associated with the index score, but this association disappeared after energy adjustment. 
For the micronutrients riboflavin, vitamin A, vitamin B12, and vitamin E significant positive associations 
were observed for the energy adjusted intakes, but not for the unadjusted intakes.  
The mean DHD15-index score based on FFQ data was 15.5 points higher than based on 24hR data 
(p<0.001; Table 2.4; Supplemental Figure 2.1). The correlation between the DHD15-index scores based 
on 24hR and FFQ data was 0.58 (95% CI 0.53-0.62), also after energy adjustment (0.56, 95% CI 0.52-
0.61). The correlations between the component scores based on FFQ and 24hR data ranged between 
0.14 and 0.65. The lowest correlations were observed for the components legumes and red meat, 
while the highest correlations were seen for tea and alcohol. For most components mean component 
scores were higher based on FFQ data compared with 24hR data (p<0.001). Largest differences in mean 
component score were seen for legumes (5.0 point difference) and fish (3.8 point difference). Results 
from cross-classification showed that 78% was classified in the same or neighbouring quintile and only 
1% was classified in the opposite quintile, with Kendall’s τ-b coefficient of 0.41 (95% CI 0.36-0.45).  
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Table 2.2: Mean (SD) scores of the DHD15-index components in 885 Dutch men and women aged 20-75 
years*. 
 Total Men Women P-value between sex† 
DHD15-indexǂ 73.7 (16.9) 68.7 (16.1) 79.4 (16.0) <0.001 
Vegetables 6.2 (3.2) 5.9 (3.2) 6.6 (3.1)  0.001 
Fruit 6.2 (3.7) 5.8 (3.8) 6.7 (3.5) <0.001 
Wholegrain products 5.7 (2.7) 6.0 (2.5) 5.5 (2.8)  0.006 
Legumes 0.8 (2.6) 0.6 (2.4) 0.9 (2.9)  0.055 
Nuts 2.6 (3.9) 2.4 (3.9) 2.8 (3.9)  0.023 
Dairy 6.0 (3.2) 5.9 (3.2) 6.2 (3.3)  0.189 
Fish 2.2 (3.8) 2.4 (4.0) 2.0 (3.6)  0.447 
Tea 5.8 (4.0) 4.7 (4.0) 7.1 (3.7) <0.001 
Fats and oils 6.2 (4.5) 6.2 (4.5) 6.1 (4.5)  0.881 
Red meat 8.6 (3.0) 8.2 (3.3) 9.0 (2.6) <0.001 
Processed meat 4.3 (4.0) 3.4 (3.8) 5.3 (4.1) <0.001 
Sweetened beverages and 
fruit juices 5.8 (4.0) 5.4 (4.1) 6.2 (3.7)  0.007 
Alcohol 7.1 (4.0) 6.6 (4.0) 7.7 (3.9) <0.001 
Salt 6.2 (3.4) 5.3 (3.4) 7.3 (2.9) <0.001 
* Dietary intakes are based on average intake of two-24hR. 
† Independent t-test comparing men and women for total DHD15-index score and Mann-Whitney U test comparing men 
and women for the individual component scores. 
ǂ DHD15-index score ranging from zero to 140 points.  
 
The mean DHD15-index score based on FFQ was also significantly higher for women than men (mean 
difference 9.5 points). Significant differences between men and women in component scores based 
on FFQ were largely similar to the differences between men and women based on 24hR (Supplemental 
Table 2.1). Associations and trends observed across quintiles of DHD15-index score based on FFQ with 
participant characteristics, macronutrient intake and energy-adjusted micronutrients showed similar 
results to the results based on 24hR (Supplemental Table 2.2). The only exception was energy-adjusted 
vitamin B12 where a positive trend across quintiles of DHD15-index was observed based on 24hR data 
but not with FFQ data.  
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Table 2.3: Distribution of characteristics, macronutrient intake and selected micronutrient intakes (means 
(SD)) across sex-specific quintiles of the DHD15-index in 885 Dutch men and women*. 
 Sex-specific quintiles DHD15-index  
 Q1 
N=178 
Q2 
N=178 
Q3 
N=175 
Q4 
N=177 
Q5 
N=177 
P for 
trend 
Mean DHD15-index score 51.8 64.0 72.7 80.8 96.0  
Mean DHD-index score† 40.0 (8.9) 44.3 (9.2) 49.1 (9.1) 53.3 (9.6) 58.8 (8.7) <0.001 
Age (y) 51.4 (11.9) 52.8 (11.6) 54.4 (12.3) 55.7 (10.6) 55.9 (11.5) <0.001 
BMI (kg/m2) 26.7 (4.4) 26.3 (4.4) 25.9 (3.9) 25.8 (3.8) 25.0 (3.2) <0.001 
Supplements (%) 34.3  41.0  40.6  46.3  50.1  0.001 
Education (%)ǂ           0.346 
Low 7.3  5.1  9.8  5.1  3.4   
Middle 29.9  29.4  24.9  32.7  29.4   
High 63.7  65.5  65.3  62.2  67.2   
Smoking (%) 20.5  8.3  8.0  4.5  5.6  <0.001 
            
Macronutrient intake            
Energy intake (MJ/day) 9.3 (2.4) 8.9 (2.1) 8.8 (2.2) 8.7 (2.1) 8.6 (1.9) <0.001 
Protein intake (g/day) 84.8 (25.6) 81.9 (21.7) 81.3 (21.1) 83.6 (22.4) 81.1 (17.0) 0.281 
Protein intake (E%) 15.6 (3.1) 15.8 (2.7) 16.0 (3.1) 16.7 (3.0) 16.5 (2.9) <0.001 
Vegetable protein intake 
(g/day) 32.4 (11.1) 32.9  (10.3) 33.2 (10.8) 33.7  (10.6) 37.1  (11.2) <0.001 
Animal protein intake (g/day) 52.2 (21.5) 49.0 (18.3) 48.0 (17.1) 50.0  (19.6) 44.1 (14.3) <0.001 
Carbohydrate intake (g/day) 236 (70) 225 (66) 224 (62) 225 (63) 222 (58) 0.077 
Carbohydrate intake (E%) 43.3 (7.3) 43.2 (7.1) 43.8 (7.0) 44.6 (6.8) 44.4 (6.5) 0.035 
Added sugar (g/day)  53.3 (31.0) 47.2 (26.9) 47.0  (28.1) 43.2 (27.6) 37.7 (23.0) <0.001 
Fibre (g/day) 19.8 (6.6) 21.4 (6.9) 22.5 (6.7) 24.4 (6.9) 27.0 (7.7) <0.001 
Total fat intake (g/day) 86.6 (26.8) 82.4 (24.7) 80.7 (26.5) 78.0 (25.8) 77.7 (23.7) <0.001 
Total fat intake (E%) 33.9 (5.4) 33.9 (5.3) 33.4 (5.8) 32.8 (5.7) 33.1 (5.8) 0.042 
Saturated fat intake (g/day) 32.9 (10.7) 30.6 (10.5) 30.0 (10.8) 28.5 (10.4) 26.4 (9.0) <0.001 
Saturated fat intake (E%) 13.1 (3.0) 12.7 (3.0) 12.6 (2.9) 12.2 (3.0) 11.3 (2.7) <0.001 
            
Micronutrient intake per 4.2 
MJ (day)            
Calcium (mg)  435 (144) 456 (141) 505 (163) 529 (174) 538 (147) <0.001 
Folate (mcg)  115 (38) 130 (42) 143 (59) 152 (50) 169 (51) <0.001 
Iron (mg)  5.1 (1.1) 5.2 (1.0) 5.5 (1.4) 5.6 (1.2) 5.9 (1.4) <0.001 
Magnesium (mg)  152 (31) 166 (25) 174 (35) 186 (33) 197 (36) <0.001 
Potassium (mg)  1473 (294) 1568 (269) 1641 (389) 1731 (344) 1779 (329) <0.001 
Riboflavin (mg) 0.67 (0.22) 0.68 (0.19) 0.71 (0.22) 0.76 (0.24) 0.74 (0.19) <0.001 
Thiamine (mg)  0.48 (0.19) 0.48 (0.15) 0.47 (0.14) 0.48 (0.14) 0.48 (0.13) 0.957 
Vitamin A (RE) 455 (380) 446 (338) 450 (297) 495 (323) 534 (496) 0.019 
Vitamin B6 (mcg) 697 (377) 755 (318) 763 (354) 854 (367) 882 (367) <0.001 
Vitamin B12 (mcg)  2.3 (1.9) 2.1 (1.3) 2.2 (2.1) 2.6 (2.0) 2.5 (1.5) 0.030 
Vitamin C (mg)  42 (27) 44 (28) 48 (31) 53 (31) 56 (32) <0.001 
Vitamin E (mg) 5.8 (2.5) 6.1 (2.3) 6.1 (2.0) 6.2 (2.0) 6.8 (2.5) <0.001 
RE, retinol equivalents 
* Dietary intakes are based on average intake of two-24hR. 
† Dutch Healthy Diet (index) score based on 8 components without components physical activity and acidic foods and 
drinks, with a total score ranging from zero (no adherence to Dutch dietary guidelines 2006) to 80 (maximum adherence).  
ǂ Low education=primary school, vocational and lower general secondary education. Moderate=higher secondary 
education and intermediate vocational training. High=higher vocational education and university. 
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Table 2.4: Mean (SD) of the DHD15-index and its component scores based on two 24hR and on a FFQ in 885 
Dutch men and women and partial correlation scores (95%CI) between the two scores. 
 24hR  FFQ   
 Mean (SD)  Mean (SD) Correlation* 95% CI 
DHD15-index† 73.7 (16.9)  89.2 (15.4) 0.56 0.52, 0.61 
1.Vegetables 6.2 (3.2)  6.8 (2.7) 0.33 0.27, 0.39 
2.Fruit 6.2 (3.7)  7.1 (3.4) 0.55 0.50, 0.59 
3.Wholegrain products 5.7 (2.7)  5.8 (2.0) 0.32 0.26, 0.38 
4.Legumes 0.8 (2.6)  5.8 (4.5) 0.14 0.07, 0.20 
5.Nuts 2.6 (3.9)  3.9 (3.6) 0.32 0.26, 0.37 
6.Dairy 6.0 (3.2)  6.5 (3.1) 0.29 0.23, 0.35 
7.Fish 2.2 (3.8)  6.1 (3.1) 0.26 0.19, 0.32 
8.Tea 5.8 (4.0)  3.6 (3.5) 0.65 0.61, 0.69 
9.Fats and oils 6.2 (4.5)  6.8 (4.0) 0.33 0.27, 0.39 
10.Red meat 8.6 (3.0)  9.1 (2.1) 0.16 0.10, 0.23 
11.Processed meat 4.3 (4.0)  6.0 (3.2) 0.40 0.34, 0.45 
12.Sweetened beverages 
and fruit juices 
5.8 (4.0) 
 
6.4 (3.4) 0.51 0.46, 0.56 
13.Alcohol 7.1 (4.0)  7.7 (3.6) 0.60 0.56, 0.64 
14.Sodium 6.2 (3.4)  7.9 (2.7) 0.21 0.14, 0.27 
* Adjusted for energy intake as assessed by 24hR. 
† DHD15-index score ranging from zero to 140 points. 
Only total DHD15 score was normally distributed (Pearson correlation) 
 
Discussion 
The DHD15-index score assesses adherence to the Dutch dietary guidelines 2015 and is able to rank 
participants according to their adherence as was reflected by the variation in scores of the individual 
components of the index and the normally distributed total score. The index was positively associated 
with age, supplement use, fibre intake, and nutrient density and inversely associated with BMI, energy, 
total and saturated fat intake. The most pronounced differences in the score based on FFQ compared 
with 24hR data were found in the components reflecting episodically consumed foods such as fish, but 
associations of the DHD15-index with participants’ characteristics and nutrient intakes were similar for 
the scores based on 24hR and on FFQ data.  
The DHD15-index score was developed as an update of the previously developed DHD-index reflecting 
adherence to the Dutch dietary guidelines of 2006. Therefore we kept the design aspects of this 
updated score similar to the DHD-index: the different components reflected the guidelines as close as 
possible, for each component a minimum score of zero and a maximum score of ten points could be 
allotted, and intakes between the minimum and maximum were scored proportionally. Contrary to 
the dietary guidelines of 2006, the guidelines of 2015 are formulated in terms of foods [10]. Only foods 
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and food groups with sufficient scientific evidence for an effect on chronic diseases were included in 
the dietary guidelines. A consequence of this approach is that the dietary guidelines do not cover the 
complete dietary intake and recommended intakes in the guidelines apply to the general population. 
However, subgroups might benefit from a higher or lower intake of a food group to meet specific 
nutrient recommendations. For example, vegetarians might benefit from a higher legume or nut intake 
to meet recommended protein intake. This applies to indices based on both foods and nutrients as 
well such as the Healthy Eating Index-2010. It should also be noted that within food-groups there is 
still room for discussion whether all foods within that food group should be included. For example, for 
dairy it could be argued that only low-fat dairy should be included as some studies show more 
favourable health effects for low-fat dairy compared to total dairy [23, 24]. However, as the evidence 
is ambiguous and the debate is still ongoing, the Health Council of the Netherlands decided to set the 
guideline for total dairy [9] and we stayed as close as possible to the guidelines.  
To quantify the guidelines additional information from additional documents from the Health Council 
of the Netherlands (background documents) [18-21] and interpretation by experts was sometimes 
necessary. The evidence regarding intake levels at which adverse health effects occur, as described in 
the background documents, was used to set threshold values (i.e. the intake that deserves zero points). 
This could be done for the moderation components red meat, processed meat, sweetened beverages 
and fruit juices, and alcohol. For example, according to the background document an intake of 250g 
sweetened beverages and fruit juices a day is associated with an increased risk of weight gain and 
therefore the threshold value for this component was set at 250g/day. For alcohol, adverse health 
effects associated with alcohol intake occur at different intake levels for men and women, therefore 
we set a different threshold values for men and women. For the components salt and the ratio 
components wholegrain products and fats and oils there was not enough information to set an 
evidence-based threshold value. For those components the threshold value was based on the 85th 
percentile of the intake distribution based on two day averages of the Dutch reference population [17]. 
This was also done for the DHD-index and is comparable to other indices such as the Healthy Eating 
Index-2010 [25]. For the ratio components the cut-off value was based on the 15th percentile of this 
intake distribution as there was no information on the ratio that deserves the maximum score. We 
used the information regarding standard portion sizes of the Netherlands Nutrition Centre [16] for the 
components legumes, dairy, fish, tea and red meat, as the guidelines do not specify the recommended 
intake or only in number of servings.  
The DHD15-index score based on 24hR data showed a moderate correlation (0.56, 95% CI 0.52-0.61) 
with the DHD15-index score based on FFQ data and is comparable with the correlation found for the 
initial DHD-index (0.48, 95% CI 0.33-0.61) [1]. Ranking of participants showed moderate agreement as 
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shown by Kendall’s τ-b coefficient and fairly good concordance as 78% was ranked in the same or 
neighbouring quintile and only 1 percent in the opposite quintile. The cut-off and threshold values for 
the scores are absolute levels of intakes. We assume that a 24hR is more suitable to estimate dietary 
intakes on a group level as the used FFQ is designed to cover at least 90% of energy intake, but not 
able to capture 100% of the total intake [14]. However, several components are episodically consumed 
foods including fish, legumes and nuts. Using two-day averages of the 24hR can result in excess zeros 
and maximum scores, whereas an FFQ is better able to assess usual intakes of these episodically 
consumed foods because it assesses foods eaten during a longer period of time. This could be one 
explanation for the low correlations seen for these components when comparing the component score 
based on 24hR and FFQ data. Other reasons for the low correlations between the scores based on the 
two methods are the biases inherent to the 24hR (e.g. high day-to-day variability) and FFQ (e.g. 
aggregation of food items, standard portion sizes) [26]. Surprisingly, also red meat showed a very low 
correlation, and appeared to be an episodically consumed food in this health conscious population. 
Mean intakes were substantially lower than the intake of the Dutch reference population, which could 
not be explained by a difference in number of non-consumers. A possible alternative to better estimate 
these episodically consumed foods would be using 24hR with an additional short propensity 
questionnaire as also advised for surveillance [27]. Additionally, the FFQ used in the present study was 
not able to distinguish between unsalted and salted nuts, and between types of tea, whereas the 24hR 
is able to make these distinctions. Both methods were not able to distinguish between types of coffee 
(filtered vs. unfiltered). In future studies, an adapted FFQ able to distinguish between types of nuts, 
tea and coffee as well as an adapted 24hR to assess type of coffee should be used.  
Other limitations of the used dietary assessment methods should also be considered. Firstly, for both 
the 24hR and the FFQ it is known that estimates for salt intake are biased and usually underestimated 
because information on salt added during cooking and at the dinner table is lacking. By reducing the 
cut-off level with 20% we tried to adjust for this, but realize this decreases variation between people 
and thus results on the sodium component should be interpreted with caution. Ideally, sodium intake 
is estimated based on 24-hour urinary nitrogen, which is considered the gold standard for estimating 
sodium intake [28]. Secondly, for alcohol intake it was not possible to assess binge drinking with only 
two 24hR and the used FFQ. Finally, a difficulty arises in the handling of mixed foods (i.e. foods 
consisting of several (types of) ingredients). These mixed foods were broken down into their 
ingredients as coded by the Dutch Food Composition Table [13] and the individual ingredients were 
used in the calculation of the food intakes. However, some foods in the Dutch Food Composition Table 
still consist of several different ingredients from different food groups. For these mixed foods, we 
included the food if more than half of the weight of the mixed food consisted of a food group of one 
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of the components. For example, vegetables on pizza (component vegetables), sausage roll (processed 
meat) and pea soup (legumes) are not included in calculation of food intake, but porridge is (≥50% 
dairy). 
The DHD15-index score presented in this study was designed to capture the dietary pattern of the 
general Dutch population. The components of the DHD15-index are familiar components of Western 
dietary patterns and similar to components of several well-known and much used indices such as the 
Healthy Eating Index-2010 (vegetables, fruit, grains, dairy, alcohol, salt, fats and oils, and the 
components meat, fish, nuts and legumes in the protein foods) [25] and the Mediterranean Diet Score 
(vegetables, fruits, legumes, cereals, dairy, meat, alcohol, and fats and oils) [29]. However, it might be 
that for ethnic minorities with non-Dutch eating habits the score is limited in its use [30]. Furthermore, 
we evaluated the DHD15-index score in a population that might not be representative of the general 
Dutch population, as participants had in general a high level of education. Also, the high proportion of 
supplement users could indicate that this population is health conscious. Therefore, we used the intake 
distribution of the Dutch reference population [17] for the intake-based threshold values in the 
development of the score instead of the intake distribution of our study population. This also has the 
advantage that results of future studies can be compared as the same threshold values are used. 
Evaluation of indices is necessary to establish whether an index is suitable for further use. In this study, 
several types of evaluation were carried out. First of all, we examined the relationship between the 
DHD15-index with nutrient intakes and observed positive trends between the DHD15-index score and 
energy-adjusted micronutrient intakes. This indicates that participants with higher DHD15-index 
scores have a more nutrient dense diet. We also observed an inverse association with total energy 
intake, total fat intake and saturated fat intake, and a positive relationship with fibre intake, also 
suggesting that a higher DHD15-index score indicates a healthier diet. Secondly, construct validity was 
examined by assessing the relationship between the DHD15-index score and participants’ 
characteristics such as age, educational level and supplement use. Although the trend observed was 
not significant, the proportion of highly educated participants increased with higher DHD15-index 
scores whereas the proportion of lower educated participants decreased. Additionally, the supplement 
users, older participants, and participants with a lower BMI had higher DHD15-index scores. Also, the 
variation in total score and the individual component scores indicate discriminative power of the 
DHD15-index. Lastly, comparability of the index based on different dietary assessment instruments 
was satisfactory. In addition, we saw an acceptable correlation between the DHD15-index score and 
the previously validated DHD-index score based on the 2006 guidelines. Based on these observations 
we think that the DHD15-index is a good measure of diet quality. Further evaluation steps include 
assessing the relationship between the DHD15-index and chronic diseases and mortality and its ability 
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to monitor trends in dietary intake over time. As energy intake and BMI are inversely associated with 
the DHD15-index score, energy adjustment should be considered when studying diet-disease 
associations, to be able to distinguish between effects from energy intake and the effects of diet quality 
as reflected by the DHD15-index score. 
 
Conclusions 
The DHD15-index score assesses adherence to the Dutch dietary guidelines of 2015 and is an indicator 
of diet quality as it is positively associated with nutrient density. Both 24hR and FFQ data can be used 
to assess the DHD15-index score resulting in some differences in individual components but an 
acceptable correlation between the total scores. In future research, the DHD15-index score can be 
used to study associations between diet quality and chronic diseases. 
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Supplementary material  
Supplemental Figure 2.1: Histogram of the mean Dutch Healthy Diet 2015 (DHD15) index score based on 2 
24hR and based on FFQ data in 885 Dutch men and women. Mean (SD) DHD15-index score based on 2 24hR 
was 73.7 (16.9) points and mean (SD) score based on FFQ data was 89.2 (15.4) points. 
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Supplemental Table 2.1: Mean (SD) scores of the DHD15-index components based on FFQ data in 885 Dutch 
men and women aged 20-75 years. 
 Total Men Women P-value between sex* 
DHD15-index† 89.2 (15.4) 84.8 (15.4) 94.3 (13.8) <0.001 
1. Vegetables 6.8 (2.7) 6.4 (2.7) 7.2 (2.6) <0.001 
2. Fruit 7.1 (3.4) 6.6 (3.6) 7.7 (3.2) <0.001 
3. Wholegrain products 5.8 (2.0) 5.8 (2.0) 5.7 (2.0)  0.463 
4. Legumes 5.8 (4.5) 6.0 (4.5) 5.5 (4.4)  0.046 
5. Nuts 3.9 (3.6) 3.7 (3.6) 4.1 (3.7)  0.083 
6. Dairy 6.5 (3.1) 6.3 (3.1) 6.6 (3.0)  0.097 
7. Fish 6.1 (3.1) 6.2 (3.0) 5.9 (3.2)  0.107 
8. Tea 3.6 (3.5) 2.8 (3.2) 4.4 (3.7) <0.001 
9. Fats and oils 6.8 (4.0) 6.9 (4.0) 6.8 (4.0)  0.843 
10. Red meat 9.1 (2.1) 8.8 (2.3) 9.4 (1.7) <0.001 
11. Processed meat 6.0 (3.2) 5.1 (3.3) 6.9 (2.7) <0.001 
12. Sweetened beverages 
and fruit juices 6.4 (3.4) 5.9 (3.4) 7.0 (3.2)  <0.001 
13. Alcohol 7.7 (3.6) 7.1 (3.7) 8.4 (3.3) <0.001 
14. Salt 7.9 (2.7) 7.1 (3.0) 8.7 (2.0) <0.001 
* Independent t-test comparing men and women for total DHD15-index score and Mann-Whitney U test comparing men  
and women for the individual component scores. 
† DHD15-index score ranging from zero to 140 points. 
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Supplement Table 2.2: Distribution of characteristics, macronutrient intake and selected micronutrient intakes 
(means (SD)) across sex-specific quintiles of the DHD15-index based on FFQ data in 885 Dutch men and 
women. 
 Sex-specific quintiles DHD15-index based on FFQ data  
 Q1 
N=178 
Q2 
N=176 
Q3 
N=178 
Q4 
N=177 
Q5 
N=176 
P for 
trend 
DHD15-index score* 68.8 81.2 89.6 97.0 109.7  
Mean DHD-index score† 50.3 (9.1) 53.1 (10.7) 56.0 (9.4) 58.4 (9.4) 61.2 (8.7) <0.001 
Age (y) 50.5 (12.6) 52.8 (12.6) 55.9 (10.7) 55.0 (10.8) 56.0 (10.7) <0.001 
BMI (kg/m2) 26.4 (4.3) 26.3 (4.7) 25.9 (3.8) 25.8 (3.7) 25.1 (3.3) <0.001 
Supplements (%) 34.3  44.9  36.0  44.1  54.0  0.001 
Education (%)ǂ            
Low 8.0  9.0  5.7  4.6  3.4  0.070 
Middle 30.1  27.8  30.0  27.8  30.7   
High 61.9  63.1  64.4  67.6  65.9   
Smoking (%) 16.9  8.5  9.6  8.5  3.3  <0.001 
            
Macronutrient intake            
Energy intake (MJ/day) 9.1 (3.1) 8.9 (2.7) 8.5 (2.3) 8.4 (2.2) 8.4 (1.9) 0.001 
Protein intake (g/day) 76.5 (22.4) 77.6 (22.4) 73.8 (18.4) 73.0 (17.2) 75.1 (16.2) 0.116 
Protein intake (E%) 14.6 (2.8) 15.2 (2.4) 15.0 (2.4) 15.0 (2.2) 15.3 (2.1) 0.028 
Vegetable protein intake 
(g/day) 32.3 (11.7) 33.6 (11.0) 33.0 (11.0) 35.7 (10.9) 37.9 (10.7) <0.001 
Animal protein intake (g/day) 44.3 (15.2) 44.0 (15.3) 40.9 (13.1) 37.5 (11.7) 37.3 (11.5) <0.001 
Carbohydrate intake (g/day) 228 (86) 224 (74) 218 (67) 220 (65) 223 (54) 0.367 
Carbohydrate intake (E%) 42.6 (6.5) 42.9 (5.9) 43.4 (6.0) 44.4 (5.5) 45.1 (5.1) <0.001 
Mono-and disaccharides 
(g/day) 97 (43) 96 (38) 98 (35) 96 (29) 100 (26) 0.649 
Fibre (g/day) 21.0 (7.5) 22.7 (7.0) 23.4 (6.5) 25.8 (7.1) 27.8 (6.9) <0.001 
Total fat intake (g/day) 89.4 (36.4) 86.5 (30.2) 79.4 (26.1) 78.6 (26.8) 78.0 (23.9) <0.001 
Total fat intake (E%) 35.8 (5.8) 35.8 (5.3) 34.4 (5.2) 34.2 (5.5) 34.0 (5.0) <0.001 
Saturated fat intake (g/day) 32.3 (13.4) 30.7 (11.9) 27.4 (9.7) 26.6 (9.8) 24.6 (9.2) <0.001 
Saturated fat intake (E%) 13.0 (2.8) 12.7 (2.7) 11.8 (2.1) 11.5 (2.5) 10.7 (2.3) <0.001 
            
Micronutrient intake per 4.2 
MJ (day)            
Calcium (mg)  435 (149) 467 (140) 487 (134) 487 (128) 500 (127) <0.001 
Folate (mcg)  114 (35) 128 (39) 139 (44) 151 (43) 165 (52) <0.001 
Potassium (mg)  1516 (280) 1594 (286) 1699 (316) 1706 (309) 1753 (293) <0.001 
Riboflavin (mg) 0.68 (0.19) 0.72 (0.18) 0.75 (0.20) 0.73 (0.16) 0.74 (0.18) 0.002 
Thiamine (mg)  0.49 (0.10) 0.50 (0.11) 0.50 (0.10) 0.51 (0.1) 0.50 (0.09) 0.052 
Vitamin A (RE) 604 (360) 680 (444) 636 (349) 714 (401) 717 (361) 0.005 
Vitamin B6 (mcg) 751 (17) 764 (16) 800 (17) 820 (17) 853 (17) <0.001 
Vitamin B12 (mcg)  2.1 (1.0) 2.3 (1.2) 2.2 (0.9) 2.0 (0.8) 2.1 (0.9) 0.398 
Vitamin C (mg)  35 (16) 40 (21) 46 (21) 49 (23) 51 (21) <0.001 
Vitamin E (mg) 5.8 (1.4) 6.1 (1.3) 6.6 (1.7) 6.6 (1.5) 7.0 (1.6) <0.001 
RE, retinol equivalents 
* DHD15-index score ranging from zero to 140 points. 
† Dutch Healthy Diet (index) score based on 8 components without components physical activity and acidic foods and 
drinks, with a total score ranging from zero (no adherence to Dutch dietary guidelines 2006) to 80 (maximum adherence).  
ǂ low education=primary school, vocational and lower general secondary education. Moderate=higher secondary 
education and intermediate vocational training. High=higher vocational education and university. 
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Abstract 
Background: Measurement error in dietary intake estimates leads to biased estimates of diet-disease 
associations. Statistical methods can partly correct the bias when at least one other superior 
measurement is available. Combining data from 24-hour recalls (24hR) and food frequency 
questionnaires (FFQ) using enhanced regression calibration (ERC) could result in unbiased association 
estimates.  
Objective: To illustrate the impact of combining 24hR and FFQ estimates using regression calibration 
(RC) and ERC on diet-disease associations.  
Methods: For 236 subjects of the NQplus study, two 24hR, a FFQ and urinary biomarkers for protein 
and potassium were collected. Five approaches for obtaining self-reported dietary intake estimates 
were compared: 1) uncorrected FFQ intakes (FFQ), 2) uncorrected average of two 24hR (R�), 3) average 
of FFQ and R� (F�R�), 4) RC from regressing 24hR on FFQ, and 5) ERC by adding individual random effects 
to the RC approach. Empirical attenuation factors (AF) were derived by regressing biomarker 
measurements on the resulting intake estimates. The AFs were compared using bootstrap (1000 
replicates).  
Results: Both FFQ and 24hR dietary intake estimates were measured with substantial error and large 
underestimation was present for protein (FFQ 22.7%, R� 14.7%) and potassium (FFQ 12.5%, R� 10.2%). 
Using statistical techniques to correct for measurement error (i.e. RC and ERC) reduced bias in diet-
disease associations as indicated by their AF approaching 1 (RC 1.14, ERC 0.95 for protein; RC 1.28, ERC 
1.34 for potassium). The SD of the corrected intake estimates obtained with ERC was larger, and AF 
95%CI intervals were narrower for ERC compared to RC, indicating that using ERC has more power that 
using RC. However, the difference in AFs between RC and ERC was not statistically significant, 
indicating no significantly better deattenuation by using ERC compared to RC. AFs larger than 1, 
observed for the ERC for potassium, indicate possible overcorrection.  
Conclusion: Our study highlights the potential of combining FFQ and 24hR data. Using RC and ERC 
resulted in less biased associations for protein and potassium. In future studies, preferably both FFQ 
and 24hR data are collected for the entire study population. 
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Introduction 
Despite efforts to develop innovative ways to estimate dietary intake using new emerging 
technologies, nutrition research and especially large epidemiological studies still rely heavily on 
traditional dietary assessment tools such as the food frequency questionnaire (FFQ), 24-hour recalls 
(24hR) and dietary records. These methods all have their strengths and limitations [1]. The FFQ is, for 
example, relatively cheap and easy to administer, but relies on memory and can lead to social desirable 
answers, while a limited set of aggregated food items leads to loss of precision, and portion sizes are 
difficult to assess accurately. The 24hR and dietary records assess all foods consumed on a single day, 
but also rely on memory, can lead to social desirable answers and dietary records can influence actual 
intake due to reactivity. Furthermore, multiple recalls and records are necessary to capture individual 
habitual intake. Altogether, dietary intake estimates assessed with the FFQ, 24hR or dietary records 
are known to be biased due to random and systematic measurement error [2, 3].  
Measurement error leads to bias, usually attenuation of estimated diet-health associations, loss of 
precision of estimated associations and loss of power to detect diet-health associations [4]. Statistical 
methods can partly correct the bias in diet-health associations introduced by measurement errors. To 
do so, such methods rely on intake estimates from a second (superior) assessment method, i.e. a 
reference method [1]. The reference method is allowed to have random error, but should be unbiased, 
that is, free of systematic error. Regression calibration is the most well-known method, in which dietary 
intake estimates obtained with a reference instrument are regressed on dietary intake estimates 
obtained with the main method to correct diet-health associations [5, 6]. Regression calibration is 
relatively intuitive and simple to use and is applicable in many situations, such as linear and logistic 
regression and survival analysis. 
The 24hR is often used as reference instrument because objective and unbiased biomarkers of intake 
are only available for a limited number of nutrients and very costly to collect. Since the development 
of web-based 24hR and dietary records [7] it is less burdensome for researchers and cheaper to obtain 
recalls or records from (a subsample of) a study population. Therefore, regression calibration can be 
used more often to correct for measurement error. With regression calibration equations are obtained 
that will give predicted dietary intake estimates based on reported intake estimates from the main 
instrument. However, the calibrated values from the prediction equations only incorporate individual 
variations that are assessed with the main method, while individual information from the 24hR 
measurement is lost. This is unavoidable when 24hR measurements are only present for a subsample. 
However, when both the main method (usually FFQ) and the reference instrument (usually 24hR or 
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dietary records) are used in the entire study population, this implies unnecessary loss of information. 
Dietary intake estimates obtained from both methods can be combined to obtain better estimates [8].  
The aim of the current study is to demonstrate the impact of combining FFQ and 24hR estimates by 
using standard RC and by using a relative simple extension of RC using all available information, i.e. 
enhanced regression calibration (ERC), on resulting diet-disease associations. We will compare protein 
and potassium intake estimates from RC and ERC with more naive approaches, namely using only the 
24hR as measured, only the FFQ as measured and from averaging 24hR and FFQ. In this study, the FFQ 
is used as the main instrument and the average of two telephone administered 24hR are considered 
as the superior reference instrument. The extent of the measurement error in the resulting diet-
disease associations is assessed for each of the five approaches by calculating the association between 
the intake estimate and a truly unbiased intake measurement obtained with urinary recovery 
biomarkers for protein and potassium (i.e. attenuation factors (AF)). With perfect adjustment, this 
association (or AF) would be 1.  
 
Methods 
Study population 
For the current analyses, data from the NQplus study collected within the National Dietary Assessment 
Reference Database (NDARD) was used [9]. Briefly, a total of 2,048 men and women were included 
between May 2011 and February 2013. They were aged between 20 and 70 years and randomly 
selected inhabitants of the cities Wageningen, Renkum, Ede, Arnhem, and Veenendaal which are 
located in the central part of the Netherlands. All participants gave written informed consent before 
the start of the study. The NQplus study was approved by the medical ethical committee of 
Wageningen University, and was conducted according to the guidelines of the declaration of Helsinki.  
Baseline measurements consisted of, among others, a physical examination, dietary assessment with 
multiple telephone administered 24hR and an FFQ, and a 24-hour urine collection. For this study, we 
selected participants with data of two 24hR, a baseline FFQ and biomarker data of protein and 
potassium (n=236). Twenty-four hour urines were collected in the first year of the study (on average 5 
months (interquartile range (IQR) 3-6 months) after the start of the study). The FFQ was administered 
on average 7.5 months after the start of the study (IQR 5-10 months). The first 24hR was administered 
on average 7.8 months after the start of the study (IQR 4-16 months); whereas the second recall was 
administered on average after 15 months (IQR 10-20 months). Recalls of the same participant were at 
least one month apart. An overview of the timeframe of the different assessments is presented in 
Figure 3.1.  
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Figure 3.1: Schematic overview of the timeframe of the different dietary assessments and urine collection. The 
black line represents the median, the grey box represents the interquartile range (p25-p75) and the error bars 
the minimum and maximum.  
 
Dietary assessment 
24hR 
Trained dieticians of the Division of Human Nutrition of Wageningen University made an unannounced 
phone call to the participant. They asked about foods and drinks consumed the previous day according 
to a standardized protocol based on the five-step multiple-pass method [10]. Energy and nutrient 
intakes were estimated using the 2011 Dutch food composition table [11]. For various outcomes 
(energy, nutrients, and foods) the highest and lowest ten values were checked for errors, such as errors 
in coding number or amounts (e.g. 150 cups instead of 150g of milk).  
FFQ 
A 180-item semi–quantitative FFQ was self-administered using the open-source online survey tool 
LimesurveyTM (LimeSurvey project team/Carsten Schmitz, Hamburg, Germany, 2012). The FFQ has 
been previously evaluated for energy intake, macronutrients, dietary fibre and selected vitamins [12, 
13]. Portion sizes were estimated using natural portions (bread shapes) and commonly used household 
measures (e.g. spoon and cup). The reference period for reporting was the past month. Average daily 
nutrient intakes were calculated by multiplying frequency of consumption by portion size and nutrient 
content per gram using the 2011 Dutch food composition table [11]. 
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Biomarker assessment 
Participants received verbal and written instructions for the 24 hour urine collection. The urine 
collection started after discarding the first voiding on the morning of the collection day and ended 
after the first voiding on the morning of the next day. To check for completeness of the urine collection, 
participants were instructed to ingest a tablet containing 80mg para-amino benzoic acid (PABA) during 
breakfast, lunch and dinner on the day of the collection. Possible deviations from the protocol (e.g. 
missing urine) were registered by the participant. The urine collections were mixed, weighted, 
aliquoted and stored at -20°C until further analysis at the study centre.  
The nitrogen content of the urine was assessed with the Kjeldahl technique [14]. The amount of protein 
was calculated using a nitrogen to protein conversion factor of 6.25 [15] and an average ratio of urinary 
nitrogen excretion to dietary nitrogen of 0.81 [16] was assumed. Potassium in urine were determined 
with an ion-selective electrode and potassium intake was calculated taking into account 19 % 
potassium [17] extra-renal and faecal losses. PABA in urine was assessed by the HPLC method. 
Incomplete urines, based on the cut-off value of 78% PABA recovery [18], were excluded from the 
analysis (n=16).  
Combining FFQ and 24hrecalls 
Measurement error model 
A diet-disease model is usually structured in the following way:  
E (Y|T) = β0 + β1T 
with disease Y related to dietary exposure of interest T through a generalized linear model. E denotes 
the expectation of developing disease Y given consumption of T.  
However, as stated previously, dietary exposures are rarely measured without measurement error. 
Therefore, the true value of T cannot be measured. Instead, we use the following calibration model to 
express the expected dietary exposure measured with measurement instrument Q: 
E (T|Q) = ϑ0 + ϑ1Q  
Where ϑ0 and ϑ1 represent the systematic errors.  
If we replace T with E(T|Q) in our diet-disease model we obtain: 
E (Y|Q) = β0 + β1(E(T|Q)) = β0 + β1( ϑ0 + ϑ1Q) 
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To be able to detect the association between the dietary exposure of interest and the disease, the 
expected value of T needs to be as close to the true intake as possible. Otherwise, the added error 
from measurement error will reduce the correlation between Y and Q, and thus the power to detect 
an association. 
Approaches to combine FFQ and 24hR 
In this study, we used the FFQ as main instrument and the average of two 24hR as reference 
instrument. We assumed that the 24hR provides unbiased estimates of usual intake and contains only 
random within-person error. We present five approaches to obtain intake estimates for use in diet-
disease associations (Table 3.1). First, we used the uncalibrated FFQ estimates (FFQ). For the second 
approach the mean of two 24hR (R�) is used. The third approach is simply the average of the FFQ and R� 
(F�R�). Fourth is a regression calibration (RC) of regression the average value of both 24hR measurements 
per person on FFQ, resulting in E(R|Q). When R is unbiased, this is equal to E(T|Q). The fifth and last 
approach is the enhanced regression calibration (ERC). ERC is an extension of RC in which the individual 
random effect is included in the regression calibration equation [19]. While RC can be used if intake 
data from a second method are available for a subsample of the population, ERC needs data from two 
methods for all subjects in a population. The following formula is used for the ERC: 
E (T|R1, R2, Q)= w x R� + (1-w) x E (T|Q) 
Where R� is the average of two 24hR, E(T|Q) is set equal to E(R|Q), assuming that R is unbiased, and w 
is var(u)/ (var(u)+var(e)/2), where var(u) is between person-variance in 24hR and var(e) is within-
person variance in 24hR.  
Proc Reg was used to obtain RC estimates and Proc Mixed was used to obtain estimates for ERC. The 
SAS syntax is given in Supplemental file 3.1. 
 
 
 
Table 3.1: Overview of the five approaches used in the current study 
1) FFQ Uncorrected FFQ estimate 
2) R�  Uncorrected average of two 24hR estimates 
3) F�R� Average of 1) uncorrected FFQ estimate and 2) uncorrected average of two 24hR estimates 
4) RC  Predicted intake estimate based on regression of the average of two 24hR estimates on FFQ 
5) ERC Predicted intake estimate based on a mixed model predicting 24hR from FFQ, including the individual 
random effect estimate 
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Statistical analyses 
Descriptive statistics were presented in percentages and as means with their standard deviation. The 
percentage bias was calculated by dividing the difference between the intake assessed by one of the 
approaches and the intake as estimated from the biomarker, divided by the intake from the biomarker. 
A linear regression model was used to calculate empirical AFs with the biomarker regressed on the 
intake estimate obtained by each approach. The attenuation factor provides information on the extent 
to which diet-disease associations are affected by measurement error. Regressing a recovery 
biomarker on a perfect intake estimate, that is, an estimate that should deliver an unbiased estimate 
of association, should result in a regression coefficient (i.e. AF) of 1. An AF lower than 1 indicates 
attenuation of the diet-disease association due to measurement error, with a larger deviation from 1 
indicating more attenuation. To test whether empirical AFs of the different approaches differed 
statistically significantly from each other, we used a bootstrap approach (1000 replicates). To correct 
for multiple testing, we used the Bonferroni correction and thus considered a p-value <0.01 statistically 
significant for the comparison of the AFs between the five approaches. Finally, we used the empirical 
AFs to illustrate the impact of measurement error in estimates from the five approaches using an 
example diet-disease association with an assumed true relative risk (RR) of 2.0. The observed RR for 
each approach was calculated with the following formula: RRtrue = (RRobserved)1/AF. Rewriting the formula 
gives: RRobserved = (RRtrue)AF. All statistical tests were performed using SAS 9.3 (SAS institute Inc. Cary, 
NC, USA). 
 
Results 
At baseline, participants (n=236; 89 men and 147 women) were on average 54.0 (SD 10.9) years old, 
had a mean body mass index of 25.4 (SD 4.0) kg/m2 and 68.5% was classified as highly educated 
(university or college degree).  
The mean intakes estimated using the RC and ERC approaches were similar to R�, as this is the reference 
method used. (Table 3.2). The SD of the ERC was larger compared to that of RC due to the inclusion of 
the random effect in the estimation, thus theoretically increasing power to detect an association with 
disease or other outcome. However, the SD was still considerably smaller than the SD of the R� and 
biomarker, which are high due to random day-to-day error.  
Both the FFQ and R� underestimated protein and potassium intake compared to their respective urinary 
biomarkers (Table 3.2), with FFQ showing the largest underestimation. Protein intake was 
underestimated by 22.7% when using FFQ estimates and 14.7% when using R� estimates as compared 
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to protein intake based on urinary nitrogen. Averaging FFQ and 24hR (F�R�) resulted in an average 
underestimation of 18.7%, whereas estimates based on RC underestimated 13.8% and ERC estimates 
underestimated protein intake with 14.1%. For potassium, the FFQ underestimated potassium intake 
the most, with an average bias of 12.5%. For the R� the underestimation was 10.2% on average, whereas 
for F�R� this was 11.3%. RC and ERC underestimated potassium intake the least with 8.4% 
underestimation for RC and 9.2% for ERC.  
Table 3.2: Mean estimated intake and bias per approach. 
 Protein (g) Potassium (mg) 
 Mean (SD) Bias (%)a Mean (SD) Bias (%)a 
Biomarker 97.2 (22.1)  4047 (1331)  
1) FFQ 73.1 (16.6) -22.7 (18.7) 3288 (751) -12.5 (32.6) 
2) R�  80.3 (21.1) -14.7 (24.2) 3400 (824) -10.2 (29.9) 
3) F�R� 76.7 (15.7) -18.7 (18.2) 3344 (683) -11.3 (29.2) 
5) RC  80.3 (8.0) -13.8 (18.1) 3400 (413) -8.4 (30.8) 
6) ERC 80.3 (10.9) -14.1 (18.1) 3400 (523) -9.2 (28.8) 
a percentage (%) bias was calculated on the individual level using the biomarker as the true 
intake and displayed as mean (SD).  
 
For protein intake estimates, the empirical AF was smallest for R� estimates (0.40) and slightly but not 
significantly higher for FFQ intake estimates (0.55) (Figure 3.2a). The average of FFQ and R� (F�R�) 
improved intake estimates with an AF of 0.66 and performed significantly better than FFQ and R� intake 
estimates. The RC and ERC intake estimates produced significantly higher AFs being 1.14 and 0.95, 
respectively. For potassium, AFs were smallest for FFQ estimates (0.70) and slightly but not significantly 
higher for R� intake estimates (0.80) (Figure 3.2b). The AF was 1.01 for the F�R� estimates, whereas the 
AFs for RC and ERC were higher than 1 (1.28 and 1.34 respectively). The latter value differs statistically 
significantly from 1, indicating that a correction using ERC based on the average of two 24hr recalls as 
reference value could lead to an overestimation of the strength of the association between potassium 
intake and health effect. For protein, however, an ERC correction using the average of two 24hr recalls 
from our data seems to yield an approximately correct strength of association.  
While for both nutrients RC and ERC AFs did not differ statistically significantly from each other, the 
ERC estimate had the smallest 95% CI, indicating higher precision of the AF and potentially more power 
to detect diet-disease association.  
To illustrate the impact of applying RC or ERC on dietary intake estimates used in diet-disease 
associations, we give an example using AFs obtained for the five approaches for protein and potassium. 
We assume to have a hypothetical diet-disease association with a true relative risk (RR) of 2.0. If we 
would use the FFQ estimate for protein, we would obtain an observed RR of 1.46 (i.e. 2.00.55), whereas 
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with the R� estimate a RR of 1.36 (i.e. 2.00.40) would be obtained (Figure 3.3, left side). For the F�R� an RR 
of 1.58 (i.e. 2.0 0.66) would be observed. Using RC intake estimates for protein would give a RR of 2.20 
(i.e. 2.01.14). For the ERC the observed RR would be 1.93 (i.e. 2.00.95) which is closest to the true RR. For 
potassium, the observed relative risk would be 1.62 (i.e. 2.00.70) when using FFQ intake estimates and 
1.74 (i.e. 2.00.80) when using R� intake estimates (Figure 3.3, right side). Using F�R� intake estimates would 
result in an observed RR of 2.01 (i.e. 2.01.01), which is closest to the true RR. Using RC and ERC would 
lead to an observed RR of 2.45 (i.e. 2.01.28) and 2.53 (i.e. 2.01.34), respectively, indicating overcorrection 
as these are higher than the true RR of 2.0.  
 
 
Figure 3.2: Empirical attenuation factors (95% CI) for the 5 approaches for a) protein and b) potassium from 
regression of the biomarker on the intake estimates. Different letters indicate statistically significant 
attenuation factors.  
R = mean of 2 telephone-based 24 hour recalls, FR = mean of FFQ and 2 telephone-based 24 hour recalls, RC = 
regression calibration with the FFQ as main instrument and 2 telephone-based 24 hour recalls as superior 
instrument, and ERC = enhanced regression calibration with the FFQ as main instrument and 2 telephone-
based 24 hour recalls as superior instrument. 
 
 
Discussion 
RC and ERC significantly improved estimates of diet-disease associations, as demonstrated by AFs 
approaching 1, as compared to simply averaging estimates from two different assessment methods 
and uncorrected estimates. For both potassium and protein, RC and ERC AFs did not differ statistically 
significantly from each other. The ERC AF, however, had the narrowest 95% CI, indicating higher 
precision of the AF and potentially more power to detect diet-disease associations than the RC 
approach.  
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Figure 3.3: Visualization of the impact of the five presented approaches on diet-disease relative risks assuming 
a hypothetical true relative risk of 2.0.  
R = mean of 2 telephone-based 24 hour recalls, FR = mean of FFQ and 2 telephone-based 24 hour recalls, RC = 
regression calibration with the FFQ as main instrument and 2 telephone-based 24 hour recalls as superior 
instrument, and ERC = enhanced regression calibration with the FFQ as main instrument and 2 telephone-
based 24 hour recalls as superior instrument. 
 
Although our finding of substantial measurement error is not new [2, 20], it does underscore the 
importance of validation studies. In our study, we used the average of two 24hR as reference 
instrument for the regression calibration and enhanced regression calibration approaches, as is 
common in nutritional epidemiology. However, this requires the assumption that 24hR intakes are 
unbiased, which often does not hold [21]. Also in our study, we can see that this assumption is violated, 
as there is an average underreporting of 14.7% for protein and 10.2% for potassium intake estimates 
based on two 24hR compared to intake estimates based on urinary recovery biomarkers. It should be 
noted that RC and ERC calibrate the main instrument (i.e. the FFQ) to the reference instrument (i.e. 
24hR) to correct the intake and distribution on a population level. Estimates obtained with RC and ERC 
do not reflect corrected individual intake levels and cannot be used as such. 
However, the aim of our study was not to corrected individual intake levels, but to assess the impact 
of combining FFQ and 24hR estimates on resulting diet-disease associations, as this is usually the main 
interest in nutritional epidemiology. In our study, we used AF as measure for bias in resulting diet-
disease associations, with an AF of 1 indicating no bias present. AFs for the FFQ and 24hR showed that 
there was substantial bias, especially for protein intakes, that would result in attenuation of diet-
disease associations (i.e. AF << 1). Averaging FFQ and 24hR resulted in AFs closer to 1, while using RC 
and ERC improved protein estimates with resulting AFs close to 1. However, for potassium, using RC 
and ERC led to overcorrection, as indicated by AFs >1. This possible overcorrection warrants further 
investigation.  
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The mean intake estimates and the AFs for RC and ERC did not differ much, which could raise the 
question if ERC has additional benefits to RC, as it implies a lot of extra effort and labour to collect two 
24hR for each participant instead of only a subsample. However, the SD of RC is smaller than the SD of 
the ERC, indicating a narrower intake distribution resulting from RC than from ERC. This narrower 
distribution of the RC makes it more difficult to discriminate between individuals and indicates a loss 
of power. The wider distribution of the ERC intake estimates thus underlines the theoretical advantage 
of the ERC having more power to detect diet-disease associations than RC. Another example can be 
found in the 95%CI of the AFs being smaller for ERC than for RC indicating more precision with the ERC 
in estimating diet-disease associations.  
In the current study, we used the average of two telephone administered 24hR as reference 
instrument, as this is a well-documented reference instrument. However, this method is too labour 
intensive and expensive to administer in the entire study population of large epidemiological studies. 
Using recalls as reference method would thus be limited to validation studies, excluding the possibility 
to use the proposed ERC method. However, with the availability of 24hR administered via the internet 
(e.g. ASA24 [22], Compl-eat [23]) costs of collecting 24hR are substantially reduced making the web-
based 24hR a viable option for large epidemiological studies. Evaluations indicated that web-based 
24hR are in general in good agreement with interview-administered 24hR [7]. For example, the ASA24 
had an average relative mean difference of 1.6% for energy intake, 2.9-11.1% for macronutrients and 
-4.2-11.9% for micronutrients, compared to the telephone administered 24hR [24]. Furthermore, the 
Dutch web-based 24hR tool Compl-eat underestimated macronutrients on average with 8% and 
micronutrients with 13% compared to telephone administered 24hR [23]. These results indicate that 
web-based 24hR could also be used as reference instruments for the RC and ERC.  
We propose a rather simple method to combine the 24hR and FFQ dietary intake estimates. Others 
have shown that adding covariates such as BMI to the regression calibration model might improve the 
regression calibration [25, 26]. However, these covariates should be measured accurately and without 
bias to prevent introducing additional bias. Furthermore, covariates could also act as mediator or 
confounder in the diet-disease association of interest, and including such covariates in the model could 
potentially even lead to bias in the regression calibration rather than improvement [4, 27]. Another 
method suggested including biomarker measures in the regression calibration model to provide 
unbiased diet-disease estimates [28]. The advantage of using biomarkers is that they are objectively 
measured and are assumed to have uncorrelated errors with the self-report instrument, in contrast to 
using two self-report dietary assessment tools such as FFQ and 24hR. Additionally, recovery 
biomarkers are free of intake-related bias. A limitation is the limited availability of biomarkers for 
nutrient intake, and the substantial burden and costs associated with biomarker measurements. 
Using enhanced regression calibration to combe FFQ and 24hR data 
63 
Therefore, combining two self-report dietary assessment tools has much more potential in the field of 
nutritional epidemiology.  
A limitation of the current study is that recovery biomarkers were needed for validation of the 
proposed approaches. Therefore, we were limited to studying protein and potassium intake estimates 
as no other recovery biomarkers were available. We can only speculate whether the proposed 
approaches also improve estimates for intakes of other (micro) nutrients, energy and foods. However, 
the study of Carroll et al. demonstrated a large gain in power and precision when combining FFQ and 
two 24hR data for micronutrients and food groups compared to only two 24hR or one FFQ [8]. They 
used the NCI method to obtain usual intake estimates [29, 30] and only used the frequency information 
from the FFQ as covariate in the regression calibration [31], whereas in the ERC more information from 
the FFQ is used to correct intake estimates and consequently diet-disease associations. The benefits 
of combining FFQ and 24hR demonstrated by Carroll et al. should also apply to the ERC approach in 
our study, suggesting the suitability of the ERC for micronutrients and food groups. As the 24hR tends 
to be less reliable in estimation of episodically consumed foods, we believe the largest gain in 
improving intake estimates for diet-disease associations can be achieved in those foods.  
Future research should focus on identifying error structures of intake estimates from using the RC and 
ERC approach using measurement error models. This information can be used to further improve the 
regression calibration models, possibly by including other covariates. However, keeping the simplicity 
of the suggested ERC approach is desirable.  
 
Conclusions 
Measurement error is a serious problem in nutrition research. Our study highlights the potential of 
combining FFQ and 24hR data using RC and ERC, simple approaches, with substantial impact on 
correcting diet-disease associations. The availability of web-based 24hR reduces burden and costs, 
making it easier to use in large population study. Preferably, FFQ and 24hR data are collected for the 
entire study population and ERC is used.  
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Supplementary material  
 
Supplemental file 3.1: The SAS syntax for the Proc Reg procedure to obtain regression calibration (RC) estimates 
and the SAS syntax for the Proc Mixed procedure to obtain enhanced regression calibration (ERC) estimates. 
a. SAS syntax for regression calibration of the FFQ using two 24hR as reference instrument 
For the regression procedure, the mean of the two 24hR (R�) needs to be calculated and is the dependent variable 
in the regression equation. The FFQ estimate is the independent variable in the equation. Generic labels for the 
variables are used (recalls is named R�, FFQ is named FFQ). The dataset is called mydataset. 
Proc reg data=mydataset; 
Model R�=FFQ; 
Run; 
 
Parameter estimates can be found in the output. Regression calibration equation to obtain RC predicted dietary 
intake estimates: 
 
 RC= intercept parameter estimate + (FFQ parameter estimate*FFQ)  
 
b. SAS syntax for enhanced regression calibration of the FFQ using two 24hR as reference instrument while 
adding random effects to the regression calibration 
For the mixed procedure, the dataset needs to be ordered using a long data format, i.e. 24hR1 en 24hR2 are 
listed below each other for each participant. FFQ estimates are duplicated on each row. Generic labels for the 
variables are used (participant identifier is named pID, recalls is named 24hR, FFQ is named FFQ). The dataset is 
called mydataset. 
Ods output solutionr=solutionrandom solutionf=solutionfixed; 
Proc mixed data=mydataset; 
Class pID; 
Model 24hR=FFQ / solution; 
Random intercept /subject=pID solution; 
Run; 
 
Parameter estimates can be found in the output. Regression calibration equation to obtain ERC predicted dietary 
intake estimates: 
 
 ERC= estimateSF1 + (estimateSF2*FFQ) + estimateR 
 
Where estimateSF1 represents the fixed effect intercept estimate, estimateSF2 represents the fixed effect FFQ 
parameter estimate, both obtained from the solutionfixed output. EstimateR represents the random effect 
individual estimate, obtained from the solutionrandom output. 
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Abstract  
Objective: The first objective is to compare risk of adverse pregnancy outcomes between women with 
treated gestational diabetes (GDM), women with untreated borderline gestational diabetes (BGDM) 
and women with normal glucose tolerance (NGT). Secondly, we want to verify if macrosomia is 
associated with adverse pregnancy outcomes and whether macrosomia is a mediator in the association 
between glucose tolerance during pregnancy (i.e. GDM, BGDM, NGT) and adverse pregnancy 
outcomes. 
Methods: A retrospective analysis was performed using medical file data of 1049 women with a 
singleton pregnancy who underwent glucose screening during pregnancy and who delivered in hospital 
Gelderse Vallei between 1-1-2010 and 31-12-2014. Prevalence ratios (PR) and 95% confidence 
intervals (95%CI), adjusted for gestational age, maternal age and parity, were estimated.  
Results: High rates of macrosomia were observed in women with treated GDM (17%) and untreated 
BGDM (25%). Compared to women with NGT, women with untreated BGDM had a higher risk of 
unscheduled Caesarean section (PR=1.90, 95% CI 1.20-2.99), total Caesarean section (PR=1.51, 95% CI 
1.14-2.00) and laceration (PR=1.24, 95% CI 1.06-1.46). Women with treated GDM had a higher risk of 
laceration compared to women with NGT (PR=1.28, 95% CI 1.14-1.45). Macrosomia did not mediate 
associations between glucose tolerance and adverse pregnancy outcomes, as adding macrosomia to 
the model did not change prevalence ratios. 
Conclusions: Macrosomia rates were high in both treated GDM and untreated BGDM. Women with 
untreated BGDM had a higher risk of (unscheduled) Caesarean section and laceration than women 
with NGT, whereas for women with treated GDM risk of laceration, but not other outcomes, was 
higher.  
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Introduction 
Incidence of gestational diabetes mellitus (GDM) is increasing worldwide [1, 2]. In 2008, the 
Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) study demonstrated that maternal glucose 
levels during pregnancy are associated with several adverse pregnancy outcomes including high 
birthweight, premature delivery, delivery by Caesarean section, neonatal hypoglycaemia, shoulder 
dystocia, birth injury, and pre-eclampsia [3]. Treatment of GDM with tight glucose monitoring, dietary 
counselling and, if necessary, insulin can reduce the risk of these adverse pregnancy outcomes [4-6]. 
However, it is not clear if the risk of adverse pregnancy outcomes in women with treated GDM is 
comparable to the risk of women with normal glucose tolerance (NGT) or whether treated GDM still 
increases risk of adverse pregnancy outcomes.   
The association between maternal glucose levels and adverse pregnancy outcomes in the HAPO study 
was linear. This implies that women with abnormal glucose values below the GDM diagnostic criteria, 
i.e. borderline gestational diabetes mellitus (BGDM), also have a higher risk of adverse pregnancy 
outcomes compared to women with NGT. An Australian study showed that BGDM affects 
approximately 6-8% of the pregnant women [7]. However, little is known about the risk of adverse 
pregnancy outcomes for these women. A Turkish study found no increased risk of adverse pregnancy 
outcomes for women with BGDM compared to women with normal glucose tolerance [8], whereas 
three Australian studies did find higher risk of several adverse health outcomes for mothers with 
BGDM and their children [7, 9, 10]. In the Netherlands, women with BGDM do not receive treatment 
and it is not known if women with untreated BGDM are at increased risk of adverse pregnancy 
outcomes compared to women with NGT.  
Results of the HAPO study clearly demonstrated that GDM increases risk of macrosomia (i.e. 
birthweight >4000g). Giving birth to a macrosomic infant is associated with higher risk of adverse 
pregnancy outcomes, including neonatal death, shoulder dystocia, pre-eclampsia, instrumental 
delivery, and unplanned Caesarean section [11]. Several of these adverse pregnancy outcomes are also 
associated with GDM and we hypothesize that macrosomia is a mediator in the association between 
hyperglycaemia and adverse pregnancy outcomes.  
The first objective of the current study is to compare risk of adverse pregnancy outcomes between 
women with treated GDM, women with untreated BGDM and women with NGT. Secondly, we want 
to verify if macrosomia is associated with adverse pregnancy outcomes in our Dutch population and 
whether macrosomia is a mediator in the association between glucose tolerance during pregnancy (i.e. 
GDM, BGDM, NGT) and adverse pregnancy outcomes.  
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Materials and Methods 
Study design and study population 
Electronic medical record information from Hospital Gelderse Vallei Ede in the Netherlands was used 
for this retrospective analysis. There were 8535 birth records of hospital Gelderse Vallei available for 
the study period 1-1-2010 to 31-12-2014. Of the women with multiple pregnancies during the study 
period, the first pregnancy of these women was included for analysis and further pregnancies were 
omitted (n=2846). Subsequently, women were divided into three mutually exclusive groups based on 
glucose tolerance during pregnancy. We identified women diagnosed with GDM (n=365), women with 
BGDM (n=219) and women with normal glucose tolerance (NGT) (n=4923). For the NGT group, all 
records of women with NGT who gave birth to a macrosomic infant (n=691) and a representative 
sample of the remaining women in the NGT group (n=1000) were selected for data extraction. We 
included all records of women who gave birth to a macrosomic infant to ensure enough cases for the 
second objective of this study, i.e. assess whether macrosomia is a mediator in the association of GDM 
with adverse pregnancy outcomes. Women who did not undergo glucose screening (n=1088), women 
with missing birth information (n=112), women with a multifetal pregnancy (n=26) and women with 
type 1 or 2 diabetes (n=3) were excluded. This resulted in a total of 1049 records for analysis. The flow 
chart of the study population is presented in Figure 4.1.The study was approved by the Institutional 
Review Board of Hospital Gelderse Vallei Ede.  
Diagnosis of GDM 
During the study period, a universal two-step screening method was used by the hospital to diagnose 
GDM. As first step of screening, women underwent a 50-grams Glucose Challenge Test (GCT) between 
22 and 28 weeks of gestation. Those women testing positive (1-hour glucose value ≥7.8 mmol/L) 
underwent a fasting 75-grams Oral Glucose Tolerance Test (OGTT). GDM was diagnosed if at least one 
test value from the OGTT was abnormal (fasting glucose plasma ≥ 6.0 mmol/L or 2-hour plasma glucose 
≥ 7.8 mmol/L). BGDM was defined as an abnormal GCT result and a normal OGTT result. 
Women referred to the hospital by local midwives for glucose screening underwent a selective one-
step screening using the fasting 75g OGTT (31% of the women included for analysis). Selection was 
based on the presence of one or more risk factors for GDM (history of GDM, previous macrosomic 
infant, BMI≥30 kg/m2, family history of diabetes, ethnic minority, unexplained intra-uterine death, and 
polycystic ovary syndrome). GDM was diagnosed if at least one test value from the OGTT was abnormal 
(fasting glucose plasma ≥ 6.0 mmol/L or 2-hour plasma glucose ≥ 7.8 mmol/L).  
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Women diagnosed with GDM received nutritional counselling to normalize glucose levels (1 hour post-
prandial glucose ≤7.0 mmol/L). Glucose levels were measured twice weekly with a provided self-
monitoring device provided by the hospital and discussed with medical staff during a weekly consult 
by phone. Insulin therapy was started if dietary measures were judged as insufficient by the medical 
staff, i.e. 1-hour postprandial glucose > 7.0 mmol/L on multiple occasions. Women with BGDM did not 
receive counselling or treatment. 
Outcomes 
Information for the study was obtained from reviewing electronic medical files. Macrosomia was 
defined as a birthweight of 4000g or higher. Maternal characteristics recorded were age, parity and 
smoking habits. Maternal smoking was defined as women who reported smoking at any time during 
pregnancy. Included pregnancy characteristics were gestational age at delivery, sex of infant, 
birthweight, birthweight percentile, Apgar score 5 minutes after birth, mode of delivery and pregnancy 
complications as recorded in the medical file (pregnancy hypertension or preeclampsia). Adverse 
pregnancy outcomes were defined as unscheduled Caesarean section (grade 1, 2 or 3 according to the 
classification of Lucas et al. (2000) [12]), total Caesarean section, assisted vaginal delivery (vacuum or 
forceps), shoulder dystocia (any prolonged head-to-body delivery time and/or the use of obstetric 
manoeuvres), laceration (second degree perineal tear, vaginal laceration or cervical tear, episiotomy, 
anal sphincter tear), and postpartum haemorrhage (≥1000ml blood loss).  
Statistical analysis 
Descriptive statistics included means and SDs for continuous variables and percentages for categorical 
variables. Differences between groups were tested with Chi-square test for categorical values and 
ANOVA for continuous values, including post-hoc comparisons with a Bonferroni correction. Cox 
proportional hazard models with robust variance estimates were fitted to estimate prevalence ratios 
as described by Barros and Hirakata [13] to assess associations of glucose tolerance status with adverse 
pregnancy outcomes. The first model resulted in crude prevalence ratios, weighted to account for 
oversampling of macrosomia in the NGT group (model 1). The adjusted model included the covariates 
maternal age, gestational age and parity (model 2). To assess if macrosomia mediated the association 
between adverse pregnancy outcomes and glucose tolerance status, macrosomia (yes/no) was 
additionally added to the model (model 3). The outcomes assisted vaginal delivery, shoulder dystocia 
and laceration only occur in vaginal births, therefore women who underwent a Caesarean section 
(n=307) were excluded from the analysis of these outcomes. Additionally, to describe the association 
between macrosomia and adverse pregnancy outcomes crude prevalence ratios were estimated 
(model 1). The adjusted model included the covariates maternal age, gestational age, parity (model 2) 
and glucose tolerance status (model 3). BMI is an important risk factor for GDM and macrosomia. 
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Unfortunately, information on BMI was limited and pre-pregnancy body weight was not routinely 
recorded and only available for 358 women. In a sensitivity analysis we additionally added body weight 
to model 2 (n=358). Furthermore, a sensitivity analysis excluding women who underwent a one-step 
GDM screening (n=325), was performed to assess the effect of possible undiagnosed BGDM in the NGT 
group. All statistical analyses were carried out using SAS software version 9.3 (SAS Institute Inc., Cary, 
NC, USA). A two-sided p-value of <0.05 was considered significant.  
 
Results 
Of the 1049 women included in the study, 136 had BGDM (12.7%) and 276 women were diagnosed 
with GDM (26.3%). Forty-seven mothers with GDM gave birth to a macrosomic infant (17.0%), whereas 
34 mothers in the BGDM group gave birth to a macrosomic infant (25.0%). Women in the NGT group 
were the youngest (p<0.05), whereas women with GDM had the lowest gestational age at birth 
(p<0.05) (Table 4.1). Mode of delivery differed significantly between the groups, with highest rates of 
spontaneous delivery in the NGT group, highest rates of induced labour in the GDM group and highest 
rates of unscheduled Caesarean section in the BGDM group.  
Compared to women with NGT, women with untreated BGDM had a higher risk of unscheduled 
Caesarean section (PR=1.90, 95% CI 1.20-2.99), total Caesarean section (PR=1.51, 95% CI 1.14-2.00) 
and laceration (PR=1.24, 95% CI 1.06-1.46) (Table 4.2). PRs for women with GDM  were lower and non-
significant, except for a higher risk of laceration compared to women with NGT (PR=1.28, 95% CI 1.14-
1.45). A higher risk of Caesarean section for women with GDM (PR=1.33, 95%CI 1.04-1.70) was no 
longer significant after adjustment for maternal age, gestational age at birth and parity (PR=1.15, 
95%CI 0.89-1.49).  
Giving birth to a macrosomic infant was associated with a higher risk of shoulder dystocia (PR=6.67, 
95% CI 3.46-12.83), unscheduled Caesarean section (PR=1.55, 95% CI 1.13-2.12) and total Caesarean 
section (PR=1.40, 95% CI 1.13-1.73), regardless of glucose tolerance during pregnancy (Table 4.3). 
Macrosomia was not associated with assisted vaginal delivery, laceration or post-partum 
haemorrhage. Macrosomia did not mediate associations observed for glucose tolerance status and 
adverse pregnancy outcomes, as adding macrosomia to the model did not change prevalence ratios 
(model 3, Table 4.2). The only exception was attenuation of the non-significant association of BGDM 
and GDM with shoulder dystocia after adding macrosomia to the model.  
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Table 4.1: Maternal and pregnancy characteristics of the total study population and according to glucose 
tolerance status during pregnancy. 
 Total (n=1049) NGT# 
(n=637) 
BGDM 
(n=136) 
GDM 
(n=276) 
p-value^ 
Age (yrs.) 30.9 (4.7) 29.6 (4.0)a 32.3 (5.1)b 31.9 (5.3)b <0.001 
Maternal smoking (%) 
Missing=116 
20.4 22.8 20.7 17.4 0.33 
Nulliparous (%) 45.9 49.3  39.6 44.5 0.18 
Gestational age (weeks) 39.0 (1.4) 39.3 (1.1)a 38.9 (1.6)b 38.5 (1.7)c <0.001 
Sex (% boy) 53.2 53.1 58.8 50.6 0.29 
Birthweight (grams) 3519 (463) 3533 (370) 3541 (633) 3489 (550) 0.41 
Birthweight >90th percentile (%) 10.5 9.2 14.7 10.1 0.20 
Mode of delivery (%) 
• Spontaneous 
• Induced 
• Elective Caesarean section 
• Unscheduled Caesarean section 
 
43.7 
27.1 
15.5 
13.7 
a 
52.9 
23.4 
12.6 
11.1 
b 
33.1 
27.9 
19.9 
19.1 
b 
37.0 
31.5 
17.0 
14.5 
<0.001 
Pregnancy hypertension (%) 11.6 9.1 14.7 13.4 0.11 
Preeclampsia (%) 4.8 5.6 5.9 3.3 0.32 
Apgar score <8* (%) 2.7 2.1a 5.9b 1.8a 0.04 
Data are presented as means (sd) for continuous variables and as percentages for categorical variables. 
GDM, gestational diabetes mellitus; BGDM, borderline gestational diabetes; NGT, normal glucose tolerance. 
# Weighted to account for oversampling of macrosomia 
^ p-value for differences between groups; Chi-square test for categorical variables and ANOVA for continuous variables.  
a,b,c Mean values with unlike superscript letters were significantly different (p<0.05) in post hoc testing (Bonferroni 
corrected).  
* Apgar score 5 minutes after birth.  
 
 
Sensitivity analyses, in 358 women for which body weight was available, showed similar associations 
between glucose tolerance status and adverse pregnancy outcomes. The association between 
unscheduled Caesarean section and BGDM attenuated slightly, but remained significant (data not 
shown). Furthermore, excluding women screened with a one-step screening (n=325), did not change 
results (data not shown). 
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Table 4.2: Crude and adjusted prevalence ratios of adverse pregnancy outcomes according to glucose tolerance 
status during pregnancy.  
 NGT 
n=637 
BGDM 
n=136 
GDM 
n=276 
Unscheduled Caesarean section 
n 
Model 1 
Model 2 
Model 3 
 
 
80 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
26 
1.72 (1.11-2.67) 
1.90 (1.20-2.99) 
1.83 (1.17-2.85) 
 
40 
1.31 (0.88-1.93) 
1.43 (0.96-2.13) 
1.38 (0.93-2.05) 
Caesarean section 
n 
Model 1 
Model 2 
Model 3 
 
 
167 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
53 
1.65 (1.26-2.16) 
1.51 (1.14-2.00) 
1.48 (1.12-1.95) 
 
87 
1.33 (1.04-1.70) 
1.15 (0.89-1.49) 
1.14 (0.88-1.47) 
 
Assisted vaginal delivery# 
n 
Model 1 
Model 2 
Model 3 
 
 
146 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
33 
0.58 (0.30-1.12) 
0.65 (0.34-1.27) 
0.66 (0.34-1.28) 
 
58 
0.76 (0.50-1.16) 
0.88 (0.58-1.33) 
0.91 (0.60-1.38) 
 
Shoulder dystocia# 
n 
Model 1 
Model 2 
Model 3 
 
 
49 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
 
7 
1.73 (0.77-3.89) 
1.94 (0.85-4.23) 
1.48 (0.66-3.33) 
 
13 
1.41 (0.73-2.71) 
1.64 (0.82-3.27) 
1.40 (0.73-2.71) 
Laceration# 
n 
Model 1 
Model 2 
Model 3 
 
 
299 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
61 
1.18 (1.01-1.38) 
1.24 (1.06-1.46) 
1.24 (1.06-1.46) 
 
141 
1.20 (1.06-1.34) 
1.28 (1.14-1.45) 
1.29 (1.14-1.45) 
Post-partum haemorrhage 
n 
Model 1 
Model 2 
Model 3 
 
 
49 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
 
7 
0.73 (0.33-1.63) 
0.66 (0.28-1.53) 
0.64 (0.28-1.46) 
 
16 
0.83 (0.45-1.48) 
0.73 (0.39-1.37) 
0.73 (0.39-1.35) 
GDM, gestational diabetes mellitus; BGDM, borderline gestational diabetes; NGT, normal glucose tolerance 
Model 1: Crude model, weighted for oversampling 
Model 2: Model 1 adjusted for gestational age, maternal age and parity 
Model 3: Model 2 adjusted for macrosomia 
# women undergoing a Caesarean section were excluded for this analysis (n=307) 
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Table 4.3: Crude and adjusted prevalence ratios of adverse pregnancy outcomes 
according to birthweight.  
 Normal birth weight 
n=629 
Macrosomia  
n=420 
Unscheduled Caesarean section 
n 
Model 1 
Model 2 
Model 3 
 
 
81 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
65 
1.20 (0.89-1.63) 
1.40 (1.02-1.92) 
1.55 (1.13-2.12) 
Caesarean section 
n 
Model 1 
Model 2 
Model 3 
 
 
179 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
128 
1.07 (0.89-1.30) 
1.33 (1.08-1.64) 
1.40 (1.13-1.73) 
Assisted vaginal delivery# 
n 
Model 1 
Model 2 
Model 3 
 
 
146 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
33 
0.79 (0.56-1.13) 
0.84 (0.58-1.21) 
0.80 (0.55-1.15) 
Shoulder dystocia# 
n 
Model 1 
Model 2 
Model 3 
 
 
14 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
 
55 
5.83 (3.30-10.32) 
6.29 (3.35-11.81) 
6.67 (3.46-12.83) 
Laceration# 
n 
Model 1 
Model 2 
Model 3 
 
 
308 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
193 
0.96 (0.87-1.07) 
0.95 (0.85-1.07) 
1.00 (0.89-1.12) 
Post-partum haemorrhage 
n 
Model 1 
Model 2 
Model 3 
 
 
37 
1.00 (ref) 
1.00 (ref) 
1.00 (ref) 
 
 
35 
1.42 (0.91-2.21) 
1.42 (0.86-2.34) 
1.32 (0.78-2.21) 
Model 1: Crude model  
Model 2: Model 1 adjusted for gestational age, maternal age and parity 
Model 3: Model 2 adjusted for glucose tolerance status during pregnancy ( gestational 
diabetes mellitus/ borderline gestational diabetes/, normal glucose tolerance) 
# women undergoing a Caesarean section were excluded for this analysis (n=307) 
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Discussion 
In this study, we found a high prevalence of macrosomia in the GDM and the BGDM group. Untreated 
BGDM was significantly associated with a higher risk of unscheduled Caesarean section, total 
Caesarean section and laceration, whereas treated GDM was associated with a higher risk of laceration 
compared to NGT. Macrosomia was associated with a higher risk of shoulder dystocia, unscheduled 
Caesarean section and total Caesarean section. We did not observe a mediating effect of macrosomia 
in the association of glucose tolerance status and adverse pregnancy outcomes.  
Results of the HAPO study have well established that maternal glucose levels are linearly associated 
with risk of adverse pregnancy outcomes [3], whereas two large RCTs showed that treatment of GDM 
lowered risk of adverse pregnancy outcomes [4, 5]. However, few studies have investigated whether 
women with treated GDM still have a higher risk of adverse pregnancy outcomes compared to NGT. 
We observed that women with treated GDM had more often an induction of labour for delivery and 
scheduled for Caesarean section. Furthermore, women with GDM had a higher risk of laceration than 
women with NGT, but not of other adverse pregnancy outcomes. This was also observed by another 
Dutch study, investigating the impact of different GDM diagnostic criteria on pregnancy outcomes [14]. 
A possible explanation for the higher rate of induction of labour is that induction of labour at 38-39 
weeks of gestation is recommended for women with GDM, especially for those receiving insulin 
therapy. Thus, in our study, GDM treatment appeared to be quite successful in reducing risk of adverse 
pregnancy outcomes. GDM treatment in hospital Gelderse Vallei in 2010-2014 consisted of nutritional 
counselling by a specialized dietician and phone-based consults with medical staff. Success of GDM 
treatment in other populations might depend on the degree of abnormal glucose tolerance, timely 
diagnosis and type and intensity of GDM treatment. 
At diagnosis, women with BGDM had an abnormal result on the 50g GTT screening, but a normal result 
on the subsequent fasting 75g OGTT confirmation test. These women received no counselling, 
treatment or subsequent testing. It is likely, however, that some of these women had increased 
maternal glucose levels throughout their pregnancy, which possibly exacerbated into uncontrolled 
GDM later in their pregnancy. This is supported by the fact that prevalence rates of macrosomia were 
higher in the BGDM group than in the treated GDM group (25% vs. 17%). However, it should be noted 
that women with GDM receiving insulin were often scheduled for a delivery at 38-39 weeks of 
gestation to prevent foetal complications. When looking at birth weight taking into account their 
gestational age (i.e. birth weight percentile), infants of women with BGDM were more often, although 
not statistically significantly, in the 90th birthweight percentile than infants of women with NGT or 
GDM, possibly due to an increased growth rate due to higher maternal glucose levels in BGDM. 
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Furthermore, women with BGDM had a higher risk of laceration, an unscheduled Caesarean section 
and total Caesarean section. These results imply that women in the BGDM group could benefit from a 
second GDM screening later in pregnancy and treatment consisting of dietary counselling. A meta-
analysis of four RCTs showed that dietary counselling and metabolic monitoring could reduce risk of 
macrosomia in women with BGDM [15]. However, a factor to take into account is that diagnosis of 
(B)GDM could significantly compromise quality of life [24]. Several studies observed that women with 
GDM struggle to adapt to a new complex behavioural regimen of diet and exercise, worry more about 
health and experienced more physical health problems during pregnancy [16-19].  
Our finding of the increased risk of the BGDM group is especially relevant in relation to the discussion 
about the diagnostic criteria [20-22]. The 1999 WHO diagnostic criteria were used during the study 
period to define GDM [23], with a lower 2-h glucose cut-off value than the new International 
Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria [24] (≥7.8 mmol/L versus ≥8.5), 
but a higher fasting glucose cut-off value (≥6.1 mmol/L versus ≥5.1 mmol/L). In our study, women with 
treated GDM still had higher risk of macrosomia and laceration compared to women with NGT, but 
women with BGDM did worse. This supports the use of the WHO 2-hour glucose cut-off value, i.e. ≥7.8 
mmol/L, as was also concluded by Koning et al. investigating the impact of different GDM diagnostic 
criteria on pregnancy outcomes [14].  
The most pronounced adverse pregnancy outcome associated with GDM is macrosomia [3, 25-27]. As 
mentioned above, the rate of macrosomia was almost doubled in the GDM group (17%), compared to 
the overall 10% prevalence in the hospital during the study period. Similar findings were reported by 
Koning et al. who observed a high prevalence of large for gestational age (LGA) infants in Dutch women 
with GDM living in the Northern parts of the Netherlands [28]. We found that women who give birth 
to a macrosomic infant have a higher risk of shoulder dystocia, unscheduled and total Caesarean 
section. This is in line with other studies who showed that macrosomia is associated with an increased 
risk of delivery-related adverse pregnancy outcomes, including shoulder dystocia, brachial plexus [29-
35]. Therefore, we investigated if macrosomia was a mediator in the association between GDM and 
adverse pregnancy outcomes. Adding macrosomia to our adjusted model did not substantially change 
prevalence ratios, except for attenuation of the non-significant association of BGDM and GDM with 
shoulder dystocia. Therefore, we conclude that risk of macrosomia did not mediate associations 
between glucose tolerance status and adverse pregnancy outcomes.   
The strength of our study is that we could define a BGDM group. Studies relying on selective one-step 
screening cannot identify this group. Furthermore, we are, to our knowledge, the first study to include 
macrosomia as a mediator in the association between GDM and adverse pregnancy outcomes. 
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However, some limitations should also be considered. In this study, we used medical records from one 
general hospital. Some information on maternal characteristics (e.g. smoking) was self-reported by 
women and information of pre-pregnancy weight was only available for 358 women, which could have 
led to misclassification. In addition, we could only include women who delivered in the hospital and 
not women who delivered at home. In the Netherlands, home delivery is common among women with 
an uncomplicated pregnancy and the NGT group in our study might thus comprise relatively more 
complicated pregnancies and thus higher rates of adverse pregnancy outcomes. Approximately 18 
percent of the pregnant women in the Netherlands delivered at home in the period 2011-2013 [36]. 
Furthermore, we only included women who underwent glucose tolerance screening, which resulted in 
exclusion of 1088 records. It is therefore likely that uncomplicated pregnancies are underrepresented 
in our study and that our results are possibly not representative for the general population. This could 
have affected the prevalence of adverse pregnancy outcomes, but most likely did not affect the 
prevalence ratios observed. In addition, this strict inclusion was necessary to prevent undiagnosed 
GDM and BGDM in the normal glucose tolerance group and avoid misclassification. Thirty-one percent 
of the included women were diagnosed with a one-step screening method, leaving women with BGDM 
undiagnosed and thus misclassified as normal glucose tolerance. However, in a sensitivity analysis 
excluding women screened with a one-step screening, results did not change substantially (data not 
shown).  
 
Conclusions 
In conclusion, high rates of macrosomia were observed in the GDM and the BGDM group. Macrosomia 
was associated with a higher risk of shoulder dystocia, unscheduled Caesarean section and total 
Caesarean section, but was not a mediator in the association of glucose tolerance status and adverse 
pregnancy outcomes. Women with treated GDM had a higher risk of laceration compared to women 
with NGT. Women with untreated BGDM had a higher risk of unscheduled Caesarean section, total 
Caesarean section and laceration. Screening and treating BGDM to reduce risk of these adverse 
pregnancy outcomes warrants further research.  
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Abstract 
Background: Carbohydrate quantity and quality affect postprandial glucose response, glucose 
metabolism and risk of type 2 diabetes. The aim of the present study was to examine the association 
of pre-pregnancy dietary carbohydrate quantity and quality with risk of developing gestational 
diabetes (GDM).  
Methods: We used data from the Australian Longitudinal Study on Women’s Health that included 3607 
women aged 25-30 years without diabetes who were followed-up between 2003 and 2015. We 
examined carbohydrate quantity (total carbohydrate intake and a low-carbohydrate diet (LCD) score), 
and carbohydrate quality (fibre, total sugar intake, glycaemic index, glycaemic load and intake of 
carbohydrate-rich food groups). Relative risks (RR) for development of GDM were estimated using 
multivariable regression models with generalized estimating equations.  
Results: During 12 years follow-up, 285 cases of GDM were documented in 6263 pregnancies (4.6%).  
The LCD score, reflecting relatively high fat and protein intake and low carbohydrate intake, was 
positively associated with GDM risk (RR 1.54 [1.10-2.15], highest quartile vs. lowest quartile). Women 
in the quartile with highest fibre intake had a 33% lower risk of GDM (RR 0.67 [0.45-0.96]). Higher 
intakes of fruit (0.95 per 50g/day [0.90-0.99]) and fruit juice (0.89 per 100g/day [0.80-1.00]) were 
inversely associated with GDM, whereas cereal intake was associated with a higher risk of GDM (RR 
1.05 per 20g/day [1.01-1.07]).  
Conclusions: A relatively low carbohydrate and high fat and protein intake may increase risk of GDM, 
whereas higher fibre intake could decrease risk of GDM. It is especially important to take the source 
of carbohydrates into account. 
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Introduction 
Gestational diabetes mellitus (GDM) is one of the most common metabolic complications during 
pregnancy and prevalence has continued to increase worldwide [1, 2]. GDM is associated with short-
term adverse perinatal and pregnancy outcomes such as increased risk of macrosomia, Caesarean 
section and neonatal hyperglycaemia [3].  Furthermore, mothers with GDM and their offspring are at 
increased risk of developing type 2 diabetes [4-6]. Few modifiable risk factors for GDM have been 
identified, with diet as an important one as it is relatively easy to modify [7, 8]. 
GDM is characterized by an impaired ability of the body to respond to increases in postprandial blood 
glucose [9]. Fat and protein intake affect postprandial glucose homeostasis indirectly via affecting 
insulin secretion, sensitivity or resistance [10]. However, carbohydrate is the only macronutrient that 
directly affects postprandial blood glucose and long-term postprandial response. Therefore, pre-
pregnancy carbohydrate intake might be a significant dietary factor in the prevention of GDM. 
Epidemiological studies have shown that dietary fibre, glycaemic index (GI) and glycaemic load (GL) 
are consistently associated with risk of type 2 diabetes [11, 12]. However, studies on the role of pre-
pregnancy carbohydrate intake in relation to GDM incidence are limited and, up to date, only 
performed using the Nurses’ Health Study data [13, 14].  
More studies in other populations are needed to confirm the possible relation between pre-pregnancy 
carbohydrate intake and GDM prevention. The association of carbohydrate intake and GDM risk can 
be investigated by examining the relationship between total carbohydrate intake (quantity) and GDM. 
However, carbohydrate quality (type of carbohydrate) might be more important as different types of 
carbohydrates have different rates of digestion and absorption, and thus might have different effects 
on blood glucose levels [15]. Therefore, we aimed to examine the associations between pre-pregnancy 
dietary carbohydrate quantity and quality, and GDM incidence. Carbohydrate quantity was examined 
by investigating total carbohydrate intake and a low-carbohydrate diet score [13, 16]. Carbohydrate 
quality was investigated by examining fibre, and total sugar intake, GI, GL and intake of carbohydrate-
rich food groups.  
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Subjects and Methods 
Study design and population 
The current study used data from the Australian Longitudinal Study on Women’s Health (ALSWH). 
ALSWH is an ongoing population-based prospective cohort study investigating the role of 
demographic, social, physical, psychological, and behavioural factors in women’s health. Full details on 
study design, recruitment, methods and responses have been described elsewhere [17, 18]. Briefly, in 
1996 approximately 40,000 women across three cohorts were recruited: those born in 1973–78 (18–
23 years), 1946–51 (45–50 years) and 1921–26 (70–75 years). Women were randomly selected from 
Australia’s nationalized health-care system, Medicare, with intentional oversampling in rural and 
remote areas. Participants gave informed consent at each survey. The study was conducted according 
to the declaration of Helsinki and approved by the Human Research Ethics Committees of the 
Universities of Newcastle and Queensland.  
For this study, data from the young cohort of women born in 1973-78 were used. This sample was 
broadly representative of Australian women of the same age at baseline [17].  Self-administered 
questionnaires were sent to participants every 3-4 years. Dietary intake was first collected at Survey 3 
(2003, n=9081) when women were 25-30 years and again at Survey 5 (2009, n=8200). Survey 3 was 
used as baseline for the current analyses. Women were excluded from the current analyses if they did 
not report a live birth at consecutive surveys in 2006, 2009, 2012 or 2015, had missing data on diet at 
Survey 3 and 5, had missing data on GDM, reported implausible energy intake (ratio of reported energy 
intake and predicted energy requirement <0.56 or >1.44 [19]), had a history of type 1 or type 2 diabetes 
mellitus prior to GDM diagnosis, had a history of GDM prior to baseline (Survey 3), or had missing 
covariate data (Figure 5.1). A total of 3607 women were included for the analyses.  
Dietary assessment 
Diet was assessed using the Dietary Questionnaire for Epidemiological Studies (DQES) version 2. This 
101-item food frequency questionnaire (FFQ) assesses usual food and beverage intake of the previous 
12 months. The development and evaluation of this FFQ has been described elsewhere [20, 21]. Briefly, 
participants were asked to report their usual frequency of consumption of 74 food items and six 
alcoholic beverage items using a 10-point scale ranging from ‘never’ to ‘three or more times per day’ 
and for 21 items the number of servings of milk, bread, sugar and eggs, and the type of milk, bread, fat 
spread and cheese consumed. Portion size photographs were used to assess the serving sizes. Added 
sugar intake was assessed with the question ‘On average, how many teaspoons of sugar do you usually  
use per day? (Include sugar taken with tea and coffee and on breakfast cereal, etc.)’. Nutrient intakes 
were computed using the national government food composition database of Australian foods, the  
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Figure 5.1: Flow chart of the study population. 
 
NUTTAB95 [22]. Validation of the FFQ against 7 day food diaries of 63 women of reproductive age 
showed moderate to strong energy-adjusted correlation coefficients for a wide range of macro- and 
micronutrients (ranging from 0.28 for vitamin A to 0.78 for carbohydrates) [20]. 
Carbohydrate quantity 
Carbohydrate quantity was examined by investigating total carbohydrate intake, expressed as nutrient 
density (percent of total energy intake) and the low-carbohydrate diet score (LCD). The LCD score is a 
measure of the carbohydrate content of the diet relative to fat and protein intake [16], with a low 
score reflecting a diet high in carbohydrate intake and a high score reflecting a low carbohydrate 
intake. To avoid interference of energy, energy densities were used instead of total intake in g/day. 
The LCD score was calculated by dividing the study participants into 11 equal strata each of fat, protein, 
and carbohydrate intake (E%). Women in the highest strata of fat and protein intake received 10 points 
for that macronutrient; women in the next strata received 9 points and so on. For carbohydrate, the 
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scoring was reversed, thus women in the lowest stratum received 10 points and those with the highest 
intake received 0 points. The points for the three macronutrients were summed to create the overall 
LCD score, ranging from 0 (lowest fat and protein intake and highest carbohydrate intake) to 30 
(highest fat and protein intake and lowest carbohydrate intake).  
Carbohydrate quality 
Carbohydrate quality was examined using fibre (grams/day), and total sugar intake (grams/day), GI, GL 
and intake of carbohydrate-rich food groups (grams/day). Total sugar intake comprised the intake of 
mono- and disaccharides. The GI is a relative measure of the glycaemic impact of the carbohydrates in 
different foods [23]. GI values of individual food items included in the FFQ were obtained from the 
2002 International table of GI and GL values [24], with glucose as reference food. If Australian figures 
were available, these were used. When there was more than one value available, GI values were 
averaged. For each person GI values of the food items were multiplied by carbohydrate intake (in 
grams) from that food item and summed to obtain a person’s GL. The average GI for each participant 
was calculated by dividing GL by total carbohydrate intake [24]. Alcoholic beverages were not included 
in the overall GI. Nine carbohydrate-rich food groups were comprised for additional analyses: white 
bread; high fibre bread (high-fibre white bread, whole meal bread, rye bread, multi-grain bread); cereal 
(All Bran, bran flakes, muesli, Weet-Bix, cornflakes, porridge); fruit (oranges, apples, pears, bananas, 
melon, pineapple, strawberries, apricots, peaches, mango, avocado, tinned fruit); fruit juice; staple 
products (rice, pasta); added sugar; vegetables (tomato, tomato sauce, capsicum (bell or sweet 
peppers), lettuce, cucumber, celery, beetroot, carrots, cabbage, cauliflower, broccoli, spinach, peas, 
green beans, bean sprouts, pumpkin, onion, garlic, mushrooms, zucchini, potato) and a combined 
vegetables and fruit group.  
Dietary carbohydrate (E%), fibre, and total sugar intake, GI, GL and LCD score were adjusted for energy 
using the residual method [25]. 
Assessment of GDM 
GDM was assessed using self-reported physician diagnosis at each survey and for each live birth using 
the following question: ‘Were you diagnosed by a doctor or treated for gestational diabetes?’. A 
reliability study among a subgroup of 1914 women from New South Wales demonstrated high 
agreement of 91% between self-reported GDM diagnosis in our study and administrative data records 
[26]. 
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Assessment of covariates 
Information on country of birth was assessed at Survey 1. Information on highest qualification 
completed, number of hours paid work, marital status, parity, hypertensive disorders of pregnancy, 
polycystic ovary syndrome, inter-pregnancy interval, smoking, physical activity and body mass index 
(BMI) was self-reported at Survey 3 to Survey 6. Physical activity was assessed using validated 
questions on frequency and duration of walking and on moderate- and vigorous-intensity activity and 
was categorized as sedentary/low (<600 total metabolic equivalent [MET] min/week), moderate (600 
to <1200 MET min/week) or high (≥1200 MET min/week) [27]. BMI was categorized as underweight 
(BMI <18.5 kg/m2), normal weight (BMI 18.5 to <25 kg/m2), overweight (BMI 25 to <30 kg/m2) or obese 
(BMI ≥30 kg/m2). Only a few women were classified as underweight (n=123, 3.4%); therefore, the 
underweight and normal weight groups were combined as normal weight (BMI <25 kg/m2). 
Statistical analysis  
Baseline characteristics reported at Survey 3 are shown according to quartiles of LCD-score, our main 
outcome regarding carbohydrate quantity. Characteristics were compared using ANOVA or χ2 tests. 
Characteristics were weighted by area of residence to account for oversampling of women from rural 
and remote areas. As dietary intake can change over time the most recent reported dietary intake 
before the index pregnancy was used.  
Generalized estimating equations (GEE) analyses were used to account for correlated observations due 
to multiple pregnancies by the same participant [28]. Log-Poisson models were used to estimate 
relative risks (RR) and 95% confidence intervals (95%CI) for associations between carbohydrate quality, 
quantity and GDM [29] as log-binomial models did not converge. Adjustment for time-varying 
covariates (education level, work status, marital status, BMI, smoking, physical activity, parity, PCOS) 
was performed using the value reported at the survey administered prior to the pregnancy. For 
pregnancy-specific covariates (hypertension during pregnancy and, if applicable, inter-pregnancy 
interval) the value reported for that specific pregnancy was used. Multiple gestation, alcohol intake, 
work status and marital status were not included in the analyses, as these were not significant 
confounders based on the data.  
Partial correlations, adjusted for energy intake, were calculated to investigate correlations between 
carbohydrate-rich food groups and measures of carbohydrate quantity (carbohydrate intake (E%), LCD 
score) and carbohydrate quality (fibre and total sugar intake, glycaemic index and glycaemic load). 
Associations between intake of carbohydrate-rich food groups and risk of GDM were investigated by 
comparing quartiles of intake to determine if the associations were linear (data not shown). The 
median intake of the quartiles was analysed as a continuous variable in multivariable models to obtain 
Chapter 5 
92 
a p-value for linear trend. Intakes of carbohydrate-rich food groups were subsequently analysed in 
multivariable models with intake as a continuous variable. The association between added sugar and 
risk of GDM was assessed for users vs. non-users because of the large proportion of non-users and the 
subsequently skewed distribution. 
To examine the robustness of the observed associations several sensitivity analyses were performed. 
First, we examined the associations combining dietary intake data from Surveys 3 and 5 to calculate 
long-term average dietary intake. Furthermore, to exclude the possible effect of women changing their 
normal diet to increase their chance of conception, all pregnancies within the first two years of follow-
up were excluded. Additionally, we conducted a multiple imputation analysis to assess the influence 
of participant exclusions that resulted from missing covariate data (educational level, work, marital, 
smoking and alcohol status, PCOS and BMI; n=223) using SAS procedures MI and MIANALYZE [30]. 
Finally, analyses were stratified by known risk factors for GDM including BMI (<25, 25–29.9, or >30 
kg/m2), educational level (low, moderate, high) or parity (nulliparous versus parous) as these were 
identified as potential effect modifiers in other studies on diet and GDM [14, 31].  
Statistical analyses were conducted using SAS Software Version 9.4 (SAS Institute Inc., Cary, NC, USA). 
A p value <0.05 was considered statistically significant.  
 
Results 
During 12 years of follow-up (2003-2015), 285 cases of GDM (4.6%) were reported in 6263 pregnancies 
among 3607 participants. Women with GDM were more often born in Asia, had a higher BMI, were 
more often nulliparous and more likely to have PCOS (data not shown). Women who had a pre-
pregnancy diet with a relatively low carbohydrate intake (i.e. quartile 4 compared with quartile 1 of 
the LCD score) lived on average more often in rural/remote areas (Table 5.1). Furthermore, these 
women in the highest quartile of the LCD score were more often born in Australia, overweight or 
obese, current smokers, high-risk alcohol consumers, and were less physically active and less educated 
compared to women in the lowest quartile.  
Carbohydrate quantity  
Participants in the highest quartile of carbohydrate intake had a lower risk of developing GDM 
compared to the lowest quartile, after adjustment for socio-demographic factors (including age, 
country of birth, education level), reproductive factors (including parity, hypertension during 
pregnancy, PCOS and inter-pregnancy interval) and lifestyle factors (including smoking, energy intake 
Carbohydrate intake and GDM risk 
93 
and physical activity level) (Table 5.2). However, adjustments for protein intake, fat intake, and BMI 
attenuated the observations and results were no longer statistically significant. The LCD score 
(reflecting relatively high fat and protein intakes and a low carbohydrate intake) was significantly 
associated with a 54% higher risk of GDM for women in the highest quartile compared to the lowest 
quartile (RR 1.54, 95% CI 1.10-2.15) after adjustment for socio-demographic, reproductive, lifestyle 
and dietary factors. Additional adjustment for BMI slightly attenuated the association (RR 1.43, 95%CI 
1.03-2.01).   
Carbohydrate quality 
Total sugar intake was inversely associated with risk of developing GDM after adjustment for socio-
demographic, lifestyle and reproductive factors (Table 5.2). The association was attenuated after 
adjustment for dietary factors and BMI and no longer statistically significant (RR 0.83, 95% CI 0.56-
1.23). Women in the highest quartile of total fibre intake had a 33% lower risk of GDM compared to 
women in the lowest quartile (RR 0.67, 95%CI 0.45-0.96) adjusted for smoking, physical activity, socio-
demographic, reproductive and dietary factors. Further adjustment for BMI attenuated the association 
(RR 0.72, 95%CI 0.50-1.05). A non-significant positive trend was seen between glycaemic index and 
glycaemic load with development of GDM adjusted for socio-demographic, reproductive, lifestyle and 
dietary factors. 
 
Table 5.1: Baseline characteristics of non-pregnant Australian women according to quartile of low 
carbohydrate diet (LCD) score (n=3607). 
Characteristic1 
Low carbohydrate diet (LCD) score 
p-value2 
Quartile 1 
N=903 
Quartile 2 
N=898 
Quartile 3 
N=904 
Quartile 4 
N=902 
Age (yrs) 27.5 (1.5)  27.6 (1.4)  27.5 (1.5)  27.5 (1.5)  0.53 
Area of residence     <0.001 
Urban 77.9 76.4 70.1 69.7  
Rural/remote 22.1 23.6 29.9 30.3  
Country of birth      <0.001 
Australia 89.2 90.8 92.8 92.1  
Asia 3.0 2.1 1.6 0.3  
Other 7.8 7.1 5.6 7.6  
Highest educational level     0.001 
Up to year 12 or equivalent 14.4 17.0 19.5 24.5  
Trade/apprenticeship/certificate/diploma 20.0 20.4 22.4 23.8  
University/higher degree 65.6 62.6 58.1 51.6  
Work status     0.34 
No-paid job 15.6 16.1 15.7 13.3  
Part-time 21.8 19.2 22.5 22.4  
Full-time 62.6 64.7 61.8 64.6  
Marital status     0.08 
Married/de facto 67.5 69.4 64.1 64.4  
Separated/divorced/widowed 2.2 2.0 3.5 3.0  
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Table 5.1 continued:      
Single 30.3 28.6 32.4 32.6  
BMI (kg/m2) 23.3 (4.2)  23.5 (4.3)  23.9 (4.6)  24.4 (5)  <0.001 
BMI      <0.001 
Normal weight (<25 kg/m2) 74.8 76.0 68.6 66.6  
Overweight (25 to <30 kg/m2) 17.6 15.7 21.1 21.2  
Obese (≥30 kg/m2) 7.6 8.3 10.3 12.2  
Physical activity     0.04 
Sedentary/low (<600 MET min/week) 39.5 39.7 42.5 43.0  
Moderate (600 to <1200 MET min/week) 22.7 26.4 26.7 24.6  
High (≥1200 MET min/week) 37.8 33.8 30.8 32.3  
Smoking status     <0.001 
Never smoked 68.8 65.6 59.6 54.6  
History of smoking 17.5 18.1 17.3 17.5  
Current smoker 13.7 16.3 23.1 27.9  
Alcohol intake status     <0.001 
Non drinker 7.5 4.1 5.4 3.5  
Low risk/rarely drinks 90.9 93.8 91.2 90.7  
High risk/often drinks 1.6 2.1 4.4 5.8  
Nulliparous  79.5 78.6 78.1 77.9 0.84 
Polycystic ovary syndrome 9.2 8.9 8.5 7.9 0.80 
Total energy intake (kJ/day) 6993 (1741)  7044 (1761)  7076 (1654)  7123 (1714)  0.46 
Total fat intake (E%) 31.3 (4.8)  34.8 (4.5)  37.2 (4.4)  40.4 (4.1)  <0.001 
Total saturated fat intake (E%) 12.6 (2.9)  14.3 (2.8)  15.5 (3)  16.8 (2.9)  <0.001 
Total protein intake (E%) 18 (2.6)  19.5 (2.8)  20.2 (2.8)  21.7 (3)  <0.001 
Total carbohydrate intake (E%) 50.9 (4.2)  45.9 (2.8)  42.9 (3.4)  38.2 (4.5)  <0.001 
Total fibre intake (g/MJ) 3.2 (0.8)  2.8 (0.7)  2.7 (0.6)  2.5 (0.6)  <0.001 
Total sugar intake (g) 99.3 (21.3)  87.4 (16.6)  77 (16.2)  65.7 (16.7)  <0.001 
Glycaemic index 53 (3.6)  52 (3.8)  52 (3.9)  51 (3.8)  <0.001 
Glycaemic load 114 (12.5)  101 (7.7)  93 (7.2)  80 (10.6)  <0.001 
Low carbohydrate score (LCD) 5.9 (2.7)  12.2 (1.6)  17.5 (1.5)  24.5 (2.6)  <0.001 
Values are mean (SD) or % 
1 Baseline characteristics, weighted by area of residence 
2 P values from χ2 or ANOVA 
 
Carbohydrate-rich food groups 
Carbohydrate intake, LCD score, total sugar intake, fibre intake, GI and GL were associated with 
different carbohydrate-rich food groups as indicated by partial correlations, adjusted for energy (Table 
5.3). Intake of high fibre bread, vegetables and fruit, fruit, and fruit juice was inversely linearly 
associated with risk of GDM, while white bread intake was positive linearly associated with GDM risk 
and intake of cereal, staple products and vegetables was not associated with GDM risk (Table 5.4). 
After additional adjustment for the other food groups (model 2), intake of vegetables and fruit, fruit 
and fruit juice were inversely associated with development of GDM. Intake of the combined food group 
fruit and vegetables was significantly associated with a 10% lower risk of developing GDM per 
100g/day increment. When analysing intake of fruit and vegetables separately, only fruit intake 
remained inversely associated with GDM risk (RR 0.95 per 50g/day, 95% CI 0.90-0.99). Intake of cereal 
was associated with a higher risk of GDM (RR 1.05 per 20g/day, 95% CI 1.01-1.07), but the association   
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Table 5.2: Relative risk of GDM according to quartiles of dietary intakes of carbohydrate, total sugar, and fibre, 
dietary glycaemic index and load and low carbohydrate diet (LCD) score.   
 
 
Quartiles 
P for trend Quartile 1  Quartile 2 Quartile 3 Quartile 4 
Carbohydrates (E%)      
Median  37.5 42.1 45.5 50.3  
N women/pregnancies 901/1541 901/1611 903/1601 902/1510  
GDM cases n (% pregnancies) 90 (5.8) 76 (4.7) 65 (4.1) 54 (3.6)  
Model 1 1.00 0.81 (0.60-1.08) 0.71 (0.52-0.97) 0.63 (0.45-0.88)    0.004 
Model 2 1.00 0.78 (0.53-1.13) 0.67 (0.41-1.10) 0.57 (0.27-1.18)    0.13 
Model 2+BMI 1.00 0.78 (0.54-1.12) 0.68 (0.40-1.08) 0.56 (0.27-1.16)    0.12 
LCD score      
Median 6.4 12.2 17.4 24.0  
N women/pregnancies 901/1524 902/1602 902/1600 902/1537  
GDM cases n (% pregnancies) 52 (3.4) 70 (4.4) 79 (4.9) 84 (5.5)  
Model 1  1.00 1.27 (0.90-1.80) 1.40 (0.99-1.98) 1.54 (1.10-2.15)    0.01 
Model 2+BMIa 1.00 1.26 (0.89-1.77) 1.35 (0.95-1.90) 1.43 (1.03-2.01)    0.03 
Total sugars (g/day)      
Median  59.6 76.1 89.0 106.2  
N women/pregnancies 901/1541 903/1606 902/1586 901/1530  
GDM cases n (% pregnancies) 90 (5.8) 71 (4.4) 61 (3.9) 63 (4.1)  
Model 1 1.00 0.78 (0.58-1.06) 0.71 (0.51-0.99) 0.72 (0.52-0.99)    0.04 
Model 2 1.00 0.83 (0.61-1.13) 0.78 (0.54-1.13) 0.83 (0.56-1.24)    0.33 
Model 2+BMI 1.00 0.83 (0.61-1.14) 0.77 (0.54-1.11) 0.83 (0.56-1.23)    0.32 
Total dietary fibre (g/day)      
Median  14.5 17.7 20.6 24.9  
N women/pregnancies 902/1554 902/1586 901/1552 902/1571  
GDM cases n (% pregnancies) 88 (5.7) 67 (4.2) 72 (4.6) 58 (3.7)  
Model 1 1.00 0.77 (0.56-1.04) 0.83 (0.61-1.12) 0.62 (0.45-0.87)    0.01 
Model 2 1.00 0.77 (0.56-1.06) 0.85 (0.62-1.18) 0.67 (0.45-0.96)    0.05 
Model 2+BMI 1.00 0.79 (0.58-1.08) 0.90 (0.65-1.24) 0.72 (0.50-1.05)    0.15 
Glycaemic Index      
Median  47.8 50.8 53.4 56.7  
N women/pregnancies 901/1529 902/1618 902/1579 902/1537  
GDM cases n (% pregnancies) 70 (4.6) 70 (4.3) 69 (4.4) 76 (4.9)  
Model 1 1.00 0.99 (0.73-1.36) 1.06 (0.77-1.46) 1.25 (0.90-1.73)    0.19 
Model 2 1.00 1.06 (0.77-1.46) 1.16 (0.83-1.63) 1.41 (0.99-2.02)    0.06 
Model 2+BMI 1.00 1.02 (0.74-1.40) 1.13 (0.80-1.58) 1.35 (0.94-1.94)    0.09 
Glycaemic Load      
Median 80.5 92.2 100.8 114.1  
N women/pregnancies 901/1547 902/1605 902/1555 902/1556  
GDM cases n (% pregnancies) 89 (5.8) 66 (4.1) 68 (4.4) 62 (4.0)  
Model 1 1.00 0.78 (0.57-1.06) 0.83 (0.62-1.13) 0.78 (0.57-1.07)    0.17 
Model 2 1.00 0.95 (0.66-1.36) 1.15 (0.76-1.75) 1.29 (0.77-2.18)    0.28 
Model 2+BMI 1.00 0.94 (0.65-1.35) 1.10 (0.72-1.68) 1.26 (0.73-2.14)    0.35 
Model 1: adjusted for age at pregnancy (years), country of birth (Australia, Asia, or other), educational level (low, medium, 
or high), total energy intake (kJ/day), physical activity (low, medium, or high), smoking (current, former, or never), 
polycystic ovarian syndrome (yes or no), hypertension during pregnancy (yes or no), parity (0,1, or ≥2), inter-pregnancy 
interval (not applicable [first pregnancy], <18 months, 18-60 months, >60 months) 
Model 2: model 1 + additional adjustments for fat and protein intake (E %) 
Model 2+BMI: model 2 + additional adjustments for BMI (normal weight, overweight, or obese) 
a Not adjusted for fat and protein intake, as these are part of the score 
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between cereal and GDM was slightly U-shaped (p for linear trend 0.11). Furthermore, women who 
consumed added sugar (n=2154, median intake 15.5 g/day) had a 29 % higher risk of GDM than women 
who did not consume added sugar, which slightly attenuated after adjustment for the other food 
groups and BMI, and was not statistically significant (RR 1.25, 95% CI 0.98-1.59). 
Sensitivity analyses 
Associations observed between fibre, LCD score and development of GDM persisted in sensitivity 
analyses, as well as associations between carbohydrate-rich food groups and GDM risk (data not 
shown). Interaction terms for BMI, educational level and parity were not significant. Additional 
stratification did not change the results materially.  
 
Table 5.3: Partial correlations between carbohydrate intake, LCD score, total sugar intake, fibre intake, 
glycaemic index, glycaemic load and carbohydrate-rich food groups, adjusted for energy intake. 
Carbohydrate-rich 
food groups 
Carbohydrate 
intake 
LCD score 
Total sugar 
intake 
Total fibre 
intake 
Glycaemic index 
Glycaemic 
load 
White bread - - - -0.36 0.62 0.27 
High fibre bread - - - 0.35 -0.34 - 
Cereal   0.26 - - 0.40 - - 
Fruit juice  0.26 -0.26 0.43 - - - 
Fruit  0.38 -0.35 0.54 0.58 -0.34 - 
Vegetables - - - 0.51 - - 
Vegetables + fruit 0.33 -0.30 0.48 0.67 -0.30 - 
Added sugar  - - 0.28 - 0.32 0.27 
Staple products - - - - - 0.25 
Food groups and food items included: white bread; high fibre bread (high-fibre white bread, whole meal bread, rye bread, 
multi-grain bread); cereal (All Bran, bran flakes, muesli, Weet Bix, cornflakes, porridge); fruit (oranges, apples, pears, 
bananas, melon, pineapple, strawberries, apricots, peaches, mango, avocado, tinned fruit); fruit juice; staple products (rice, 
pasta); added sugar; vegetables (tomato, tomato sauce, capsicum (bell or sweet peppers), lettuce, cucumber, celery, 
beetroot, carrots, cabbage, cauliflower, broccoli, spinach, peas, green beans, bean sprouts, pumpkin, onion, garlic, 
mushrooms, zucchini, potato) 
- correlations below 0.25 were considered not relevant and are not displayed 
 
 
Discussion 
In this large prospective cohort study, we found that carbohydrate quantity assessed with the LCD 
score was associated with GDM, whereas for carbohydrate quality we observed an inverse association 
between fibre intake and GDM. Furthermore, higher intakes of cereal were positively associated with 
GDM risk, whereas higher intakes of fruit and fruit juice were associated with lower risk of GDM.  
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Table 5.4: Relative risks of GDM for carbohydrate-rich food groups. 
 
 
Risk of GDM – per unit increment 
P for linear trend Unit increment Model 1 Model 2 Model 2+BMI 
White bread 0.01 50 g/day 1.18 (1.02-1.36) 1.05 (0.86-1.27) 1.05 (0.86-1.27) 
High fibre bread 0.01 50 g/day 0.82 (0.70-0.95) 0.84 (0.70-1.01) 0.86 (0.71-1.03) 
Cereal   0.32 20  g/day 1.03 (1.00-1.07) 1.03 (1.00-1.07) 1.04 (1.01-1.07) 
Fruit juice  0.01 100  g/day 0.88 (0.79-0.99) 0.89 (0.79-0.99) 0.89 (0.80-1.00) 
Fruit  0.01 50  g/day 0.94 (0.89-0.98) 0.94 (0.89-0.99) 0.95 (0.90-0.99) 
Vegetables 0.11 100  g/day 0.94 (0.84-1.05) 0.96 (0.86-1.07) 0.96 (0.86-1.07) 
Vegetables + fruit 0.01 100 g/day 0.90 (0.83-0.98) 0.90 (0.83-0.98) 0.91 (0.83-0.99) 
Added sugar  -a Users vs. non-users 1.29 (1.01-1.64) 1.22 (0.96-1.56) 1.25 (0.98-1.59) 
Staple products 0.45 50 g/day 0.97 (0.89-1.05) 0.96 (0.88-1.05) 0.97 (0.89-1.06) 
Food groups and food items included: white bread; high fibre bread (high-fibre white bread, whole meal bread, rye bread, 
multi-grain bread); cereal (All Bran, bran flakes, muesli, Weet Bix, cornflakes, porridge); fruit (oranges, apples, pears, 
bananas, melon, pineapple, strawberries, apricots, peaches, mango, avocado, tinned fruit); fruit juice; staple products (rice, 
pasta); added sugar; vegetables (tomato, tomato sauce, capsicum (bell or sweet peppers), lettuce, cucumber, celery, 
beetroot, carrots, cabbage, cauliflower, broccoli, spinach, peas, green beans, bean sprouts, pumpkin, onion, garlic, 
mushrooms, zucchini, potato) 
 
Model 1: adjusted for age (years), country of birth (Australia, Asia, or other), educational level (low, medium, or high), total 
energy intake (kJ/day), physical activity (low, medium, or high), smoking (current, former, or never), polycystic ovarian 
syndrome (yes or no), hypertension during pregnancy (yes or no), parity (0,1, or ≥2), inter-pregnancy interval (not 
applicable [first pregnancy], <18 months, 18-60 months, >60 months) 
Model 2: model 1 + additional adjustments for other carbohydrate food groups 
Model 2+ BMI: model 2 + additional adjustments for BMI (normal weight, overweight, or obese) 
a Because of the large proportion of non-users, the association between added sugar and risk of GDM was assessed for 
users (n= 2154; median intake 15.5 g/day) vs. non-users (n=1453) instead of a linear association 
 
In this study, we examined both pre-pregnancy carbohydrate quantity and quality of the diet. To our 
knowledge there is only one other prospective cohort study (the Nurses’ Health Study) which is 
comparable to ours and looked at carbohydrate quantity and various aspects of carbohydrate quality 
(i.e. fibre, glycaemic index and glycaemic load) in relation to GDM incidence. In our study, a higher 
total carbohydrate intake was inversely associated with GDM, but this association disappeared after 
adjustment for fat and protein intake. The LCD diet score was significantly and positively associated 
with GDM risk, thus women with a relative low carbohydrate intake had a higher risk of GDM. In the 
Nurses’ Health Study, women with a high LCD score (e.g. a low carbohydrate intake) also had a higher 
risk of GDM, with similar effect estimates [13]. Bao et al. were also able to calculate an animal and 
vegetable LCD score, which indicated that especially women with a high intake of animal fat and 
protein were at a higher risk. This is further supported by other studies showing higher GDM risk and 
impaired glucose metabolism with higher intakes of animal fat [32-34] and animal protein [35]. This 
could indicate that not total carbohydrate intake, but rather protein and fat intake are important in 
the association with GDM risk. However, the group of carbohydrates is a large group with different 
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types of carbohydrates, including complex polysaccharides, mono-and disaccharides and different 
types of fibre. Some have beneficial health effects, such as fibre and low GI-diets [11, 36, 37], whereas 
others have negative health effects such as sugars [38]. This could be a reason for the absence of an 
association of total carbohydrate intake with GDM.  
Therefore, we further examined the relationship between carbohydrates and GDM by investigating 
carbohydrate quality e.g. different types of carbohydrates. We examined fibre and total sugar (i.e. total 
mono- and disaccharide) intake, glycaemic index, glycaemic load and intake of several carbohydrate-
rich food groups. In our study, dietary fibre, vegetables and fruit, fruit and fruit juice were significantly 
associated with a lower risk of GDM, whereas cereal intake was associated with a higher risk of GDM. 
The association between fibre and GDM risk observed in our study is in line with results of the Nurses’ 
Health Study [14]. The Nurses’ Health Study adjusted for BMI in all models, whereas in our study 
adjustment for BMI attenuated the association. However, it should be noted that the magnitude of 
the association after BMI adjustment was comparable to the association observed in the Nurses’ 
Health Study. Our observation of attenuation by BMI could indicate that the association between fibre 
and GDM risk is mediated by BMI. One of the underlying mechanisms could be that increased fibre 
intake reduces appetite and energy intake [39, 40]. This could lead to reduced adiposity and improved 
insulin sensitivity [41, 42] and thus a lower risk of GDM.  
Furthermore, fibre intake was strongly correlated with fruits, vegetables, white bread, high-fibre bread 
and cereal intake. Of these food groups, the most predominant association was observed between 
high fruit intake and lower risk of GDM, followed by high cereal intake and higher risk of GDM. An 
inverse not significant association was observed for high fibre bread and a positive not significant 
association of white bread with GDM, after adjustment for other food groups. The multitude of 
directions and magnitude of the associations between different food groups high in fibre and GDM 
illustrates the complexity of the association between fibre and GDM. The association of higher cereal 
intake with higher risk of GDM could potentially be explained by the often high amounts of sugar 
present in cereal products, whereas fruit contains many other nutrients such as vitamins and minerals 
that could also have a beneficial effect on GDM risk [43]. Furthermore, although we could not 
differentiate the different types of dietary fibre in our study, this could explain the observed 
associations. Whole grain products contain mainly insoluble fibre [44], which has been associated with 
intestinal transit time [45], whereas fruit and vegetables contain relative more soluble fibres [44]. 
Soluble fibres can create a gel-like substance in the stomach, which can delay gastric emptying and 
thus slow glucose absorption [46, 47]. However, confirmation by experimental studies and more 
detailed knowledge of underlying mechanisms is needed.  
Carbohydrate intake and GDM risk 
99 
Carbohydrate quality is most often studied by using the GI and GL. We found no statistically significant 
associations between GI, GL and GDM risk. However, it should be noted that the direction and 
magnitude of the associations between GI, GL and GDM risk were similar to significant estimates 
shown in the Nurses’ Health Study [14]. Differences in study size and number of cases could explain 
the absence of statistical significance in our study. Research on GI and GL in pregnancy is limited, but 
indicates that pregnant women could benefit from low GI and GL diets to lower maternal glycosylated 
haemoglobin, plasma glucose, birth weight, and reduce insulin requirements of women with GDM [48-
50]. Furthermore, there is substantial evidence that relates low GI and GL to lower risk of T2DM [11] 
and that low GI and GL diets may reduce hyperlipidaemia and improve insulin sensitivity [51, 52]. 
Overall, this suggests a beneficial effect of low GI and GL on GDM risk. 
The potential effect of sugar intake on disease risk can be a controversial topic [38]. In our study, we 
examined associations between sugar intake and GDM risk by examining several exposures: total sugar 
intake (all mono- and disaccharides), sugar added by participants to their meals and drinks, and 
carbohydrate food groups with high sugar content (fruit and fruit juice). Total sugar intake was not 
associated with GDM in our study, but fruit, fruit juice and added sugar were (borderline significantly) 
associated with GDM risk. Higher fruit and fruit juice intakes were associated with lower risk of GDM 
whereas added sugar with a higher risk of GDM. The discrepancy in our results could be due to the 
complexity of total sugar content. Total sugar includes sugars found in nutritious foods such as fruit, 
fruit juice and dairy products, whereas on the other hand added sugar provides only excess energy. 
Our findings, except for those on fruit juice, are in line with dietary recommendations from leading 
institutes, such as the World Health Organization that recommend a reduction in free sugars [53]. 
To our knowledge, no other studies investigated intake of carbohydrate-rich food groups and risk of 
GDM. The observed associations between carbohydrate-rich food groups and GDM risk, i.e. higher 
risks observed for cereal and added sugar intake, and lower risks for vegetables and fruit, fruit, fruit 
juice and high-fibre bread, are consistent with results from studies on dietary pattern analyses and risk 
of GDM [31, 54, 55]. Healthy dietary patterns and diet quality scores (e.g. Mediterranean Diet score, 
Healthy Eating Index) often include vegetables, fruit and whole grain products and limited intake of 
refined grains. Healthy dietary patterns are consistently associated with lower risk of GDM. Pinpointing 
specific food groups underlying the associations between carbohydrates and GDM is important for 
development of effective prevention strategies, as it might be easier to change intake of specific food 
groups rather than a complete dietary pattern. However, more studies and specifically randomized 
clinical trials are needed to confirm our results and to investigate whether changing intakes of specific 
food groups have an impact on reducing GDM risk.  
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The results presented were derived using data from a large, prospective study. Women were included 
in the study early in their reproductive age and before pregnancy. The longitudinal design with multiple 
measurements enables the examination of prospective associations with risk of developing GDM. 
Additionally, we were able to use updated information on covariates such as BMI, educational level, 
and smoking, which might change over time since the start of the study, especially in this young cohort. 
Results from this nationally representative population-based sample are generalizable to the 
Australian population of reproductive-aged women [17] and other Western countries with similar 
sources of carbohydrate intake. Furthermore, in this study we looked at both quantity and quality of 
carbohydrates to provide a complete overview. 
However, some limitations should also be acknowledged. First, data from this study is observational 
and no causal effects can be established. Secondly, data is obtained from self-reports and therefore 
misclassification could be present, although self-reported GDM outcome was validated against medical 
records [26]. Furthermore, validation of the FFQ showed good agreement with food-records (energy-
adjusted correlation coefficients of 0.78 for carbohydrate) [20], indicating that most important 
carbohydrate sources are properly assessed with the FFQ. However, food group intake was not 
validated and sugar-sweetened beverages were not included. Furthermore, food group analysis was 
limited by aggregation of foods in the FFQ food items. For example, it was not possible to differentiate 
between whole-grain pasta and refined grain pasta in the staple group. Also, aggregation of foods in 
the FFQ food items might have affected the GI associations, as aggregation of foods with different GI 
values could have led to misclassification. Thirdly, dietary intake during pregnancy was not assessed in 
this study. However, a recent study investigating diet quality of women before and during pregnancy 
in the ALSWH showed that there were few differences in dietary intake between non-pregnant and 
pregnant women [56], as is also reported by other studies [57, 58]. Finally, although we were able to 
adjust for a wide variety of socio-demographic and lifestyle factors, residual confounding might still be 
present, e.g. consumption of certain food items could reflect health consciousness.  
 
Conclusions 
A relatively low carbohydrate and high fat and protein intake may increase risk of GDM; however, it is 
important to take the source of carbohydrate into account. High intake of total dietary fibre, fruit and 
fruit juice may decrease risk of GDM, whereas cereal could increase risk of GDM. This may be important 
to consider in nutritional programs for preventing GDM.  
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Abstract 
Aims: The objective of this study was to examine the prevalence of inadequate micronutrient intake 
before pregnancy and the association between pre-pregnancy dietary micronutrient adequacy, i.e. 
meeting micronutrient intake recommendations for a range of micronutrients, and risk of developing 
gestational diabetes (GDM) in an Australian population. 
Methods: In the prospective cohort Australian Longitudinal Study on Women’s Health, 3,607 women 
who were aged 25-30 years at baseline in 2003 and had no diabetes were followed-up until 2015. Diet 
was assessed with a validated 101-item food frequency questionnaire. Micronutrient intake was 
compared with Australian nutrient reference values. The Micronutrient Adequacy Ratio (MAR) was 
calculated as the micronutrient intake divided by its recommended dietary intake averaged over 
thirteen micronutrients. GDM diagnosis was self-reported and validated in a subsample. Multivariable 
regression models with generalized estimating equations were used to estimate relative risks (RR) and 
95% CI.  
Results: In 6,263 pregnancies, 285 cases of GDM were documented (4.6%). High prevalences of 
inadequate dietary micronutrient intake were observed for calcium (47.9%), folate (80.8%), 
magnesium (52.5%), potassium (63.8%) and vitamin E (78.6%), indicating suboptimal pre-pregnancy 
micronutrient intakes. Inadequate intakes of individual micronutrients were not associated with risk 
of developing GDM. However, women in the highest quartile of the MAR had a 39% lower risk of 
developing GDM compared to women in the lowest quartile (RR 0.61, 95% CI 0.44-0.86, p for trend 
0.01).  
Conclusions: These results highlight the importance of an adequate pre-pregnancy intake for 
micronutrients. Further prospective studies are needed to confirm these findings.  
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Introduction 
Adequate dietary micronutrient intake before and during pregnancy is essential for optimal growth 
and development of the foetus [1]. Micronutrients are involved in a vast array of physiological 
processes such as enzyme activity, signal transduction and transcription pathways, biological functions 
and oxidative stress [2]. The most well-known example of the importance of adequate micronutrient 
intake started before conception and continued during pregnancy is the higher risk of neural tube 
defects due to folate deficiency [3].  
Gestational diabetes mellitus (GDM) is one of the most common metabolic complications during 
pregnancy and prevalence has continued to increase worldwide [4, 5]. During normal pregnancy, the 
demand for insulin is increased due to progressive insulin resistance to ensure adequate foetal growth 
and development. If these insulin requirements are not met, women develop GDM characterized by 
exaggerated insulin resistance as well as impaired insulin secretion [6]. Few modifiable risk factors for 
GDM have been identified, but diet has been indicated as one of the most important ones as it is 
relatively easy to modify [7, 8]. Recent reviews have summarized evidence that show there is a relation 
between diet and the development of glucose intolerance in non-pregnant populations [9-11]. Both 
protective and risk-enhancing associations were observed between different dietary factors and 
glucose intolerance. Micronutrients act via multiple pathways in the glucose homeostasis [10]. For 
example, zinc is involved in insulin assembly, thiamine is an essential coenzyme, magnesium is 
involved in glucose transport, whereas vitamin E and C may mitigate metabolic stress, promoting 
glucose and fatty acid utilization [11]. Thus, micronutrients can play an important role in the complex 
system of glucose homeostasis.  
A limited number of studies have investigated the role of micronutrients in the development of GDM 
and these studies focussed on specific individual micronutrients [12-16]. A higher consumption of 
heme iron before and during pregnancy was associated with a higher risk of GDM [13, 14], whereas a 
higher consumption and plasma concentration of vitamin C and zinc during pregnancy were associated 
with a lower risk of GDM [12, 15, 16]. However, evidence on pre-pregnancy dietary micronutrient 
intake in relation to GDM is limited. Furthermore, as micronutrients may have synergistic or 
antagonistic effect, it is important to look at combined dietary micronutrient intake rather than at 
intakes of individual micronutrients. To our knowledge, no other studies investigated overall 
micronutrient adequacy and developing GDM. Therefore, we investigated dietary micronutrient 
adequacy, which was defined as dietary intake of 13 micronutrients relative to the recommended 
intake of each micronutrient, and overall dietary micronutrient adequacy before pregnancy using the 
Micronutrient Adequacy Ratio (MAR). The objective of this study was to examine the prevalence of 
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inadequate micronutrient intake before pregnancy and the association between pre-pregnancy 
dietary micronutrient adequacy and risk of developing GDM in an Australian population.  
 
Methods 
Study design and population 
The current study used data from the young cohort of the Australian Longitudinal Study on Women’s 
Health (ALSWH). ALSWH is an ongoing population-based prospective cohort study investigating the 
role of demographic, social, physical, psychological, and behavioural factors in women’s health. The 
study design, recruitment, methods and responses have been described elsewhere [17, 18]. Briefly, in 
1996 approximately 15,000 women born in 1973–78 (18–23 years) were recruited. Women were 
randomly selected from Australia’s nationalized health-care system, Medicare, with intentional 
oversampling in rural and remote areas. Self-administered questionnaires were sent to participants 
every 3-4 years. Dietary intake was first collected in 2003 (n=9,081) when women were 25-30 years, 
and this time point was therefore used as baseline for the present analyses. Informed consent was 
obtained from all participants at each survey and the study was approved by the Human Research 
Ethics Committees of the Universities of Newcastle and Queensland.  
In Figure 6.1, a flowchart for detailed breakdown of the sample size for this project is displayed.  
Women were excluded from the current analyses if they did not report a live birth at follow-up surveys 
in 2006, 2009, 2012 or 2015, were pregnant at the baseline survey, had missing data on diet at the 
baseline survey (2003) or follow-up survey (2009), had missing data on GDM, reported implausible 
energy intake (ratio of reported energy intake and predicted energy requirement <0.56 or >1.44 [19]), 
had a history of type 1 or type 2 diabetes mellitus prior to GDM diagnosis, had a history of GDM prior 
to baseline, or had missing covariate data. In total 3,607 women who experienced a total of 6,263 
pregnancies were included in the analyses.  
Dietary assessment 
Dietary intake was assessed using the Dietary Questionnaire for Epidemiological Studies (DQES) FFQ 
version 2. This 101-item FFQ assesses usual food and beverage intake of the previous 12 months. 
Information on frequency and dose of vitamin and/or mineral supplementation was not included in 
the FFQ. The development and evaluation of this FFQ has been described elsewhere [20, 21]. Briefly, 
participants were asked to report their usual frequency of consumption of 74 food items and six 
alcoholic beverage items using a 10-point scale ranging from ‘Never’ to ‘Three or more times per 
day’. Portion size photographs were used to adjust the serving sizes. Twenty-one items were  
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Figure 6.1: Flow chart of the study population. 
 
included on the number of servings of milk, bread, sugar and eggs, and the type of milk, bread, fat 
spread and cheese consumed. Nutrient intakes were computed using the national government food 
composition database of Australian foods, the NUTTAB95 [22]. Available micronutrient intakes in this 
study were: vitamin A, folate, niacin, riboflavin, thiamine, vitamin C, vitamin E, calcium, iron, 
potassium, zinc, phosphorus and magnesium. Validation of the FFQ against 7 day food diaries of 63 
women of reproductive age showed moderate to strong energy-adjusted correlation coefficients for 
a wide range of macro- and micronutrients (ranging from 0.28 for vitamin A to 0.69 for magnesium) 
[20]. Information on dietary intake was collected at baseline (2003) and during a follow-up survey in 
2009. As dietary intake can change over time the most recent reported dietary intake before the 
pregnancy was used.  
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Micronutrient adequacy 
Nutrient Reference Values for Australia and New Zealand, published in 2005 by the National Health 
and Medical Research Council of Australia, were used to assess adequacy and inadequate 
micronutrient intakes [23]. The definitions of the Australian Nutrient Reference Values used in this 
study can be found in Table 6.1. The Estimated Average Requirement (EAR) cut point method was 
used to assess the prevalence of inadequate micronutrient intake on a population level, by assessing 
the proportion of the population below the EAR [24]. No EAR was available for vitamin E and 
potassium, therefore, the Adequate Intake (AI) was used as an alternative to assess the prevalence of 
inadequate micronutrient intake on a population level.  
To assess micronutrient adequacy for individuals, the Nutrient Adequacy Ratio (NAR) was calculated 
[25, 26]. The NAR is a measure of an individual’s micronutrient adequacy, by comparing the 
individual’s daily intake of a nutrient with the RDI for that nutrient. A NAR ranges between 0 and 1.0. 
A NAR of 1.0 indicates that intake of that nutrient equals the RDI, whereas a value below 1.0 indicates 
an intake lower than the RDI (i.e. inadequacy). The Mean Adequacy Ratio (MAR) is calculated as the 
average of the NAR values for the selected nutrients for a certain individual [25, 26]. The MAR is 
derived by summing the NARs and dividing by the number of micronutrients assessed. The MAR is 
thus a summary measure of micronutrient adequacy with a MAR of 1.0 indicating that for all 13 
micronutrients intake is equal or higher than recommended. As micronutrient intake was highly 
correlated with total energy intake (r 0.50-0.81), the nutrient residual method was used to adjust for 
energy intake [27].  
 
Table 6.1: Definitions and abbreviations of the nutrient reference values used in the current study. 
Nutrient Reference Value  Abbreviation Definition Level 
Estimated Average 
Requirementa  
EAR 
Daily nutrient intake level needed to meet the requirements 
of half the healthy individuals in a particular life stage and 
gender group 
Population 
Adequate Intakeb AI 
Average daily nutrient intake level based on observed or 
experimentally determined approximations or estimates of 
nutrient intakes by a group (or groups) of apparently 
healthy people that are assumed to be adequate 
Population 
Recommended Dietary Intake  RDI 
The average daily dietary intake level that is sufficient to 
meet the nutrient requirements of nearly all (97–98 per 
cent) healthy individuals in a particular life stage and gender 
group 
Individual 
a EAR was available for vitamin A, folate, niacin, riboflavin, thiamine, vitamin C, calcium, iron, zinc, phosphorus, 
magnesium. 
b AI was used for vitamin E and potassium.   
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 Assessment of GDM 
Diagnosis of GDM was assessed at each survey and for each live birth using the following question: 
‘Were you diagnosed by a doctor or treated for gestational diabetes?’. During the study period, 
diagnostic criteria for GDM in Australia included a 1-hour venous plasma glucose level ≥6.55% (7.8 
mmol/l) after a 50g glucose load; or a 1-hour venous plasma glucose level ≥6.65% (8.0 mmol/l) after 
a 75g glucose load. Diagnosis was confirmed with a 75g oral glucose tolerance test (fasting) with a 
venous plasma glucose level at 0-hours of ≥5.1% (5.6 mmol/l) and/or at 2-hours of ≥6.65% (8.0 mmol/l) 
[28]. A reliability study among a subgroup of women from New South Wales (n = 1,914) has 
demonstrated high agreement of 91% between self-reported GDM diagnosis in the study and 
administrative data records [29]. 
Covariates 
Self-reported information on country of birth was reported at the first questionnaire at the start of 
the cohort study. Information on highest qualification completed, number of hours paid work, marital 
status, parity, hypertensive disorders of pregnancy, polycystic ovary syndrome, inter-pregnancy 
interval, smoking, physical activity and body mass index (BMI) was self-reported at each survey round 
(2003, 2006, 2009, 2012 and 2015). Physical activity was assessed using validated questions on 
frequency and duration of walking and on moderate- and vigorous-intensity activity and was 
categorized as sedentary/low (<600 total metabolic equivalent [MET] min/week), moderate (600 to 
<1200 MET min/week) or high (≥1200 MET min/week) [30]. BMI was categorized as underweight (BMI 
<18.5 kg/m2), normal weight (BMI 18.5 to <25 kg/m2), overweight (BMI 25 to <30 kg/m2) or obese 
(BMI ≥30 kg/m2). Only a few women were classified as underweight (n=123, 3.4%); therefore, the 
underweight and normal weight groups were combined as normal weight (BMI <25 kg/m2). 
Statistical analysis  
Participants’ characteristics reported at baseline were compared across the four quartiles of the MAR 
score using ANOVA and χ2 tests. Characteristics were weighted by area of residence to account for 
oversampling of women from rural and remote areas.  
Generalized estimating equations (GEE) analyses were used to account for correlated observations 
due to multiple pregnancies by the same participant [31]. As log-binomial models did not converge, 
log-Poisson models were used to estimate relative risks (RR) and 95% confidence intervals (95%CI) 
[32] for associations between inadequate micronutrient intakes, MAR and development of GDM. 
Model 1 was adjusted for age at pregnancy, country of birth, educational level, vitamin and mineral 
supplement use, smoking, physical activity, energy intake, PCOS, hypertension during pregnancy, 
inter-pregnancy interval, and parity. Model 2 was additionally adjusted for carbohydrate, protein, 
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saturated fat, and fibre intake. Model 3 was additionally adjusted for BMI. Adjustment for time-varying 
covariates (age at pregnancy, education level, BMI, vitamin and mineral supplement use, smoking, 
physical activity, parity, PCOS, dietary factors) was performed using the value reported at the survey 
administered prior to the pregnancy. For pregnancy-specific covariates (hypertension during 
pregnancy and, if applicable, inter-pregnancy interval) the value reported for that specific pregnancy 
was used. Multiple gestation, alcohol intake, area of residence, work status and marital status were 
not included in the analyses, as these were not significant confounders based on the data. Smoking, 
vitamin and mineral supplement use and physical activity were also not significant confounders based 
on the data, but were kept in the model. 
Additional analyses were conducted to investigate effect modification by BMI, parity and education 
level, as these are known risk factors for GDM and have been reported as possible effect modifiers 
[33-35]. Effect modification was investigated by adding a cross-product interaction term to the main-
effects multivariable model and by stratification.  
To examine the robustness of the associations observed we performed several sensitivity analyses. 
First, we averaged dietary intake data from the baseline survey in 2003 and follow-up survey in 2009 
to estimate long-term average dietary intake (n=2,613). Furthermore, to exclude possible 
misclassification due to women changing their normal diet to increase chance of conception, all 
pregnancies within the first two years of follow-up (n=864) were excluded. Additionally, we conducted 
a multiple imputation analysis to assess the influence of participant exclusions that resulted from 
missing covariate data (BMI, physical activity, educational level, smoking status, and alcohol intake; 
n=223) using SAS procedures MI and MIANALYZE [36].  
Statistical analyses were conducted using SAS Software Version 9.4 (SAS Institute Inc., Cary, NC, USA). 
A p value <0.05 was considered statistically significant. 
 
Results 
During 12 years of follow-up (2003-2015), 285 cases of GDM (4.6%) were reported among 3,607 
women with 6,263 pregnancies. Women with a MAR in the lowest quartile were younger when they 
were pregnant, more likely to live in an urban area, be born in Asia, have a lower educational level, be 
less physically active, be a current smoker, use vitamin and mineral supplements less often, and be 
multiparous compared to women in the highest quartile (Table 6.2). Although energy intake 
significantly differed between the four quartiles, no clear trend was observed. Women with a MAR in 
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the highest quartile had lower intakes of fat and saturated fat and higher intakes of protein, 
carbohydrates, and fibre than women in the lowest quartile. In Supplementary Table 6.1, median 
micronutrient intakes for the MAR quartiles are provided. 
In Table 6.3, median micronutrient intakes and prevalence of inadequate micronutrient intakes are 
shown for women who developed GDM and those who did not. Vitamin C intake was lower in women 
who developed GDM (99 mg (interquartile range [IQR] 64 mg) vs. 109 mg (IQR 73 mg), p=0.002)), 
whereas micronutrient intakes of zinc and phosphorus were higher (p<0.05) in women who developed 
GDM compared to those without GDM (Table 3). Prevalence of inadequate micronutrient intakes, 
based on the EAR-cut point method, ranged from 80.9% for folate to 0% for niacin, vitamin C and 
phosphorus. High prevalence of inadequate dietary micronutrient intake was observed for calcium 
(47.9%), folate (80.8%), magnesium (52.5%), potassium (63.8%) and vitamin E (78.6 %). Prevalence of 
inadequate intakes for individual micronutrients did not differ between women who developed GDM 
and those without, and inadequate intake of a single micronutrient was not associated with a higher 
or lower risk of developing GDM after adjustment for covariates (Table 6.3).  
Table 6.2: Baseline characteristics of 3,607 non-pregnant Australian women according to quartile of mean 
adequacy ratio (MAR). 
 Quartiles of mean adequacy ratio (MAR) 
p-valueb Characteristicsa 
Quartile 1 
N=901 
Quartile 2 
N=899 
Quartile 3 
N=904 
Quartile 4 
N=903 
Median MAR 0.81 0.87 0.90 0.95  
Age at baseline (yrs) 27.5 (1.5) 27.6 (1.5) 27.5 (1.4) 27.5 (1.5) 0.72 
Age at pregnancy (yrs) 30.3 (3.2) 30.4 (3.0) 30.9 (3.2) 31.1 (4.1) <0.001 
Area of residence     <0.001 
Urban 78.3 71.3 70.3 74.3  
Rural/remote 21.7 28.7 29.7 25.7  
Country of birth      <0.001 
Australia 88.4 91.6 92.8 92.2  
Asia 4.5 0.9 0.9 0.6  
Other 7.1 7.5 6.3 7.2  
Highest educational level     <0.001 
Up to year 12 or equivalent 22.0 20.5 18.5 14.0  
Trade/apprenticeship/certificate/diploma 25.4 23.4 19.5 18.1  
University/higher degree 52.6 56.1 62.0 67.9  
Work status     0.13 
No-paid job 15.6 15.4 15.4 14.5  
Part-time 19.7 22.1 24.4 19.6  
Full-time 64.7 62.5 60.3 65.9  
Marital status     0.002 
Married/in a relationship 64.0 71.0 64.7 66.2  
Separated/divorced/widowed 3.8 2.9 1.9 2.0  
BMI (kg/m2) 
 
23.7 (4.8) 24.0 (4.6) 23.9 (4.6) 23.4 (4.1) 0.01 
Chapter 6 
116 
  
The MAR was inversely associated with GDM risk (p for trend 0.011) adjusted for BMI, vitamin and 
mineral supplement use, smoking, physical activity, socio-demographic, reproductive and dietary 
factors (Table 6.4). Women in the quartile with the highest MAR had a 39% lower risk of developing 
GDM compared to women in the lowest quartile (RR 0.61, 95% CI 0.44-0.86). Excluding the 
micronutrients from the MAR one by one did not change the results (data not shown). BMI, parity and 
educational level were no significant effect modifiers based on adding interaction terms to 
multivariable models (p value all >0.20). Similar associations were observed between inadequate 
micronutrient intakes, MAR and development of GDM in the sensitivity analyses performed (i.e. 
combining dietary intake dat a from surveys in 2003 and 2009, using multiple imputation for missing 
covariate data and excluding pregnancies occurring in the first 2 years of follow-up) (data not shown).  
 
  
 
Table 6.2 continued:      
BMI      0.02 
Healthy weight (<25 kg/m2) 72.4 69.3 69.3 75.1  
Overweight (25 to <30 kg/m2) 17.6 19.2 20.6 18.1  
Obese (≥30 kg/m2) 10.0 11.5 10.1 6.9  
Physical activity     <0.001 
Sedentary/low (<600 MET min/week) 48.5 46.5 37.7 31.9  
Moderate (600 to <1200 MET min/week) 23.4 23.8 27.5 25.7  
High (≥1200 MET min/week) 28.1 30.7 34.5 42.3  
Smoking status     <0.001 
Never smoked 58.8 62.0 32.3 66.2  
History of smoking 17.2 15.7 18.3 19.1  
Current smoker 24.0 22.3 19.4 14.7  
Alcohol intake status     0.17 
Non drinker 5.4 5.6 5.1 4.6  
Low risk/rarely drinks 90.4 90.1 92.5 92.6  
High risk/often drinks 4.2 4.3 2.4 2.8  
Vitamin and mineral supplement use     0.04 
Never/rarely 36.9 34.2 33.2 30.3  
Sometimes 25.7 23.5 24.7 25.3  
Often 37.4 42.3 42.1 44.4  
Nulliparous  75.9 76.1 77.7 84.2 <0.001 
Polycystic ovary syndrome 9.3 8.2 8.1 8.9 0.75 
      
Total energy intake (kJ/day) 6975 (2197) 7190 (1711) 7179 (1526) 6892 (1263) <0.001 
Total fat intake (E%) 38.3 (5.4) 37.6 (5.0) 35.7 (4.9) 33.4 (5.2) <0.001 
Total saturated fat intake (E%) 16.3 (3.2) 15.7 (3.1) 14.6 (2.8) 13.2 (2.9) <0.001 
Total protein intake (E%) 19.4 (3.3) 19.9 (3.1) 20.1 (3.0) 20.5 (3.1) <0.001 
Total carbohydrate intake (E%) 42.7 (6.4) 42.8 (5.7) 44.5 (5.4) 46.2 (5.9) <0.001 
Total fibre intake (g/day) 16.1 (6.1) 18.6 (5.7) 20.7 (5.6) 23.6 (5.4) <0.001 
Values are mean (SD) or % 
a Baseline characteristics (2003), weighted for area 
b P values from χ2 or ANOVA 
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Discussion 
In our cohort of reproductive-aged women, prevalence of inadequate dietary micronutrient intake 
was more than 50% for the micronutrients calcium, potassium, magnesium, vitamin E and folate, 
indicating suboptimal pre-pregnancy micronutrient intakes. Inadequate micronutrient intake of 
individual nutrients was not associated with risk of developing GDM. However, women in the highest 
quartile of overall higher micronutrient intake as expressed by the MAR had a 39% lower risk of 
developing GDM compared to women in the lowest quartile and a declining trend over the quartiles 
was shown.  
Maternal nutritional status during pregnancy is an essential factor in the health and development of 
their offspring, and thus having an adequate dietary intake of essential micronutrients is extremely 
important. However, as demonstrated by our study, women do not meet dietary reference values for 
a number of micronutrients in the years leading up to pregnancy, especially for folate. This was also 
observed in other studies [37, 38] including a recent study investigating micronutrient intake of 
Australian women before and during pregnancy [39]. The gap between recommended and actual 
dietary intake can be partly met by taking supplements. We had no information on frequency and 
dose of specific supplements and thus micronutrient intake in our study was based on dietary intake 
only. We did have information on vitamin and mineral supplement use, and observed associations 
between MAR and GDM were independent of reported vitamin and supplement use. It should be 
noted that women with a higher MAR were more likely to use vitamin or mineral supplements than 
women in the lowest quartile of MAR. This confirms results of previous research that those who need 
supplements the most (i.e. those with the lowest micronutrient intake) are the least likely to consume 
micronutrient supplements [39-41]. A recent study using data of 485 preconception women of the 
Table 6.4: Relative risks (95% CIs) for associations between mean micronutrient adequacy ratio and incidence 
of gestational diabetes (n=3607). 
 Quartiles of mean adequacy ratio (MAR) P for 
trend  Quartile 1 Quartile 2 Quartile 3 Quartile 4 
Median MAR 0.81 0.87 0.90 0.95  
N women/pregnancies 901/2084 899/1290 904/1242 903/1647  
GDM cases n (% pregnancies) 112 (5.4) 66 (5.1) 55 (4.4) 52 (3.2)  
Model 1a 1.00 (ref) 1.05 (0.79-1.43) 0.91 (0.66-1.25) 0.57 (0.40-0.80) 0.001 
Model 2b 1.00 (ref) 1.04 (0.77-1.41) 0.92 (0.66-1.27) 0.59 (0.42-0.83) 0.005 
Model 3c 1.00 (ref) 1.06 (0.79-1.43) 0.93 (0.67-1.29) 0.61 (0.44-0.86) 0.011 
a Adjusted for age, country of birth, educational level, vitamin and mineral supplement use, smoking, physical activity, 
energy, PCOS, hypertension during pregnancy, inter pregnancy interval and parity  
b Model 1 + additional adjustment for carbohydrate (E%), protein (E%), saturated fat (E%) and fibre (g/d)  
c Model 2 + additional adjustment for BMI 
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ALSWH study identified that 63% of the women used at least one supplement preconception and that 
51% used a supplement containing folic acid [42]. This is in line with another Australian study that 
observed that 64% of the women took a dietary supplement in the preconception period, with 40% of 
the women using a supplement containing folic acid [39]. However, still a large proportion of women 
in this study did not achieve an adequate folate (46%), iron (80%) or zinc (36%) intake in the 
preconception period. This underlines the need for further efforts to promote adequate dietary 
micronutrient intakes before pregnancy.  
It should be noted that 40% of the pregnancies included in the current analyse were after 2009. In 
2009 folic acid fortification of flour was started. This was not taken into account in our dietary intake 
estimates of folate. Fortification increases dietary folate intakes with approximately 150 μg for women 
of childbearing age [43] and is therefore expected to substantially decrease prevalence of inadequate 
folate intake to approximately 11% in this study population.  
In our study, we observed no significant associations between intakes of individual micronutrients and 
risk of developing GDM. This was furthermore supported by the fact that excluding each micronutrient 
from the MAR one by one did not affect the results. This indicates that not one single micronutrient 
was driving the observed association between MAR and GDM. In contrast to the results of our study, 
other studies did report associations between intakes of individual micronutrients and risk of 
developing GDM. A recent review summarized the limited evidence suggesting an association 
between higher intake of iron, particularly heme iron, and higher risk of GDM [44]. In our study, we 
observed a 30% increased risk of GDM in women with inadequate iron intakes, but this was not 
statistically significant, and we were not able to distinguish between heme and non-heme iron intakes. 
It highlights, however, the need to further investigate iron intake in relation to GDM risk. Especially, 
since iron supplementation during pregnancy is recommended when iron deficiency anaemia is 
suspected (9-37% of pregnant women [38, 45]). Furthermore, one study observed a lower risk of GDM 
with higher intake of vitamin C [16]. This is in line with our observation that women who developed 
GDM had lower pre-pregnancy vitamin C intake compared to those who did not. However, intakes of 
vitamin C were adequate in both women who developed GDM and those with did not and we could 
not calculate a relative risk of GDM when vitamin C intake was inadequate. Another study observed a 
lower risk of GDM with higher plasma concentrations of zinc or selenium [12]. It should be noted that 
some of the strongest observed associations in these studies were associations using biomarkers 
indicating nutrient status instead of dietary intake. Unfortunately, we had no information on nutrient 
status, which might reflect nutrient stores better than dietary intakes and includes information on 
supplement intake and fortification.  
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To study micronutrient adequacy, we used a summary measure of micronutrient intake across 13 
micronutrients, i.e. the MAR, and observed an overall higher micronutrient intake to be associated 
with a lower risk of developing GDM. To our knowledge, no other studies investigated overall 
micronutrient adequacy and developing GDM. However, several studies investigated pre-pregnancy 
dietary patterns and risk of GDM [33, 35, 46]. Those studies, in general, observed a lower risk of GDM 
with dietary patterns reflecting high intakes of nutritious foods such as fruit, vegetables, whole grains 
and low-fat dairy (e.g. Mediterranean dietary pattern, prudent dietary pattern). Although adherence 
to a dietary pattern high in nutritious foods does not necessarily mean that recommended 
micronutrient intakes are met, it is associated with higher micronutrients intakes [26]. The observed 
relationship between dietary patterns high in nutritious foods and lower risk of GDM are thus in line 
with our observed relationship between micronutrient adequacy and lower risk of GDM.  
Our study had several strengths. The longitudinal design of the study allowed us to examine 
associations between micronutrient adequacy and risk of GDM prospectively. In addition, information 
on 13 micronutrients and a wide variety of possible confounders was available. Finally, the design of 
the study enabled us to study pre-pregnancy dietary intake and included all pregnancies, including 
unplanned pregnancies.  
However, some limitations need to be acknowledged. Data used in this study were self-reported. Self-
report could have led to misclassification of both the exposure and outcome. However, a reliability 
study among a subgroup of 1914 women from New South Wales demonstrated 91% agreement 
between self-reported GDM diagnosis in our study and administrative data records [11]. In addition, 
the FFQ was validated against 7-day weighted food records in 63 Australian women. Energy-adjusted 
correlation coefficients for the micronutrients showed good to moderate agreement between the FFQ 
and the food records (correlation between 0.40-0.70), except for vitamin A (correlation coefficient 
0.28) [20]. Furthermore, the MAR was not weighted, assuming equal importance of the different 
micronutrients. The MAR is a summary measure of overall micronutrient intake relative to 
recommended intakes, i.e. micronutrient adequacy, and therefore weighing was judged 
inappropriate.  
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Conclusions 
Pre-pregnancy dietary micronutrient intakes were suboptimal in this cohort of Australian women. A 
higher overall dietary micronutrient intake was associated with a lower risk of developing GDM, 
whereas inadequate intakes of individual micronutrient intakes were not associated with risk of GDM. 
This highlights the importance of an overall adequate micronutrient intake in the pre-pregnancy 
period. Future studies should investigate whether interventions improving overall dietary 
micronutrient adequacy before pregnancy reduce the risk of GDM and whether supplements could 
potentially play a role in improving overall micronutrient adequacy and, consequently, lower risk of 
GDM. 
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Supplementary material  
 
Supplemental table 6.1: Micronutrient intake of 3,607 non-pregnant Australian women according to quartile 
of mean adequacy ratio (MAR) 
Dietary intake EARa 
Quartiles of mean adequacy ratio (MAR) 
Quartile 1 
N=901 
Quartile 2 
N=899 
Quartile 3 
N=904 
Quartile 4 
N=903 
Vitamin A (RE/day) 500 584 (465-754) 682 (563-878) 714 (575-917) 745 (617-897) 
Folate (FE/day) 320 182 (154-221) 223 (195-268) 254 (224-300) 300 (263-347) 
Niacin (NE/day) 11 29.4 (24.4-38.0) 34.3 (28.6-42.8) 36.3 (30.4-42.9) 37.7 (32.3-43.7) 
Riboflavin (mg/day) 0.9 1.63 (1.37-2.14) 2.09 (1.74-2.56) 2.32 (1.97-2.76) 2.54 (2.20-2.99) 
Thiamine (mg/day) 0.9 1.07 (0.87-1.41) 1.31 (1.09-1.65) 1.43 (1.19-1.74) 1.56 (1.31-1.88) 
Vitamin C (mg/day) 30 85 (59-119) 103 (76-144) 119 (87-158) 127 (95-170) 
Vitamin E (mg/day) AI 7 4.53 (3.64-5.83) 5.30 (4.33-6.60) 5.74 (4.7-6.76) 5.99 (5.10-7.24) 
Calcium (mg/day) 840 696 (590-838) 822 (700-1004) 910 (768-1076) 963 (830-1087) 
Iron (mg/day) 8 8.9 (7.5-11.2) 10.6 (9.0-12.9) 11.6 (9.9-13.9) 13.3 (11.3-15.7) 
Potassium (mg/day) AI 2800 2013 (1763-2393) 2413 (2146-2916) 2682 (2383-3067) 2881 (2606-3187) 
Zinc (mg/day) 6.5 9.1 (7.4-11.6) 10.2 (8.6-12.8) 10.6 (8.9-12.8) 10.8 (9.2-12.4) 
Phosphorus (mg/day) 580 1156 (996-1423) 1336 (1154-1609) 1442 (1262-1689) 1506 (1356-1690) 
Magnesium (mg/day) 255-265 201 (176-241) 237 (2123-283) 266 (237-309) 300 (267-337) 
Values are median (p25-p75) 
EAR, estimated average requirement; AI, adequate intake; p25, 25th percentile; p75, 75th percentile ; RE, retinol 
equivalents; FE, folic acid equivalents; NE, niacin equivalents; 
a EAR values were obtained from National Health and Medical Research Council (2005) Nutrient Reference Values for 
Australia and New Zealand. In. NHMRC, Canberra 
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Abstract 
Objective: The aim of this research is firstly to describe changes in folate, vitamin B6, vitamin B12, 
vitamin D and iron intake, their status markers and diet quality from preconception to the second 
trimester of pregnancy, and secondly to examine the association of these micronutrient intakes, their 
status markers and diet quality with glucose tolerance during pregnancy. 
Methods: Data from 91 women aged 18-40 years with either a wish to get pregnant within one year 
or those less than 24 weeks pregnant were collected longitudinally. Women with an increased risk of 
GDM were oversampled, whereas multifetal pregnancies were excluded. Women were measured at 
preconception (n=67), 12 weeks of pregnancy (n=47) and 24 weeks of pregnancy (n=55). At each time 
point women underwent a fasting venipuncture and a 75-grams oral glucose tolerance test. Dietary 
intake was assessed at each time point with a validated food frequency questionnaire and two non-
consecutive 24-hour recalls. Adjusted repeated measures mixed models were used to assess 
longitudinal associations of micronutrient intakes, status markers and diet quality with glucose 
tolerance during pregnancy.  
Results: Micronutrient intakes changed significantly throughout pregnancy, due to changes in 
supplemental intakes, whereas dietary micronutrient intakes and diet quality remained stable. 
Nutrient status levels changed significantly from preconception to the second trimester of pregnancy. 
For folate, vitamin B6 and vitamin D this could be partly explained by changes in intake. In general, 
fasting and 2-hour glucose levels and HbA1c levels were not associated with diet quality, micronutrient 
intake or status levels, except for a weakly inverse association of folate intake with 2-hour glucose 
levels (β=-0.001 mmol/L for each FE µg (95% CI -0.001;0.000) p=0.052), and a weakly positive 
association between ferritin and 2-hour glucose levels (β=0.009 mmol/L for each µg/L increase (95%CI 
-0.00; 0.018); p=0.058). Diet quality was in a sensitivity analysis, excluding data from participants with 
only one measurement, inversely associated with fasting glucose (β=-0.007 mmol/L for each DHD15-
index point, 95% CI -0.010; -0.0001); p=0.024). 
Conclusions: Micronutrient intakes and their status markers changed significantly during pregnancy.  
More research is needed with respect to the role of micronutrients in relation to GDM development. 
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Introduction 
Micronutrient levels may affect pregnancy outcomes through alterations in maternal and foetal 
metabolism, as micronutrients are involved in enzyme activity, signal transduction and transcription 
pathways and oxidative stress [1, 2]. Adequate dietary intake and nutrient status during pregnancy are 
conditions needed to ensure optimal foetal development and birth outcomes [3, 4]. Despite wide 
availability of healthy and nutrient-rich foods in high-income countries, nutrient deficiencies remain as 
high-fat, high-sugar diets with low nutrient density are increasingly consumed [5]. A recent review 
indicated that pregnant women are at high risk of inadequate intakes of iron, folate and vitamin D [6]. 
As vitamin B6 and B12 are, like folate, cofactors in the one-carbon metabolism responsible for DNA 
and RNA synthesis and methylation [7], these micronutrients are of interest as well. 
Micronutrient intake might also affect maternal health. Gestational diabetes mellitus (GDM), defined 
as hyperglycaemia with onset or first detection during pregnancy, is one of the most common 
metabolic pregnancy complications, affecting approximately 7% of pregnancies [8, 9]. Risk of GDM is 
linked with diet and micronutrient intake [10, 11]. Large prospective cohort studies observed 
associations of preconception dietary intake with diagnosis of GDM [12-14], whereas randomized 
controlled trials investigated the effect of dietary counselling during pregnancy on GDM prevention 
[15-17]. Thus far, evidence has linked a healthy preconception diet with a decreased risk of GDM [18]. 
Only few studies have investigated the role of folate, vitamin B6, vitamin B12, vitamin D, and iron in 
relation to risk of GDM. These studies linked higher vitamin B12 and vitamin D status to a lower risk of 
GDM [19-22], whereas higher folate and iron status were associated with an increased risk of GDM 
[21, 23]. However, it should be noted that most of these studies had a cross-sectional or retrospective 
design and did not account for changes in dietary intake or nutrient status throughout pregnancy.  
Furthermore, when investigating dietary micronutrient intake during pregnancy, supplement use is an 
important factor to take into account. The WHO recommends daily iron and folic acid supplement use 
for pregnant women [24] and studies report that up to 90% of pregnant women use at least one 
supplement during pregnancy [25, 26]. Ideally, when investigating micronutrient intakes in relation to 
health outcomes, micronutrient status should also be included, as it provides additional information 
on nutrient stores. However, maternal haemodynamic, cardiovascular, renal and gastrointestinal 
adaptations occur during pregnancy, which influences blood micronutrient levels. Few studies have 
described micronutrient status levels throughout pregnancy [27-31], and, to our knowledge, none has 
studied the impact of dietary intake and supplement use during pregnancy.  
We aim to complement previous described research by 1) describing changes in selected 
micronutrients intake, i.e. folate, vitamin B6, vitamin B12, vitamin D and iron, their status markers and 
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overall diet quality from preconception to the second trimester of pregnancy, and 2) examining the 
association of micronutrients and overall diet quality with glucose tolerance during pregnancy in a 
sample of healthy women at increased risk of GDM with a singleton pregnancy. 
 
Methods 
Study design and subjects 
This study was performed using data of the GLIMP2 study; a small prospective cohort study aiming to 
assess the role of diet, nutrient status and other risk factors in the development of gestational diabetes 
mellitus (GDM). Women with a wish to get pregnant within one year or those less than 24 weeks 
pregnant were recruited between June 2015 and May 2017 at the Department of Gynaecology and 
Department of Internal Medicine at three non-university hospitals in the eastern part of the 
Netherlands: Gelderse Vallei Hospital (Ede); Rijnstate (Arnhem); and Slingeland (Doetinchem). Women 
with a higher risk of developing GDM (i.e. previous pregnancy with GDM or macrosomic infant or 
overweight/obese) were oversampled. Main inclusion criteria were age between 18 and 40 years, 
willing to get pregnant within one year or less than 24 weeks pregnant at time of recruitment, and 
competent to make their own decisions. Women were excluded when they were not able to read and 
speak Dutch. The Medical Ethics Committee of Wageningen University & Research approved the study. 
All women gave their written informed consent before the start of the study. 
Measurements took place before pregnancy (T0), at 12 weeks of gestation (T1), and at 24 weeks of 
gestation (T2). All participants filled out a baseline questionnaire at the start of the study. At each time 
point, participants visited one of the research centres. Measurements included anthropometrics, a 
fasting venipuncture followed by a 75-grams oral glucose tolerance test (OGTT) including a 
venipuncture 2 hours after the glucose load, filling out a food frequency questionnaire (FFQ) and 
questionnaires on lifestyle, health and pregnancy-related factors. Additionally, women were asked to 
fill out a 24-hour recall (24hR) on two non-consecutive days within four weeks after each visit.   
Dependent on whether participants were pregnant at the start of the study and duration of gestation 
women started at either T0, T1 or T2. In total, 115 women were included for participation in the study 
(Figure 7.1). For the current analysis, we used T0-T2 data collected until August 2017. Seven women 
dropped out before completing any of the measurements, and 17 women were excluded for the 
current analyses because of missing data (blood measurements or dietary intake data), leaving a total 
of 91 women for the current analyses. Eleven women dropped out after the T0 measurement. Main 
reasons for drop out were lack of time, and burden of the OGTT. In total, 57 women completed the 
Micronutrient intake, status, diet quality and glucose tolerance 
131 
measurement at T0, 43 women completed a measurement at T1 and 47 women completed a T2 
measurement. Forty-four women completed at least two measurements and 19 women completed all 
three measurements. Women who did not get pregnant after T0 measurements (n=19) did not differ 
significantly regarding age, BMI, ethnicity, education level and smoking status from those who did get 
pregnant after T0 measurement (n=34) (data not shown). Furthermore, women who completed two 
or three measurements (n=44) did not differ regarding age, ethnicity, education level and smoking 
status from women who completed only one measurement (n=47) (data not shown). 
 
Figure 7.1: Flowchart of the GLIMP2 study. 
 
Dietary assessment  
Food frequency questionnaire (FFQ) 
A semi-quantitative 173- item FFQ was used to assess usual dietary intake of the previous month. The 
FFQ was an updated version of a FFQ previously designed and validated to estimate habitual dietary 
intake of energy, macronutrients, fibre and B-vitamins in Dutch women of reproductive age [32-34]. 
Answer categories for frequency questions ranged between ‘not in this month’ to ‘6–7 days/week’, 
and portion sizes were estimated using natural portions (bread shapes) and commonly used household 
measures (e.g. spoon and cup). Average daily nutrient intakes were calculated by multiplying 
frequency of consumption by portion size and nutrient content per gram using the 2011 Dutch food 
composition table [35]. 
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24 hour recalls (24hR) 
The 24hR were self-administered using the web-based program Compl-eat™ [36]. Unannounced 
invitations were sent via e-mail on two randomly selected days within four weeks after a completed 
measurement, with a median of 19 (interquartile range (IQR) 16) days between recalls. The web-based 
program Compl-eat™ guided participants to accurately report all foods and drinks consumed the 
previous day using the five-step multiple pass method [37]. Portion sizes were reported in commonly 
used household measures, standard portions, weight in grams, or volume in liters. Energy and nutrient 
intakes were estimated using the 2011 Dutch food composition table [35]. Trained dieticians checked 
all the 24hRs for their completeness and unusual portion sizes. Recalls were completed after the FFQ. 
Median time between completion of the FFQ and the first recall was 7 (IQR 6) days.   
Supplement use 
All participants were asked to report whether they used dietary supplements. For each supplement, 
the frequency, number of tablets or drops, type, and brand were reported. The nutrient content of the 
supplements was based on the product label information as obtained from the manufacturer. Total 
micronutrient intake for folate, vitamin B6, B12, D and iron was obtained by summing dietary intake 
and supplemental intake. To account for differences in bioavailability of natural and synthetic folate, 
folate intake was expressed as folate equivalents (FE). Total folate intake (FE µg/day) was obtained by 
summing dietary folate intake (FE µg/day) + 1.7*supplemental folic acid (µg/day) [38]. 
Dutch Healthy Diet 2015 (DHD15) index score 
The Dutch Healthy Diet index 2015 (DHD15-index) was used as measure of diet quality. Dietary intake 
data from the FFQ was used to calculate the scores. This index was developed based on the Dutch 
dietary guidelines of 2015 [39] and its design and calculation have been described elsewhere [40]. In 
brief, the DHD15-index comprises of 15 components on fruits, vegetables, wholegrain products, 
legumes, nuts, fish, tea, dairy, coffee, fats and oils, red meat, processed meat, sweetened beverages 
and fruit juices, alcohol and salt. The coffee and sodium component were omitted, as the type of coffee 
and sodium intake were not assessed. The scores for each component ranged between 0 and 10 points, 
resulting in a total DHD15-index score ranging from zero to 130 points. Higher scores indicate a higher 
level of adherence to the Dutch dietary guidelines.  
Combining FFQ and 24hR data 
To partly correct for measurement error present in dietary intake estimates, we used the enhanced 
regression calibration approach to combine dietary intake data obtained with FFQ and 24hR. This 
approach has been described in detail elsewhere [41]. In brief, enhanced regression calibration is a 
simple extension of classic regression calibration using a random effect mixed model approach. The 
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random effect estimate provides additional individual information as assessed with the 24hR 
measurement that is lost in classical regression calibration. The ERC approach was used for all dietary 
intake estimates including energy, macro- and micronutrient intake. However, the ERC method cannot 
be used to for the DHD15-index, as the DHD15 index is calculated based on individual intakes of 15 
food groups, and the ERC method is not suited to correct individual intakes. As several components 
are episodically consumed foods, which cannot be accurately assessed with only two 24hR, we based 
the DHD15-index score on FFQ data. 
Biochemical analysis 
Fasting blood samples were obtained by venipuncture in the morning at one of the hospitals followed 
by a 75-grams OGTT. Blood samples were transported in a cool storage box with a temperature around 
7°C to the laboratory of Gelderse Vallei Hospital (Ede, the Netherlands) and processed within three 
hours after collection. Plasma fasting and 2-h glucose levels, fasting folate, ferritin and vitamin B12 
were analysed using the Siemens Dimension Vista® System, a quantitative, competitive 
chemiluminescence immunoassay method based on LOCI® technology (Siemens Healthcare, The 
Hague, the Netherlands). Plasma ferritin was used as marker for iron status. Whole blood of the 
participant was used to measure HbA1c with the HA-8180V analyser (Menarini Diagnostics, Florence, 
Italy). Whole blood vitamin B6 concentration was measured with a validated Isocratic HPLC system 
with UV detector (Chromsystems Instruments & Chemicals HmbH, Gräfelfing, Germany) till March 
2017 and after March 2017 a liquid chromatography–mass spectrometry (LCMS) consisting of a Waters 
Acquity UPLC I-Class system, coupled to a Waters Xevo TQ-S micro mass spectrometer (Waters 
Corporation, Millford, Massachusetts, USA) was used. Serum 25(OH)D levels were measured using the 
HPLC system with UV detector as described above till July 2016 and after July 2016 a method using the 
above-described the LCMS system was used.  
Covariates 
Body weight and height were measured by trained professionals at each visit. Body Mass Index (BMI) 
was calculated as body weight divided by squared body height (kg/m2). Data on maternal age, ethnicity 
(western/non-western), marital status (married/living together), parity (no/one or more child), 
educational level (low/intermediate/high), and smoking habits (yes/no), nausea and vomiting during 
pregnancy were collected using standardized questionnaires. Birth country of the participant and her 
biologic parents was used to determine ethnicity. Highest completed education was classified into 
three categories: low: primary school, vocational or lower general secondary education, intermediate: 
higher secondary education or intermediate vocational training and high: higher vocational education 
or university. Physical activity was assessed with the validated Short QUestionnaire to Assess Health-
enhancing physical activity (SQUASH) [42]. The durations (minutes per week) and intensity (Total 
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Metabolic Equivalents (MET)) of total and light-, moderate-, and vigorous-intensity physical activities 
were calculated. Date of blood sampling was used to define a covariate for season (summer: May - 
November and winter: December - April) [43]. A participant was diagnosed with GDM if at least one 
test value from the OGTT performed at 12 weeks of pregnancy or 24 weeks of pregnancy was abnormal 
(fasting glucose plasma ≥ 6.1 mmol/L or 2-hour plasma glucose ≥ 7.8 mmol/L), according to the 
diagnostic criteria of the WHO established in 1999 [44] . 
Statistical analysis 
Participant characteristics of the study population at each time point were reported as median (IQR), 
or as percentage (%). Spearman’s rank correlation coefficients were used to determine the correlation 
between measurements at different time points, as the distribution of most variables was skewed. To 
describe changes of micronutrient status, total intake, dietary intake and supplemental intake of 
folate, vitamin, B6, B12, D and iron during pregnancy a repeated measures mixed model with time as 
fixed effect was used, i.e. crude model. Repeated measures mixed models can account for missing 
observations and correlated measurements [45]. The covariance structure that resulted in the best 
model fit was chosen for each analysis. To assess whether dietary or supplemental intake was 
associated with (changes in) micronutrient status these variables were analysed in a model with 
micronutrient status as dependent outcome variable, and included covariates that influenced effect 
estimates, i.e. fully adjusted model. Potential covariates included age, education, ethnicity, parity, 
smoking, nausea during pregnancy, vomiting during pregnancy, season of blood collection, physical 
activity, energy intake, alcohol intake, time between measurements, BMI, and intakes and status of 
the other micronutrients.  
To determine if micronutrient intakes, micronutrient status and diet quality were associated with 
markers of glucose tolerance, these were analysed as independent variables with glucose tolerance 
markers as dependent outcome variable. Covariates that significantly affected effect estimates were 
included in the model to adjust for confounding. Potential confounders included age, education, 
ethnicity, parity, smoking, season of blood collection, physical activity, energy intake, alcohol intake, 
time between measurements, history of GDM and BMI.  
To assess if the large proportion of women who completed only one measurement (n=47 out of n=91) 
affected results, we compared sociodemographic characteristics between women who completed only 
one measurement (n=47) and women who completed at least two measurements (n=41) and 
performed a sensitivity analysis using only data from participants who completed at least two 
measurements (n=44 out of n=91).  
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Statistical analyses were conducted using SAS Software Version 9.4 (SAS Institute Inc., Cary, NC, USA). 
A p-value of ≤0.05 (two-sided) was considered statistically significant. 
 
Results 
Participants (n=91) were on average 32.2±4.3 years old, and mostly highly educated (67.0%). Four of 
the 91 women (4.4%) had a non-western ethnicity and the majority of the women (92.3%) were 
multipara, i.e. had one or more children. Characteristics of the study population at each measurement 
moment are presented in Table 7.1. Over the course of pregnancy, median BMI increased from 24.3 
(IQR 5.3) kg/m2 at preconception until 26.8 (7.6) kg/m2 at 24 weeks of pregnancy with high correlations 
between measurements (rT0-T1 0.966 and rT1-T2  0.985). Similar trends were observed for waist- and hip-
circumference. Physical activity decreased after women got pregnant and women were on average the 
least physically active at 12 weeks of pregnancy. Measures of physical activity were moderately 
correlated (rT0-T1 0.424 and rT1-T2 0.379). Most women (90%) experienced nausea and 30% suffered 
from vomiting at 12 weeks gestation. These numbers decreased at the second trimester. Energy intake 
increased during pregnancy from 7691 (1469) kJ at preconception to 8764 (1609) kJ at 24 weeks of 
gestation. The relative contribution of proteins, carbohydrates and fat consumed remained quite 
stable throughout pregnancy. Median alcohol consumption before pregnancy was 0.6 (4.0) g/d with 
59.7% drinking no alcohol at all. During pregnancy, only two women reported consumption of a small 
amount of alcohol.  
Changes in micronutrient intake, micronutrient status and diet quality throughout pregnancy  
Mean changes in micronutrient intake, micronutrient status and diet quality during pregnancy are 
presented in Figure 7.2, whereas the estimates of the adjusted repeated mixed model are presented 
in Table 7.2.  
Total folate intake was highest at T1, due to a significant average increase in supplemental folate intake 
between T0 and T1 (Figure 7.2a). At T2, total and supplemental folate intakes were as low as 
preconception levels. Dietary folate intake remained stable from T0 to T2. Plasma folate levels 
increased significantly from 30.7±2.3 nmol/L at T0 to 42.0±2.3 at T1, and subsequently significantly 
decreased significantly to T0 levels (Supplemental table 7.1). Supplemental folate intake was 
significantly associated with plasma folate levels (β 0.03 nmol/L for each FE µg, 95%CI 0.025-0.041, 
p<0.001) (Table 7.2). Adjustment for supplemental folate intake attenuated the time effect in plasma 
folate, which became non-significant, suggesting that the observed change in plasma folate was due 
to changes in supplemental intake.  
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Total, dietary and supplemental vitamin B6 intake did not significantly change from T0 to T2 (Figure 
7.2b). Vitamin B6 levels decreased slightly from 89.9±3.9nmol/L at T0 to 88.4±3.3nmol/L at T1, and 
decreased significantly to 78.3±3.4nmol/L at T2. Both supplemental and dietary vitamin B6 intake were 
positively associated with vitamin B6 levels (Table 7.2). The observed significant decrease in vitamin 
B6 levels from T1 to T2 remained significant after adjustment for vitamin B6 intake. 
Total vitamin B12 decreased slightly from T0 to T1 and subsequently decreased significantly from T1 
to T2, due to a significant decrease in supplemental vitamin B12 intake. Dietary vitamin B12 intake 
decreased slightly, but not significantly, from T0 to T2 (Figure 7.2c). Vitamin B12 levels significantly 
decreased from on average 308.2±11.7pmol/L at T0 to 264.8±12.3nmol/L at T1 and further decreased 
to 210.3±8.8nmol/L at T2. This time effect was not explained by supplemental and dietary vitamin B12 
intake as these were both not associated with vitamin B12 levels (Table 7.2).  
 
Table 7.1: Characteristics of the study population according to measurement moment: preconception (T0), 12 
weeks gestation (T1) and 24 weeks gestation (T2), including correlation between T0 and T1 measures and T1 
and T2 measures.  
 Total  
N=91 
T0 
N=57 
T1 
N=43 
T2 
N=47 
rT0-T11  
n=23 
rT1-T21 
n=31 
Gestational age - -13 (24) 12 (3) 24 (2) - - 
Age (yrs) 32.2 (4.3) 31.8 (4.4) 32.6 (4.1) 32.9 (4.3) 0.996 0.999 
Educational level (%) 
- Low 
- Moderate 
- High  
 
2.2 
30.8 
67.0 
 
1.8 
26.3 
71.9 
 
4.7 
25.6 
69.8 
 
4.3 
29.8 
65.9 
- - 
Western ethnicity (%) 95.6 96.5 97.7 95.7 - - 
Smokers (%) 4.1 8.8 2.5 0 - - 
Parity (% ≥1 child 92.3 91.2 95.4 91.5 - - 
Nausea during pregnancy (%) - - 90.0 53.2 - - 
Vomitting during pregnancy 
(%) - - 30.0 17.0 - - 
BMI (kg/m2) 24.9 (6.4) 24.3 (5.3) 24.7 (9.8) 26.8 (7.6) 0.966 0.985 
Waist circumference (cm) 88.5 (15.6) 84.0 (13.5) 87.5 (12.5) 97.3 (15.2) 0.956 0.914 
Hip circumference (cm) 106.1 (13.0) 105.3 (12.8) 106.4 (15.3) 109.0 (16.1) 0.978 0.956 
Physical activity (MET 
min/week) 1215 (1279) 1380 (1183) 930 (518) 980 (998) 0.424 0.379 
Energy intake (kJ) 7972 (1746) 7691 (1469) 8347 (2747) 8764 (1609) 0.735 0.330 
Carbohydrates (E%) 48.4 (4.9) 48.2 (5.2) 49.0 (3.9) 48.7 (4.4) 0.510 0.774 
Fat (E%) 33.5 (3.8) 33.5 (4.2) 33.4 (2.9) 33.7 (3.6) 0.453 0.742 
Protein (E%) 15.3 (1.6) 15.5 (1.9) 15.2 (1.8) 14.7 (1.9) 0.620 0.567 
Alcohol (g/d) 0.1 (1.3) 0.6 (4.0) 0 (0.5) 0 (0.5) 0.413 0.542 
Blood sampling between 
December and April (%) 24.5 15.8 30.2 29.8 - - 
Values are median (IQR) or percentage  
1 Spearman rank correlations  
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Figure 7.2: Changes in total, dietary and supplement nutrient intake and status for a) folate, b) vitamin B6, c) 
vitamin B12, d) vitamin D, e) iron, and f) diet quality as assessed by the DHD15-index. Values are mean (SEM). 
T0 is preconception, T1 is 12 weeks pregnant, and T2 is 24 weeks pregnant.  
 
 
Total vitamin D intake significantly increased over the course of the pregnancy, due to a significant 
increase in supplemental vitamin D intake (Figure 7.2d). Observed supplemental vitamin D intake was 
on average highest at T1, whereas dietary vitamin D intake remained stable throughout pregnancy. 
Serum 25(OH)D levels, adjusted for season, significantly increased throughout pregnancy, from 
70.4±3.2 nmol/L at T0 to 81.3±3.6 at T1 and 89.9.0±4.6 nmol/L at T2. Supplemental vitamin D intake 
was significantly associated with 25(OH)D serum levels (β 1.17 nmol/L per 1μg supplemental vitamin 
D, 95%CI 0.50-1.81, p=0.001) (Table 7.2). After adjustment for dietary and supplemental vitamin D 
intake, time was still significant, indicating that supplemental vitamin D intake could only partly explain 
the observed increase in 25(OH)D serum levels. 
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Table 7.2: Regression coefficients (β) of association of pregnancy (time), dietary intake and supplemental 
intake with changes in folate, vitamin B6, vitamin B12, 25(OH)D and ferritin blood levels. 
Outcome Characteristic β 95% CI P-value 
Folate statusb (nmol/l) Time – 12 weeks pregnancya 3.25 -5.64;64.6 0.099 
 Time – 24 weeks pregnancya -1.69 -1.84;8.36 0.206 
 Supplemental folate intake (FE μg) 0.023 0.016;0.029 <0.001 
 Dietary folate intake (FE μg) -0.01 -0.06;0.05 0.836 
     
Vitamin B6 statusc (nmol/L) Time – 12 weeks pregnancya -2.06 -10.8;6.68 0.638 
 Time – 24 weeks pregnancya -10.9 -19.4;-2.45 0.013 
 Supplemental vitamin B6 intake (mg) 2.23 0.88;3.59 0.002 
 Dietary vitamin B6 intake (mg) 14.9 0.58;29.2 0.042 
     
Vitamin B12 statusd (pmol/L) Time – 12 weeks pregnancya -55.3 -76.3;-34.3 <0.001 
 Time – 24 weeks pregnancya -100.3 -121.3;-79.2 <0.001 
 Supplemental vitamin B12 intake (μg) 0.12 -1;01;1.25 0.832 
 Dietary vitamin B12 intake (μg) 6.66 -17.9;31.3 0.589 
     
25(OH)D statuse (nmol/L) Time – 12 weeks pregnancya 12.9 4.36;21.5 0.004 
 Time – 24 weeks pregnancya 27.2 17.7;36.7 <0.001 
 Supplemental vitamin D intake (μg) 1.17 0.50;1.84 0.001 
 Dietary vitamin D intake (μg) 4.09 -1.86;10.0 0.174 
     
Ferritin statusf (µg/L) Time – 12 weeks pregnancya -4.33 -12.4;3.69 0.284 
 Time – 24 weeks pregnancya -22.1 -28.6;-15.6 <.001 
 Supplemental iron intake (mg) 0.12 -0.18;0.42 0.416 
 Dietary iron intake (mg) -1.69 -4.30;0.93 0.201 
a Preconception is reference category. 
b Estimates are adjusted for age, education level, season of blood collection, BMI, energy intake, vitamin B12 and B6 
intake. 
c Estimates are adjusted for age, educational level, vitamin B12 intake and energy intake. 
d Estimates are adjusted for parity, season of blood collection, BMI, energy intake, vitamin B6 intake. 
e Estimates are adjusted for education level, parity, season of blood collection, BMI and energy intake.  
f Estimates are adjusted for alcohol intake, nausea during pregnancy, BMI and energy intake. 
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Total iron intake increased from T0 to T2, due to a significant increase from T0 to T1. This was 
attributable to a significant increase in supplemental iron intake from T0 to T1, while dietary iron intake 
remained stable (Figure 7.2e). Ferritin levels remained stable from T0 to T1 (32.0±2.4nmol/L and 
33.2±2.8nmol/L, resp.) but significantly decreased to 13.5±1.5nmol/L at T2. Supplemental and dietary 
iron intake were not associated with ferritin levels and could not explain the time effect (Table 7.2). 
Diet quality as reflected by the DHD15-index score decreased not significantly  from 77.3±1.8 points at 
preconception to 75.4±2.0 at 24 weeks of pregnancy (p=0.72) (Figure 7.2f). 
Associations of micronutrient intake, micronutrient status and diet quality with glucose tolerance 
during pregnancy 
In total, nine of the 91 (9.9%) women developed GDM. Two women were diagnosed with GDM at 12 
weeks of pregnancy and the other seven at 24 weeks of pregnancy. In general, micronutrient intake 
and status levels were not significantly associated with glucose tolerance over the course of the 
pregnancy (Table 7.3). Total folate intake was weakly inverse associated with 2-hour glucose levels 
(β=-0.001 mmol/L for each FE µg, 95% CI -0.001-0.000; p=0.052), whereas plasma ferritin levels was 
weakly positive associated with 2-hour glucose levels (β=0.009 mmol/L for each µg/L increase, 95%CI 
0.00-0.018, p=0.058). A higher diet quality was associated with lower fasting glucose, 2-hour glucose 
and HbA1c levels, but these associations did not reach statistical significance (p>0.20). 
Sensitivity analyses 
Age, ethnicity, education level and smoking status did not differ between women who completed only 
one measurement (n=47) compared to women who completed two or three measurements (n=44) 
(data not shown). Furthermore, similar trends were observed regarding changes in micronutrient 
intake and status level, intake-status relationships and associations of micronutrient intake and status 
with glucose tolerance when the study population was limited to participants who completed at least 
two measurements (n=44), with one exception; in the sensitivity analyses we observed a significant 
inverse association between the DHD15-index and fasting glucose (β=-0.007 mmol/L for each DHD15-
index point, 95% CI -0.010; -0.0001); p=0.024). 
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Table 7.3: Regression coefficients (β) of associations between pregnancy (model 1), diet quality as assessed 
with DHD15-index (model 2), micronutrient intake (model 3) and micronutrient status (model 4) and fasting 
glucose, 2h glucose levels and HbA1c.   
Outcome Model Exposure variable β 95% CI P-value 
Fasting glucose  1)b Time – 12 weeks pregnancya -0.24 -0.37;-0.11 0.001 
(mmol/L)  Time – 24 weeks pregnancya -0.42 -0.57;-0.28 <0.001 
 2)c DHD-15 index score -0.003 -0.01;0.00 0.219 
 3)c Total folate intake (FE μg) 0.0001 -0.001;0.0003 0.433 
  Total vitamin B6 intake (mg) 0.016 -0.001;0.040 0.179 
  Total vitamin B12 intake (μg) -0.002 -0.008;0.005 0.614 
  Total vitamin D intake (μg) -0.0001 -0.013;0.013 0.990 
  Total iron intake (mg) -0.003 -0.014;0.008 0.556 
 4)d Serum folate -0.001 -0.007;0.003 0.845 
  Serum 25(OH)D -0.000 -0.005;0.005 0.970 
  Whole blood vitamin B6 0.001 -0.000;0.002 0.172 
  Serum vitamin B12 -0.000 -0.001;0.001 0.989 
  Serum ferritin 0.000 -0.004;0.004 0.944 
      
2h glucose  1)b Time – 12 weeks pregnancya 0.16 -0.14;0.45 0.289 
(mmol/L)  Time – 24 weeks pregnancya 0.84 0.39;1.27 <0.001 
 2)c DHD-15 index score -0.005 -0.018;0.007 0.400 
 3)c Total folate intake (FE μg) -0.001 -0.001;0.000 0.052 
  Total vitamin B6 intake (mg) -0.005 -0.060;0.049 0.851 
  Total vitamin B12 intake (μg) -0.001 -0.013;0.011 0.830 
  Total vitamin D intake (μg) 0.005 -0.027;0.036 0.763 
  Total iron intake (mg) 0.018 -0.009;0.045 0.192 
 4)d Serum folate -0.004 -0.015;0.008 0.510 
  Serum 25(OH)D -0.001 -0.008;0.006 0.883 
  Whole blood vitamin B6 -0.001 -0.003;0.002 0.514 
  Serum vitamin B12 -0.000 -0.002;0.002 0.776 
  Serum ferritin 0.009 -0.00;0.018 0.058 
      
HbA1c  1)b Time – 12 weeks pregnancya -1.99 -2.72;-1.26 <0.001 
(mmol/mol)  Time – 24 weeks pregnancya -3.36 -4.08;-2.63 <0.001 
 2)c DHD-15 index score -0.02 -0.05;0.01 0.255 
 3)c Total folate intake (FE μg) 0.001 -0.004;0.002 0.190 
  Total vitamin B6 intake (mg) 0.060 -0.062;0.182 0.328 
  Total vitamin B12 intake (μg) 0.33 -0.034;0.030 0.802 
  Total vitamin D intake (μg) 0.010 -0.064;0.083 0.795 
  Total iron intake (mg) -0.015 -0.077;0.048 0.631 
 4)d Serum folate 0.020 -0.007;0.044 0.158 
  Serum 25(OH)D -0.002 -0.015;0.012 0.802 
  Whole blood vitamin B6 -0.003 -0.009;0.004 0.419 
  Serum vitamin B12 0.003 -0.002;0.008 0.180 
  Serum ferritin -0.013 -0.035;0.009 0.227 
a Preconception is reference category. 
b Adjusted  for age, ethnicity, education level, parity, history of GDM, BMI   
c Adjusted  for time, age, ethnicity, parity, history of GDM, BMI, energy intake 
d Adjusted  for time, age, ethnicity, parity, history of GDM, BMI 
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Discussion 
In our longitudinal study, folate, vitamin B6, vitamin B12, vitamin D and iron intake changed 
significantly from preconception to 24 weeks of pregnancy. This was attributable to changes in 
supplemental intake. Folate, vitamin B6 and vitamin D intakes were significantly associated with their 
status markers. We observed a weakly inverse association between total folate intake and 2-hour 
glucose levels, whereas a weakly positive association was observed between serum ferritin with 2-
hour glucose levels. Other micronutrient intakes and status markers were not associated with glucose 
tolerance. Diet quality was in a sensitivity analysis, excluding data from participants with only one 
measurement, inversely associated with fasting glucose.  
We observed that participants increased their energy intake on average with 14% from preconception 
to 24 weeks of pregnancy; however, we did not observe changes in macronutrient composition, dietary 
folate, vitamin B6, vitamin B12, vitamin D and iron intake, and diet quality. This is in line with other 
research investigating changes in dietary intake during pregnancy [46, 47]. This is of concern, as 
pregnancy poses an important window of opportunity for improving diet quality [48-50], and recent 
studies have observed that women enter pregnancy with suboptimal micronutrient intakes [6, 25]. 
Adequate micronutrient stores is one of the conditions needed to ensure an optimal intrauterine 
environment for foetal development [51, 52]. 
Supplementation can help in meeting recommendations and improving micronutrient status. Eighty-
nine percent of the women in this study population used at least one supplement at 12 weeks of 
pregnancy. This is comparable with percentages reported in other studies [25, 26, 53]. The most 
commonly used supplements were folic acid, folic acid combined with vitamin D and prenatal 
multivitamin supplements. The usage, number of and type of supplements changed throughout 
pregnancy, with most pronounced the doubling of supplemental folate intake (mean 680 FE μg) at 12 
weeks of pregnancy compared to the mean 340 FE μg intake at preconception and 24 weeks of 
pregnancy. The observed drop in supplemental folate intake from 12 to 24 weeks of pregnancy could 
be explained by the recommendation to take folic acid supplements from at least 4 weeks before 
conception to 12 weeks of gestation [54], and is also observed in other studies [25, 26]. We observed 
substantial contributions from supplements to total micronutrient intakes. Considering that most 
women who take supplements are often women with a higher educational level, who, in general, 
already achieve higher intakes of micronutrients [55, 56], there is a risk of excess intake above the 
upper level of intake that might negatively affect health of the offspring. In our population, 13 women 
(14%) consumed folate above the upper level of intake (1000 FE µg). For other micronutrients, we 
observed no intake above upper levels. The intake of folate above the upper level of intake is of 
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concern as a recent study has found a link between high doses of folic acid during pregnancy (>5 mg/d) 
and impaired psychomotor development at 12-23 months of age [57]. It should be noted that the 
maximum folate intake in our population was 1.6 mg/d, but it indicates that excess intake should not 
be taken lightly and more research is needed to unravel the adverse effects of excess micronutrient 
intake, especially for potential adverse effects in the offspring. 
We observed significant intake-status associations for folate, vitamin D and vitamin B6, but not for 
vitamin B12 and iron. This is in line with findings from validation studies in pregnant populations using 
nutritional biomarkers as reference instrument to validate dietary intake assessment methods [58]. 
The absence of an intake-status association for vitamin B12 might be due to a small range of intake, 
which limits the ability to detect an association. Ferritin levels is a marker of iron body stores in non-
pregnant healthy individuals, but ferritin levels are during pregnancy affected by haemodilution, 
increased erythropoiesis and, pregnancy provoked acute-phase response [59] and might explain the 
absence of an association of ferritin with iron intakes. Supplemental folate intake was the strongest 
predictor for folate status levels. For the other micronutrients, intake could not (entirely) explain 
observed changes in status levels. In general, we observed that the status markers of water-soluble B-
vitamins decreased from the end of the first trimester to the end of the second trimester. This decrease 
was likely attributable to haemodilution, the increase in blood volume in the second and third 
trimester [28, 60], in addition to changes in micronutrient intakes.   
Vitamin D is essential for bone development and has important immune functions [61]. Vitamin D 
deficiency is linked to adverse pregnancy-outcomes including preeclampsia, low birthweight, neonatal 
hypocalcaemia, poor postnatal growth and bone fragility [62]. In our study, vitamin D status, i.e. 
25(OH)D levels, increased from preconception to 24 weeks of pregnancy. This is in line with findings of 
most [31, 63, 64], but not all [65], other studies investigating vitamin D levels over the course of the 
pregnancy. This observed increase in 25(OH)D in our study remained after adjustments for dietary and 
supplemental intake, and other known potential confounders such as season, BMI and weight change. 
A possible explanation for the observed increase in 25(OH)D levels is increased production, potentially 
driven by placental vitamin D metabolism [66]. Worldwide, there has been increasing attention for the 
high prevalence of vitamin D deficiency in general and during pregnancy, with prevalences reported 
up to 84%, depending on the country of residence [62]. However, cut-offs for vitamin D deficiency are 
derived on non-pregnant populations [67]. The observation of increasing 25(OH)D levels in our study 
and by others [31, 63, 64] question the usability of these criteria in pregnant population as prevalence 
of deficiency might depend on the gestational age of the study population. 
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Although the evidence regarding a beneficial effect of a healthy diet in GDM prevention is growing, 
research regarding micronutrient intake and status is limited. We observed no significant associations, 
micronutrient intake or status levels with glucose tolerance markers, except for a weakly inverse 
association between total folate intake and 2-hour glucose levels, a weakly positive association 
between serum ferritin with 2-hour glucose levels, and, in a sensitivity analysis, an inverse association 
between diet quality and fasting glucose. In contrast to our results, two cross-sectional Asian studies 
reported a higher risk of GDM with higher folate levels during pregnancy, and an inverse association 
for vitamin B12 status during pregnancy with GDM risk [20, 21]. A retrospective study in the UK also 
observed a lower vitamin B12 status in women with GDM, but did not find an association with of folate 
status with GDM risk [22]. Furthermore, several observational studies found an inverse association of 
vitamin D status during pregnancy with GDM development, but this could not be confirmed in 
randomized controlled trials [19] and in our longitudinal study, we also did not observe a significant 
association between vitamin D intake, 25(OH)D status levels and markers of glucose tolerance.  
A recent review concluded that there is a potential link between greater iron status and increased risk 
of GDM. Adequate iron status is critical to normal beta cell function and glucose homeostasis, but 
excess iron may disrupt glucose homeostasis, by damaging beta cell function, increasing oxidative 
stress and impaired insulin signalling [68-70]. Evidence is most consistent for iron stores, with higher 
iron stores being associated with higher risk of GDM [23]. This is in line with our weakly positive 
association of ferritin levels with 2-hour glucose levels. As iron supplementation is often prescribed to 
prevent or treat iron deficiency anaemia, the potential association of a higher GDM risk with higher 
iron status warrants more research.  
Major strengths of the present study include its prospective design, inclusion of measurements before 
conception and detailed information on dietary intake, supplemental intake and micronutrient status 
markers. However, the present study also has limitations. Firstly, due to the extensive nature of our 
study, with measurements at preconception as well as during pregnancy, including a visit to the 
research centre, an OGTT and various dietary assessment at each time point, our sample size was 
limited, making our study potentially underpowered to assess significant associations. However, we 
were able to use continuous effect measures, and had extensive information regarding dietary intake, 
supplement intake, serum levels and potential confounders. Secondly, due to various reasons (women 
who did not get pregnant, sickness, holidays etc.), more than half of the participants completed only 
one measurement. However, we used a repeated measures mixed model to account for the missing 
data. In addition, similar trends and effect estimates were observed in our sensitivity analysis using 
data from women who completed two or three measurements. Thirdly, participants included in the 
present study were mainly highly educated, recruited in a certain region of the Netherlands and 
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women with a high risk of GDM were oversampled. These factors may limit external validity to the 
general population of pregnant women. Lastly, as the primary outcome of the study was development 
of GDM, the last measurement took place at 24 weeks of pregnancy. To accurately describe changes 
in micronutrient levels over the pregnancy additional measurements after 24 weeks of pregnancy 
would give a more complete picture.   
 
Conclusions 
Micronutrient intake changes throughout pregnancy, due to changes in supplemental intake, whereas 
dietary micronutrient intake and diet quality remained on average stable. Nutrient status levels 
changed significantly from preconception to the second trimester of pregnancy, which could be partly 
explained by changes in intake from diet and supplements. This should be confirmed in future 
research, as well as the implication for micronutrient deficiency thresholds during pregnancy. We did 
not observe significant associations of micronutrient intake, status levels and diet quality with fasting, 
2-hour glucose and HbA1c levels; except for except for a weakly inverse association between total 
folate intake and 2-hour glucose levels, a weakly positive association between serum ferritin with 2-
hour glucose levels, and, in a sensitivity analysis, an inverse association between diet quality and 
fasting glucose. More research is needed with respect to the role of micronutrients in relation to GDM 
development.  
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Supplementary material  
 
 
  
Supplemental table 7.1: Micronutrient intake, micronutrient status, diet quality and glucose tolerance 
markers of the study population according to measurement moment: preconception (T0), 12 weeks 
gestation (T1) and 24 weeks gestation (T2).   
 T0 
N=67 
T1 
N=47 
T2 
N=55 
DHD15 score  77.2 (1.8) 76.2 (2.0) 75.4 (1.8) 
Plasma folate (nmol/L) 30.7 (2.3) 42.0 (2.3) 30.0 (2.1) 
Total folate intake (FE µg) 587 (46) 856 (53) 660 (54) 
- Dietary intake 216 (5) 226 (7) 229 (7) 
- Supplemental intake 368 (45) 631 (52) 429 (52) 
Whole blood vitamin B6 (nmol/L) 90 (3.9) 88 (3.3) 78 (3.4) 
Total vitamin B6 intake (mg) 2.6 (0.4) 2.0 (0.6) 2.9 (0.6) 
- Dietary intake 1.4 (0.04) 1.5 (0.04) 1.5 (0.04) 
- Supplemental intake 1.2 (0.4) 0.5 (0.6) 1.4 (0.6) 
Serum vitamin B12 (pmol/L) 308 (12) 265 (12) 210 (9) 
Total vitamin B12 intake (µg) 8.2 (2.8) 6.6 (1.0) 5.5 (0.7) 
- Dietary intake 3.4 (0.1) 3.5 (0.1) 3.5 (0.1) 
- Supplemental intake 4.7 (2.8) 3.1 (1.0) 2.1 (0.7) 
Serum 25(OH)D (nmol/L) 70 (3.2) 81 (3.6) 90 (4.5) 
Total vitamin D intake (µg) 6.6 (0.8) 9.9 (0.8) 8.7 (0.6) 
- Dietary intake 2.8 (0.1) 2.9 (0.1) 2.8 (0.1) 
- Supplemental intake 3.8 (0.8) 7.1 (0.8) 5.9 (0.6) 
Plasma ferritin (µg/L) 32.0 (2.4) 33.1 (2.8) 13.5 (1.5) 
Total iron intake (mg) 13.4 (1.0) 18.4 (1.2) 18.1 (1.1) 
- Dietary intake 9.6 (0.1) 9.6 (0.2) 9.8 (0.2) 
- Supplemental intake 3.8 (1.0) 8.6 (1.2) 8.3 (1.0) 
    
Fasting glucose (mmol/L) 4.8 (0.1) 4.6 (0.1) 4.5 (0.1) 
Glucose 2h after OGTT (mmol/L) 4.7 (0.1) 4.9 (0.2) 5.9 (0.1) 
HBA1c (mmol/mol) 33.6 (0.3) 31.8 (0.3) 30.9 (0.4) 
Values are mean (SEM) 
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Abstract  
Background: An adequate nutritional status during the preconception period is important, particularly 
for folate, vitamin D, and n-3 fatty acids (i.e. EPA+DHA). We aimed to determine supplement intake 
and the main dietary sources of folate, vitamin D, and EPA+DHA. Additionally, associations of these 
intakes with their blood levels were examined. 
Methods: Data of 66 Dutch women aged 18-40y who wished to become pregnant was used. Dietary 
intake was assessed with a validated food frequency questionnaire, supplement use with a structured 
questionnaire. 25-hydroxyvitamin D levels were determined in serum and folate and phospholipid 
EPA+DHA levels in plasma. Partial Spearman’s correlations, restricted cubic splines and trend analyses 
over tertiles of nutrient intakes were performed to examine intake-status associations.  
Results: A large proportion of women did not meet the Dutch recommended intakes of folate (50%), 
vitamin D (67%), and EPA+DHA (52%). Vegetables were the main contributor to dietary folate intake 
(25%), oils and fats to dietary vitamin D intake (39%), and fish to dietary EPA+DHA intake (69%). 
Fourteen percent of the women had an inadequate folate status and 23% an inadequate vitamin D 
status. Supplemental folate intake, supplemental and dietary vitamin D intake and dietary EPA+DHA 
intake were significantly associated with their blood levels.  
Conclusions: Even in our highly educated population a large proportion did not achieve recommended 
folate, vitamin D and n-3 fatty acid intakes. Promotion of folate and vitamin D supplement use and fish 
consumption is needed to improve intakes and blood levels of these nutrients in women who wish to 
become pregnant.  
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Introduction 
A woman’s dietary intake and nutritional status before conception and during pregnancy are important 
determinants of maternal and foetal health, and child’s health later in life [1-3]. Consequently, 
maternal dietary habits during the preconception period are considered increasingly important to 
cover the nutritional needs of the foetus and placenta during pregnancy [4], and to optimize maternal 
and infant health [5]. To promote the health of prospective parents, the Health Council of the 
Netherlands has published preconception care guidelines [6]. Despite these guidelines, recent studies 
showed that preconception dietary intake is still suboptimal with high prevalence of inadequate 
habitual diet and nutrient status [5, 7].   
Preconception care dietary guidelines including recommendations on optimal intakes of folate, vitamin 
D, and fish (i.e. n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)). 
Recommendations regarding folate intake are predominantly based on the knowledge that an 
adequate folate intake in the preconception period reduces the risk of a neural tube defect [8]. 
Although folate naturally occurs in many dietary sources, such as green leafy vegetables, fruits, meat, 
and dairy products, it is difficult for Dutch women to obtain the recommended amounts of folate 
through diet alone [6]. Therefore, a daily folic acid supplement (≥400μg folic acid) is recommended as 
part of routine preconception and antenatal care [6].  
An adequate preconception vitamin D status is important as vitamin D deficiency in the mother has 
been linked to various issues in the pregnancy such as preeclampsia [9] and gestational diabetes [10] 
and in their offspring such as low birth weight [11], poor bone growth [12], and an increased risk of 
recurrent wheeze or asthma [13, 14].. Sunlight is the predominant source of vitamin D [15]. Whereas 
dietary vitamin D can only be obtained through the consumption of a limited number of foods, such 
as fatty fish, fat spreads, oils, liver, meat, eggs, and dairy products. Therefore, vitamin D supplement 
use (i.e. 10 µg/d) is recommended for Dutch women who wish to become pregnant and pregnant 
women, particularly during winter [16].  
The n-3 fatty acids EPA and DHA are considered to be important nutrients for the foetal brain and 
retina development [17]. Therefore, women are recommended to consume 200mg/day EPA+DHA [18], 
which translates into at least 1 portion of fatty fish/week [19].  
Despite these recommendations, little is known about current intake levels of folate, vitamin D, and 
EPA+DHA among Dutch women who wish to become pregnant. Moreover, there is limited data on the 
relative contribution of these nutrients from dietary sources in relation to their blood levels in 
preconception women. More knowledge on these aspects may benefit further specification of the 
dietary recommendations in this field of practice. To address this perceived knowledge gap, we aimed 
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to: (i) describe current intake levels of folate, vitamin D, and the n-3 fatty acids EPA+DHA from dietary 
sources and supplements; (ii) determine the relative contribution of the top-5 of dietary sources to the 
total intake of these nutrients; (iii) examine how dietary and supplementary intakes of these nutrients 
relate to their blood levels; and (iv) identify which sources contribute the most to the nutritional status 
per nutrient. 
 
Methods 
Study population  
This cross-sectional study was performed using baseline data of the GLIMP2 study; an observational 
prospective cohort study designed to assess the role of diet, nutrient status, and other risk factors in 
the development of gestational diabetes mellitus (GDM). Participants were recruited at the 
Department of Gynaecology and Obstetrics and Department of Internal Medicine at three non-
university hospitals in the eastern part of the Netherlands: Gelderse Vallei (Ede); Rijnstate (Arnhem); 
and Slingeland (Doetinchem). Main inclusion criteria were age between 18 and 40 years, willing to get 
pregnant within one year at the time of recruitment, and competent to make their own decisions. 
Women with a higher risk of developing GDM (i.e. previous pregnancy with GDM or macrosomic infant 
or overweight/obese) were oversampled in this study population. Women were excluded when they 
were not able to read and speak Dutch. Participants who were pregnant at time of recruitment were 
excluded for current analysis as information on preconception dietary intake was missing. 
Consequently, preconception dietary intake data and blood levels of folate, vitamin D and EPA+DHA 
were available for 66 women. The GLIMP2 study was conducted by Wageningen University & Research 
between 2015 and 2017. The Medical Ethics Committee of Wageningen University & Research 
approved the GLIMP2 study. All women gave their written informed consent before the start of the 
study.  
Dietary assessment  
Dietary intake was assessed with the use of a validated, semi-quantitative 173- item FFQ assessing 
habitual food and beverage intake of the previous month. The FFQ was an updated version of a FFQ 
previously designed and validated to estimate dietary intake of energy, macronutrients, and B-vitamins 
in Dutch women of reproductive age [20-22]. The FFQ included consumption frequencies (from once 
a month to several times a day) and the number of units eaten or portion sizes (e.g., slices, cups, pieces, 
spoons, etc.) according to Dutch household measures [23]. Food groups were created and the 
contribution of each food group to total dietary folate, vitamin D and EPA+DHA intake was calculated. 
All participants were asked to report whether they used dietary supplements. For each supplement, 
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the frequency, number of tablets or drops, type, and brand were reported. The nutrient content of the 
supplements was based on the product label information as obtained from the manufacturer or ATC 
code website. Total nutrient intake was obtained by summing dietary intake and supplemental intake. 
To account for differences in bioavailability of natural and synthetic folate, folate intake was expressed 
as folate equivalents (FE). Total folate intake (FE µg/day) was obtained by summing dietary folate 
intake (FE µg/day) + 1.7*supplemental folic acid (µg/day) [24]. 
Biochemical analyses  
Fasting blood samples were obtained by venipuncture in the morning at one of the hospitals for 
assessing blood levels of folate, vitamin D, and EPA+DHA. Blood samples were transported in a cool 
storage box with a temperature around 7°C to the laboratory of Gelderse Vallei Hospital (Ede, the 
Netherlands) and processed within three hours after collection. Tubes with blood plasma containing 
EDTA for phospholipid fatty acid composition analyses were transported to the division of Human 
Nutrition of Wageningen University & Research (Wageningen, the Netherlands) and stored at −80°C.  
Plasma folate was analysed using the Siemens Dimension Vista® folate method with the Dimension 
Vista® System, a quantitative, competitive chemiluminescence immunoassay method based on LOCI® 
technology (Siemens Healthcare, The Hague, the Netherlands). Plasma folate levels below 10 nmol/L 
were considered as folate insufficient [25]. Serum 25-hydroxyvitamin D (25(OH)D) was analysed using 
a validated isocratic High Performance Liquid Chromatography (HPLC) method using UV detection 
(Chromsystems Instruments & Chemicals HmbH, Gräfelfing, Germany). Serum 25(OH)D levels below 
50 nmol/L were considered as insufficient [26]. To assess EPA+DHA status, the fatty acid composition 
of EDTA plasma phospholipids were analysed in the laboratory of the division of Human Nutrition of 
Wageningen University & Research. After isolation of the phospholipid fraction and saponification, the 
fatty acids were derivatized to fatty acid methyl esters (FAMEs), which were subsequently quantified 
with a gas chromatograph (Hewlett Packard 5890 Series II) equipped with a capillary column (WCOT 
fused silica kolom CP WAX 58, 25m x 0.25 mm id Chrompack CP 7717) and flame-ionization detection, 
using nitrogen as carrier gas. Fatty acid concentrations were reported as g/100g FAME; the sum of all 
peak areas of the fatty acids identified was set to 100% [27]. For EPA+DHA there was no generally 
acceptable cut-off for an optimal EPA+DHA status.  
Covariates 
Anthropometric measurements were performed by trained professionals. Body weight was 
determined to the nearest 0.1 kg with a calibrated balance (SECA, Germany), while women had to take 
off their shoes and empty their pockets. Body height was measured with a wall-mounted stadiometer 
(SECA, Germany) to the nearest 0.1 cm, while wearing no shoes. Body Mass Index (BMI) was calculated 
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as body weight divided by squared body height (kg/m2). Data on maternal age, ethnicity (Western/non-
Western), marital status (married/living together), parity (no/one or more child), educational level 
(low/intermediate/high), smoking habits (yes/no), and alcohol consumption (g/day) were collected 
using standardized questionnaires. Data on birth country of the participant and birth country of her 
biologic parents was used to determine ethnicity (Western or non-Western). Educational level was 
evaluated  based on the highest completed education and classified into three categories: low: primary 
school, vocational or lower general secondary education, intermediate: higher secondary education or 
intermediate vocational training and high: higher vocational education or university. Intakes of vitamin 
B6 and vitamin B12 were obtained from the FFQ and the questionnaire on supplement use. Date of 
blood sampling was used to define a covariate for season (summer: May - November and winter: 
December - April) [15].   
Statistical analysis  
Participant characteristics of the study population were reported as mean ± SD, as median 
(interquartile rage (IQR)), or as n (%) for the total population. Additionally, we made two strata: one 
for women who did meet recommended intake and one for women who did not meet recommended 
intake [6, 16, 18]. We did this for folate (<680 FE µg/d and ≥680 FE µg/d), vitamin D (<10 µg/d and ≥10 
µg/d), and EPA+DHA recommendations (<200 mg/d and ≥200 mg/d). Independent sample t-tests, Chi-
Square tests, and Mann Whitney U tests were used to compare characteristics between participants 
who met and participants who did not meet the recommendation. Spearman’s rank correlation 
coefficients and partial correlation coefficients were used to determine the correlation of total nutrient 
intake, total dietary intake, supplemental intake, and nutrient intake from the top-5 dietary sources 
with blood levels. Analysis of covariance (ANCOVA) was performed to compare blood levels across 
tertiles of nutrient intake and to calculate adjusted means with 95% confidence intervals. Additionally 
P for trend analysis was performed using the median intake of the tertile as a continuous variable in 
the ANCOVA model. Restricted cubic splines were used to visualize the dose-response relationship 
between total nutrient intake and blood levels of folate, vitamin D, and EPA+DHA. Three knots were 
used at the 1st, 5th, and 9th decile of intake. Significant predictors for blood levels in linear regression 
models (p<0.05) were included as covariates in the statistical analyses. For folate these were: season 
of blood sampling, total energy intake, total vitamin B6 intake and total vitamin B12 intake; for vitamin 
D and EPA+DHA these were: educational level, season of blood sampling, total energy intake and BMI. 
Statistical analyses were conducted using SAS Software Version 9.4 (SAS Institute Inc., Cary, NC, USA), 
except for the restricted cubic splines, which were performed using R statistical software version 3.1.1 
and R Studio 1.0. A p-value of ≤0.05 (two-sided) was considered statistically significant.  
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Results 
Participant characteristics  
Characteristics of the total study population (n = 66) stratified by intake categories of folate, vitamin 
D, and EPA+DHA are shown in Table 8.1. The mean age of the total study population was 31.7 ± 4.1 
years and mean BMI was 25.2 ± 4.0 kg/m2. Median (IQR) total folate intake was 713 (672) FE µg/d, 
median total vitamin D was 5.9 (8.5) µg/d, and median total EPA+DHA intake was  
170 (200) mg/d. Thirty-seven women (56%) used a folic acid supplement, thirty women (46%) a vitamin 
D supplement, and three women (5%) a supplement containing EPA+DHA.  
Folate intake & status 
Half of the participants met the recommended daily folate intake (≥680 FE µg; n=33). Women with an 
adequate folate intake had a significantly higher median (IQR) total folate intake (943 (124) FE µg/d 
versus 272 (102) FE µg/d, p < 0.001), used more often folate supplements (100% versus 12%, p <0.001), 
had higher intakes of vitamin B6 (2.1 (3.4) mg/d versus 1.8 (0.8) mg/d, p<0.05), higher intakes of 
vitamin B12 (5.4 (8.0) μg/d versus 4.3 (2.1) μg/d, p<0.05), and had higher plasma folate levels (40.9 ± 
18.6 nmol/L versus 17.9 ± 9.7 nmol/L, p <0.001) compared to women with an inadequate folate intake 
(Table 8.1). Nine women (13.6%) had inadequate folate plasma levels. Eight of them did not meet the 
recommended dietary folate intake. Total median (IQR) folate intake was 713 (672) FE µg/d, of which 
262 (102) FE µg/d was from dietary sources (Table 8.2). Vegetables (25%), bread and cereal products 
(22%), dairy products (10%), fruit (10%), and oils and fats (5%) were the main dietary sources of folate 
intake. Total folate intake (adjusted partial correlation coefficient 0.55, p for trend <0.001) and folate 
from supplements (adjusted partial correlation coefficient 0.75, p for trend <0.001) were significantly 
positively associated with plasma folate levels. None of the dietary sources of folate was significantly 
associated with plasma folate. The linear dose-response curve for total folate intake and plasma folate 
level is shown in Figure 8.1 (p for non-linearity=0.69). 
Vitamin D intake & status 
Twenty-two participants (33%) had an adequate vitamin D intake (≥10 µg/d), while forty-four 
participants did not meet this recommendation. Women with an adequate vitamin D intake had a 
significantly higher median (IQR) total vitamin D intake (13.0 (2.1) µg/d versus 3.7 (3.2) µg/d, p < 0.001), 
used more often vitamin D supplements (100% versus 18%, p < 0.001), and had higher serum 25(OH)D 
levels  (76 ± 19 nmol/L versus 68 ± 26 nmol/L, p = 0.16) compared to women with an inadequate 
vitamin D intake (Table 8.1). Fifteen women (22.7%) had insufficient 25(OH)D serum levels, of which 
thirteen had dietary intakes below the recommendation.  
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Table 8.1: Characteristics of the total study population (n = 66) and stratified by meeting the recommended 
intake of folate, vitamin D, and EPA + DHA for women in the preconception period according to the Health 
Council of the Netherlands. 
Characteristics  
Total 
population 
(n = 66) 
Folate intake 
< 680 FE µg/d 
(n =33) 
Folate intake 
≥ 680 FE µg/d 
(n = 33) 
Vitamin D 
intake 
< 10 µg/d 
(n = 44) 
Vitamin D 
intake 
≥ 10 µg/d 
(n = 22) 
EPA+DHA 
intake 
< 200 mg/d 
(n = 37) 
EPA+DHA 
intake 
≥ 200 mg/d 
(n = 29) 
Maternal age (years) 31.7 ± 4.1 31.2 ± 4.7 32.1 ± 3.4 31.0 ± 4.0 33.0 ± 4.0 31.7 ± 4.5 31.7 ± 3.5 
BMI (kg/m2) 25.2 ± 4.0 26.1 ± 4.4 24.3 ± 4.2 25.3 ± 4.5 25.0 ± 4.4 24.9 ± 4.6 25.6 ± 4.2 
Western ethnicity (%) 63 (95.5%) 30 (90.9%) 33 (100%) 42 (95.5%) 21 (95.5%) 34 (91.9%) 29 (100.0%) 
Marital status married 
(%) 55 (83.3%) 27 (81.8%) 28 (84.9%) 37 (84.1%) 18 (81.8%) 32 (86.5%) 23 (79.3%) 
Parity, ≥ 1 child (%) 60 (90.9%) 29 (87.9%) 31 (93.9%) 39 (88.6%) 21 (95.5%) 34 (91.9%) 26 (89.7%) 
Educational level (%)1 
Low  
Intermediate  
High  
 
3 (4.6%) 
22 (33.3%) 
41 (62.1%) 
 
2 (6.1%) 
12 (36.4%) 
19 (57.6%) 
 
1 (2.6%) 
10 (30.3%) 
22 (66.7%) 
 
3 (6.8%) 
14 (31.8%) 
27 (61.4%) 
 
0 (0.0%) 
8 (36.4%) 
14 (63.6%) 
 
2 (5.4%) 
12 (32.4%) 
23 (62.2%) 
 
1 (3.5%) 
10 (34.5%) 
18 (62.7%) 
Smokers (%)  8 (12.1%) 5 (15.2%) 3 (9.1%) 6 (13.6%) 2 (9.1%) 4 (10.8%) 4 (13.8%) 
Alcohol (g/d) 0.9 (4.1) 0.5 (4.1) 0.9 (3.6) 0.8 (3.8) 1.0 (4.3) 0.5 (1.5) 1.8 (3.9)* 
Blood sampling between 
December and April (%) 10 (15.2%) 5 (15.2%) 5 (15.2%) 7 (15.9%) 3 (13.6%) 4 (10.8%) 6 (20.7%) 
Energy (kJ) 8424 (2701) 8152 (2888) 8697 (2058) 8338 (2752) 8495 (2218) 8152 (2376) 8913 (2172) 
Total carbohydrate (E%)2 45.4 (5.8) 44.9 (6.6) 46.0 (6.3) 45.4 (7.5) 45.2 (4.6) 45.7 (6.4) 44.4 (7.7) 
Total protein (E%)2 15.7 (2.5) 15.9 (1.6) 14.9 (3.2) 15.4 (2.6) 15.9 (2.4) 15.8 (2.9) 15.6 ± 2.1 
Total fat (E%)2  36.2 (5.9) 36.2 (5.0) 36.3 (5.4) 36.2 (6.6) 36.4 (5.0) 35.1 (5.3) 37.1 (6.3) 
Total folate (FE µg) 713 (672) 272 (102) 943 (124)** 323 (657) 898 (145)** 338 (700) 892 (551) 
Folate supplement (%) 37 (56.1%) 4 (12.1%) 33 (100%)** 18 (40.9%) 19 (86.4%)** 16 (43.2%) 21 (72.4%)* 
Total vitamin D (µg) 5.9 (8.5) 3.7 (3.0) 10.3 (7.4)** 3.7 (3.2) 13.0 (2.1)** 4.8 (8.9) 6.4 (7.0) 
Vitamin D supplement 
(%) 30 (45.5%) 7 (21.2%) 23 (69.7%)** 8 (18.2%) 
22 
(100.0%)** 15 (40.5%) 15 (51.7%) 
Total EPA + DHA (mg) 170 (200) 130 (150) 220 (250) 180 (160) 160 (270) 100 (110) 310 (240)** 
EPA+DHA supplement 
(%) 3 (4.6%) 1 (3.0%) 2 (6.1%) 3 (6.8%) 0 (0.0%) 0 (0.0%) 3 (10.3%)* 
Total vitamin B6 (mg) 1.9 (1.4) 1.8 (0.8) 2.1 (3.4)* 1.8 (0.7) 2.9 (4.5)** 1.8 (1.6) 1.9 (1.2) 
Total vitamin B12 (µg) 4.6 (3.3) 4.3 (2.1) 5.4 (8.0)* 4.4 (2.3) 5.6 (9.8) 4.1 (2.2) 5.8 (4.7)** 
Plasma folate (nmol/L) 29.4 ± 18.7 17.9 ± 9.7 40.9 ± 18.6** 26.9 ± 18.4 34.4 ± 18.7 26.9 ± 15.5 32.6 ± 22.0 
Insufficient plasma folate 
(< 10 nmol/L) 9 (13.6%) 8 (24.2%) 1 (3.0%)* 8 (18.2%) 1 (4.5%) 4 (10.8%) 5 (17.2%) 
Serum 25(OH)D (nmol/L) 70.6 ± 23.8 65.7 ± 26.2 75.5 ± 20.5 67.6 ± 25.7 76.5 ± 18.5 68.6 ± 22.9 73.1 ± 25.5 
Insufficient serum 
25(OH)D (<50 nmol/L) 15 (22.7%) 10 (30.3%) 5 (15.2%) 13 (29.6%) 2 (9.1%) 9 (24.3%) 6 (20.7%) 
Plasma phospholipid 
EPA + DHA (g/100g 
FAME) 
5.2 ± 1.7 5.0 ± 1.6 5.3 ± 1.8 5.2 ± 1.8 5.0 ± 1.5 4.6 ± 1.6 5.9 ± 1.5** 
25(OH)D 25-hydroxyvitamin D; EPA eicosapentaenoic acid; DHA docosahexaenoic acid; FAME Fatty Acid Methyl Esters.  
Data are presented as mean ± standard deviation, as median (interquartile range), or as n (%). Subgroups were created 
based on the recommended intake of folate, vitamin D, and EPA + DHA for women in the preconception period according 
to the Health Council of the Netherlands.  
Independent t-tests, Chi-Square tests, and Mann Whitney U tests were performed between the group below and above 
the recommended nutrient intake of interest (* p ≤ 0.05, ** p ≤ 0.01).   
1 Low educational level: primary school, vocational or lower general secondary education; intermediate educational level: 
higher secondary education or intermediate vocational training; high educational level: higher vocational education or 
university. 
2 E%: the amount of energy derived from that nutrient. 
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Table 8.2: Absolute (µg/d) and relative (%) contribution of dietary sources to total dietary folate intake, 
Spearman’s rank and partial correlation coefficients (R) between folate intake and plasma folate levels, and 
adjusted means with 95% confidence intervals for plasma folate levels (nmol/L) according to tertiles of folate 
intake (µg/d) among Dutch women with a pregnancy wish (n = 66). 
 Contribution Correlation Adjusted means with 95%CIs P for 
trend  µg/d1 % R2 R3 Tertile 1 Tertile 2 Tertile 3 
Total folate intake  
Plasma folate 
713 (672)  0.58** 0.55** ≤ 294 
17.6 
(10.6-24.7) 
295-894 
28.6 
(21.7-35.4) 
≥ 895 
42.0 
(34.8-49.2) 
 
 
<.001 
Folate from supplements 
Plasma folate 
340 (680)  0.68** 0.67** ≤0 
17.6  
(12.2-23.0) 
 
0.1-679 
29.7 
 (19.1-40.3) 
≥680 
40.7  
(35.5-46.0) 
 
<.001 
Total dietary folate  
Plasma folate 
262 (102) 100 -0.08 -0.20 ≤223 
31.4  
(25.5-37.3) 
 
224-293 
30.2  
(24.5-35.9) 
≥294 
26.5  
(20.6-32.5) 
 
0.257 
Folate from vegetables 
Plasma folate 
63.2 (50.2) 25 0.06 0.04 ≤47.9 
30.1  
(24.6-35.6) 
 
48.0-83.3 
25.2  
(19.8-30.7) 
≥83.4 
33.1  
(27.6-38.6) 
 
0.324 
Folate from bread and cereal 
products5 
Plasma folate 
 
57.5 (39.3) 22 -0.10 -0.19 ≤46.0 
 
29.9  
(24.3-35.5) 
 
46.1-69.5 
 
29.7  
(24.0-35.4) 
≥69.6 
 
28.6  
(22.8-34.4) 
 
 
0.763 
Folate from dairy products6 
Plasma folate 
 
26.8 (24.0) 10 0.01 -0.15 ≤18.7 
 
32.6  
(26.6-38.6) 
 
18.8-34.0 
 
27.3  
(21.8-32.9) 
≥34.1 
 
28.5  
(22.2-34.8) 
 
 
0.355 
Folate from fruit 
Plasma folate 
25.6 (22.4) 10 0.13 -0.14 ≤17.6 
29.5  
(23.5-35.5) 
 
17.7-30.7 
32.0  
(26.5-37.5) 
≥30.8 
26.5  
(20.4-32.6) 
 
0.502 
Folate from oils and fats7  
Plasma folate 
0.27 (3.32) 5 -0.23 -0.20 ≤0.07 
32.0  
(26.4-37.7) 
0.08-0.63 
30.7  
(25.0-36.4) 
≥0.64 
25.4  
(19.7-31.2) 
 
0.102 
Folate intake (FE µg/d), Plasma folate (nmol/L), * p ≤ 0.05, ** p ≤ 0.01.  
1 Median (IQR).  
2 Spearman’s rank correlation with plasma folate (nmol/L) as dependent variable.   
3 Partial correlation with plasma folate (nmol/L) as dependent variable: adjusted for season of blood sampling, total energy 
intake (kJ), intake of total vitamin B6 and vitamin B12. For supplemental folate, additional adjustment was done for dietary 
folate intake; for dietary folate, additional adjustment was done for folate intake from supplement; for folate from top-5 
dietary sources additional adjustment for folate intake from other selected dietary sources (i.e., vegetables, bread and 
cereal products, dairy products, fruit, and oils and fats) was done.   
4 Means were adjusted for the same covariates as for partial correlation, and calculated with ANCOVA. 
5 includes bread, breakfast cereals, pasta, and rice.   
6 includes milk, yoghurt drinks, cheese, yoghurt, fromage frais, coffee creamer, and ice cream.  
7 includes liquid, soft and hard cooking fats and margarine, and vegetable oils.  
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Total median (IQR) vitamin D intake was 5.9 (8.5) µg/d, of which 3.3 (2.0) µg/d was obtained from 
dietary sources (Table 8.3). Oils and fats (39%) were the main contributors to total dietary vitamin D 
intake. Fish intake was the second most important contributor (20%). Furthermore, meat (14%), eggs 
(10%), and dairy products (5%) belonged to the top-5 dietary sources of vitamin D intake. Total vitamin 
D intake (adjusted partial correlation coefficient 0.42, p for trend 0.04), vitamin D from supplements 
(adjusted partial correlation coefficient 0.40, p for trend 0.006), total dietary vitamin D (adjusted 
partial correlation coefficient 0.30, p for trend 0.001) and vitamin D from oils and fats (adjusted partial 
correlation coefficient 0.38, p for trend 0.02) were significantly positively associated with serum 
25(OH)D levels. The dose-response between total vitamin D intake and serum 25(OH)D levels is shown 
in Figure 8.1 (p for linearity=0.17). 
EPA and DHA intake & status 
Forty-four percent of the participants met the recommended intake of the n-3 fatty acids EPA+DHA  
(≥200 mg/d; n=29); these women had a significantly higher median total EPA+DHA intake  
(310 (240) mg/d versus 100 (110) mg/d, p < 0.001) compared with those who did not meet the 
recommendation (Table 8.1). Only three women used a supplement containing EPA+DHA. Plasma 
phospholipid EPA+DHA levels were significantly higher in participants with an adequate EPA+DHA 
intake than in participants with an inadequate intake (5.9 ± 1.5 g/100g FAME versus 4.6 ± 1.6 g/100g 
FAME, p = 0.001). Total median (IQR) EPA+DHA intake was 170 (200) mg/d, of which 165 (190) mg/d 
was from dietary sources (Table 8.4). Fish (69%) was the main contributor to total dietary EPA+DHA 
intake, followed by meat (6%) and eggs (4%). Total EPA+DHA intake (adjusted partial correlation 
coefficient 0.67, p for trend 0.002), total dietary EPA+DHA (adjusted partial correlation coefficient 0.63, 
p for trend 0.001), EPA+DHA from total fish intake (adjusted partial correlation coefficient 0.67, p for 
trend <0.001) and EPA+DHA from fatty fish (adjusted partial correlation coefficient 0.51, p for 
trend=0.001) were significantly positively associated with plasma phospholipid EPA+DHA levels. Only 
three women took EPA+DHA containing supplements, therefore no p for trend could be calculated, 
but EPA+DHA from supplements was significantly correlated with plasma phospholipid EPA+DHA levels 
(adjusted partial correlation coefficient 0.38, p=0.02). Figure 8.1 shows the nonlinear dose-response 
curve between total EPA+DHA intake and plasma phospholipid EPA+DHA level, with the curve 
flattening at higher intake levels (p for non-linearity=0.05).  
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Table 8.3: Absolute (µg/d) and relative (%) contribution of dietary sources to total dietary vitamin D intake, 
Spearman’s rank and partial correlation coefficients (R) between vitamin D intake and serum 25(OH)D levels, 
and adjusted means with 95% confidence intervals for serum 25(OH)D levels (nmol/L) according to tertiles of 
vitamin D intake (µg/d) among Dutch women with a pregnancy wish (n = 66). 
 Contribution Correlation Adjusted means with 95%CIs P for 
trend  µg/d1 % R2 R3 Tertile 1 Tertile 2 Tertile 3 
Total vitamin D  
Serum 25(OH)D 
5.9 (8.5)  0.32** 0.42**  ≤3.6 
62.5 
(52.6-72.5) 
3.7-10.2 
71.2 
(61.5-80.9) 
≥10.3 
78.0 
(68.4-87.5) 
 
 
0.04 
Vitamin D from 
supplements  
Serum 25(OH)D 
0 (7.5)  0.30* 0.40** ≤0 
 
64.5 
(57.6-71.5) 
 
0.1-4.9 
 
55.6 
(24.8-86.3) 
 
≥5.0 
 
79.4 
(71.5-87.3) 
 
 
 
0.006 
Total dietary vitamin D  
Serum 25(OH)D 
3.3 (2.0) 100 0.12 0.30* ≤2.8 
57.4 
(48.2-66.6) 
2.9-3.8 
71.5 
(62.8-80.2) 
≥3.9 
82.8 
(72.9-92.6) 
 
 
0.001 
Vitamin D from oils and 
fats5 
Serum 25(OH)D 
1.1 (2.0) 39 0.20 0.38** ≤0.6 
 
60.6 
(50.2-71.1) 
0.7-2.0 
 
69.6 
(60.8-78.3) 
≥2.1 
 
80.7 
(70.1-91.3) 
 
 
 
0.02 
Vitamin D from fish 
Serum 25(OH)D 
0.53 (0.76) 20 -0.04 0.18 ≤0.2 
63.3 
(53.5-73.2) 
0.3-0.7 
73.8 
(65-82.6) 
≥0.8 
74.1 
(64.8-83.3) 
 
 
0.18 
Vitamin D from meat 
Serum 25(OH)D 
0.43 (0.37) 14 0.09 0.03 ≤0.3 
69.2 
(59.6-78.8) 
0.4-0.6 
69.5 
(59.9-79) 
≥0.7 
73.0 
(63.1-83.0) 
 
 
0.43 
Vitamin D from egg 
Serum 25(OH)D 
0.23 (0.35) 10 -0.14 -0.07 ≤0.1 
72.0 
(62.1-81.9) 
0.2-0.3 
67.5 
(57.4-77.6) 
≥0.4 
71.8 
(61.7-81.9) 
 
 
0.96 
Vitamin D from dairy 
products6 
Serum 25(OH)D 
0.12 (0.11) 5 -0.06 0.13 ≤0.01 
 
74.0 
(65.0-83.0) 
0.02-0.10 
 
63.7 
(54.0-73.4) 
≥0.11 
 
73.5 
(63.8-83.2) 
 
 
0.11 
25(OH)D 25-hydroxyvitamin D. 
Vitamin D intake (µg/d), and serum 25(OH)D (nmol/L), * p ≤ 0.05, ** p ≤ 0.01.  
1 Median (IQR). 
2 Spearman’s rank correlation with serum 25(OH)D (nmol/L) as dependent variable. 
3 Partial correlation with serum 25(OH)D as dependent variable: adjusted for season of blood sampling, education level 
(low/intermediate/high), BMI (kg/m2) and energy intake (kJ). For supplemental vitamin D additionally adjusted for dietary 
vitamin D intake; for dietary vitamin D additionally adjusted for vitamin D intake from supplement; for vitamin D from top-
5 dietary sources additional adjustment for vitamin D intake from other selected dietary sources (i.e., oils and fats, fish, 
meat, egg, and dairy products).  
4 Means were adjusted for the same covariates as for partial correlation, and calculated with ANCOVA. 
5 includes liquid, soft and hard cooking fats and margarine, and vegetable oils. 
6 includes milk, yoghurt drinks, cheese, yoghurt, fromage frais, coffee creamer, and ice cream. 
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Table 8.4: Absolute (mg/d) and relative (%) contribution of dietary sources to total EPA and DHA intake, 
Spearman’s rank and partial correlation coefficients between EPA and DHA intake and plasma phospholipid 
EPA and DHA, and adjusted means with 95% confidence intervals for plasma phospholipid EPA and DHA 
(g/100g FAME) according to tertiles of EPA and DHA intake (mg/d) among Dutch women with a pregnancy 
wish (n = 66). 
 Contribution Correlation Adjusted means with 95%CIs P for 
trend  mg/d1 % R2 R3 Tertile 1 Tertile 2 Tertile 3 
Total EPA + DHA intake 
PPL g/100g FAME 
170  (200)  0.63** 
 
0.67** < 100 
4.1 
(3.4 - 4.8) 
 
100 – 240 
5.3 
(4.6 - 6.0) 
> 240 
6.0 
(5.4 - 6.7) 
 
0.002 
EPA + DHA from supplements  
PPL g/100g FAME 
0 (0)  0.24 
 
0.38* 0 
5.0 
(4.6 - 5.4) 
1-500 
7.9 
(6.1 - 9.7) 
 
 
- a 
 
- a 
Total dietary EPA + DHA  
PPL g/100g FAME 
165 (190) 100 0.59** 
 
0.63** <100 
4.2 
(3.5 - 4.8) 
 
100 – 230 
5.5 
(4.8 - 6.2) 
>230 
5.9 
(5.2 - 6.5) 
 
0.001 
EPA + DHA from fish 
PPL g/100g FAME 
135 (190) 69 0.60** 
 
0.67** <70 
3.8 
(3.2 - 4.4) 
 
70-190 
5.9 
(5.2 - 6.5) 
>190 
6.0 
(5.4 - 6.5) 
 
<.001 
EPA + DHA from fatty fish 
PPL g/100g FAME 
105 (170) 46 0.60** 
 
0.51** <20 
4.4 
(3.7 - 5) 
 
20-160 
5.4 
(4.7 - 6) 
>160 
5.7 
(5 - 6.4) 
 
0.009 
EPA + DHA from lean fish 
PPL g/100g FAME 
25 (40) 18 0.22 
 
0.10 <10 
4.9 
(4.2 - 5.5) 
 
10-30 
5.3 
(4.7 – 6.0) 
>30 
5.3 
(4.6 – 6.0) 
 
0.408 
EPA + DHA from  shell fish 
PPL g/100g FAME 
0 (10) 5 0.32* 
 
0.24 0 
4.9 
(4.4 - 5.3) 
 
1 – 140 
6.0 
(5.2 - 6.8) 
 
- a 
 
- a 
EPA + DHA from meat 
PPL g/100g FAME 
10 (10) 6 -0.06 
 
-0.30* 0 
5.6 
(5 - 6.1) 
 
1 – 30 
4.8 
(4.3 - 5.3) 
 
- a 
 
- a 
EPA + DHA from egg 
PPL g/100g FAME 
0 (10) 4 0.07 
 
-0.00 0 
5.1 
(4.6 - 5.5) 
1 – 50 
5.3 
(4.7 - 5.9) 
 
- a 
 
- a 
EPA eicosapentaenoic acid; DHA docosahexaenoic acid; FAME fatty acid methyl esters; PPL plasma phospholipid.   
EPA + DHA intake (mg/d), and plasma phospholipid EPA+DHA (g/100g FAME), * p ≤ 0.05, ** p ≤ 0.01.  
1 Median (IQR).   
2 Spearman’s rank correlation with plasma phospholipid EPA + DHA (g/100g FAME) as dependent variable.   
3 Partial correlation with plasma phospholipid EPA + DHA (g/100g FAME) as dependent variable: adjusted for season of 
blood sampling, education level (low/intermediate/high), BMI (kg/m2) and energy intake (kJ). For supplemental EPA+DHA 
additionally adjusted for dietary EPA+DHA intake; for dietary EPA+DHA additionally adjusted for EPA+DHA intake from 
supplement; for EPA+DHA from top-5 dietary sources additional adjustment for EPA+DHA intake from other selected 
dietary sources (i.e., fish (fatty, lean and shell fish), meat, and egg).   
4 Means were adjusted for the same covariates as for partial correlation, and calculated with ANCOVA.  
a Due to the low amount of EPA+DHA in lean fish, shellfish, meat, and egg, two groups were made instead of tertiles and no 
p for trend could be calculated.  
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Discussion  
In our cross-sectional study in 66 Dutch women aged 18-40 years who wished to become pregnant, 
50% had an inadequate folate intake (<680 FE µg/d), 67% had an inadequate vitamin D intake (<10 
µg/d), and 56% had an inadequate EPA+DHA intake (<200 mg/d) according to the recommendations 
given by the Health Council of the Netherlands. Dietary intakes of folate, vitamin D and EPA+DHA were 
significantly positively associated with their blood levels. However, 14% of the women had an 
inadequate folate status and 23% an inadequate vitamin D status. We observed significant associations 
between folate intake from supplements with plasma folate levels, whereas dietary folate intake was 
not associated with folate status markers. Oils and fats were the main contributors to total dietary 
vitamin D intake followed by fish. Significant vitamin D intake-status associations were observed for 
total vitamin D intake, vitamin D from supplements, dietary vitamin D and vitamin D from oils and fats 
with serum 25(OH)D. Fish, mainly fatty fish, was the most important contributor to dietary EPA+DHA 
intake. In line with this, significant associations were observed between total EPA+DHA intake, total 
dietary EPA+DHA intake, and EPA+DHA obtained from (fatty) fish with plasma phospholipid EPA+DHA.  
Folate intake  
Despite the fact that all women in this study wished to become pregnant within a year, only 50% of 
the women used a folate-containing supplement and met the recommended folate intake of 680 FE 
µg/d. This is in line with previous research carried out among Dutch pregnant women that reported 
that 31% of women with a lower socioeconomic status and 63% of the women with a higher 
socioeconomic status used a folic acid supplement prior to conception [28].Folic acid supplement use 
in the preconception period reported in Australia was comparable [29, 30]. Other studies reporting 
supplement use during pregnancy found up to 95% of pregnant women using supplements, with 
multivitamin supplements and folic acid supplements were the most commonly reported [31-33]. Of 
the total folate intake reported (713 (672) FE µg/d), only 262 (102) µg/d was from dietary sources. This 
highlights the substantial contribution of folate from supplements to total folate intake in this 
population. The observed dietary folate intake is comparable to results of the Dutch National Food 
Consumption Survey (DNFCS) 2007-2010, where the dietary folate intake was 216 (92) µg/d for women 
aged 19-30 years and 242 (102) µg/d for women aged 31-50 years [34]. The strong association between 
total folate intake and plasma folate levels as observed in our study population is supported by a meta-
analysis, using data from mostly non-pregnant and non-lactating women of childbearing age, reporting 
a 47% increase in plasma folate levels when doubling total folate intake [35]. Vegetables and bread 
and cereal products were the main contributors to dietary folate intake in our population, which is in 
line with a study in healthy Norwegian women aged 47-49 years and 71-74 years [36]. However, in this 
study, vegetables, fruit, and orange juice intake were significantly associated with plasma folate levels, 
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whereas we did not observe this association. This may be explained by our specific population of 
women who wished to become pregnant and consequently included a larger proportion of supplement 
users, which resulted in a relative low contribution of dietary folate to total folate intake in our study.  
Vitamin D intake  
One-third of the women in our population had an adequate vitamin D intake (i.e. ≥10 µg) and all these 
women used a vitamin D supplement. Median total vitamin D intake of women with an inadequate 
vitamin D intake (5.9 (8.5) µg/d) was higher compared to results of the DNFCS 2007-2010, which 
estimated a median intake of 2.9 (1.9) µg/d for women aged 19-30 years and 3.3 (2.3) µg/d for women 
aged 31-50 years [34]. Of the total vitamin D intake reported in our study, 3.3 (2.0) µg/d was from 
dietary sources. Oils and fats were the most important dietary sources contributing to dietary vitamin 
D intake, followed by fish, meat, eggs, and dairy products, which is in line with a recent study in Dutch 
older adults [37]. Furthermore, we observed significant associations between tertiles of total vitamin 
D intake, total dietary vitamin D intake, vitamin D from supplements, and vitamin D intake from fats 
and oils with serum 25(OH)D levels, which is again in agreement with the recent study in Dutch older 
adults. Thus, even though sunlight is the most important source of vitamin D [15], we and Vaes (2016) 
showed that both dietary and supplemental vitamin D may have a substantial impact on serum 
25(OH)D levels. This is supported by a recent meta-analysis which observed that the intake of ±300g 
fish per week over a period of at least four weeks is associated with an increase in 25(OH)D levels [38]. 
Although fish intake was the second contributor in our population, we did not observe a significant 
association between fish intake and 25(OH)D levels. The difference between the meta-analysis and our 
study may relate to the fact that the median intake of ±100g fish per week in our study was 
substantially lower than the intake levels of 300g fish per week as suggested in the meta-analysis [38]. 
Regarding vitamin D supplement use, 45% of the women in our study used a vitamin D supplement in 
the preconception period, which is high compared to a study in Australia, where only fourteen percent 
of the participants, also mainly high educated, used a vitamin D supplement during the three months 
prior to conception [29]. Furthermore, a pregnancy multivitamin supplement commonly used in our 
cohort contained both folate and vitamin D, which may explain the higher vitamin D supplement use 
in our population. In addition, it explains why women with an adequate vitamin D intake, also had an 
adequate folate intake. Sixty-seven percent of the women in this population had an inadequate 
vitamin D intake, of which 13 women (30%) had serum 25(OH)D levels below 50 nmol/L. In the group 
with adequate vitamin D intake, only two out of 22 women (9%) had serum 25(OH)D levels below 50 
nmol/L. This effect was more pronounced in the winter season, and illustrates the importance of 
meeting the vitamin D recommendation, especially in the winter.  
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EPA and DHA intake  
Less than half of the women in our study met the recommended 200 mg daily intake of EPA+DHA. 
However, the median (IQR) intake of 170 (200) mg/d in our study was higher than the intake of 
EPA+DHA in the general population with a median intake of 75 (92) mg/d for women aged 19-30 years 
and 89 (106) mg/d for women aged 31-50 years [34]. Fish, and especially fatty fish, was the main 
contributor to dietary EPA+DHA intake in our study population. We observed strong significant 
correlations of total EPA+DHA intake, total dietary EPA+DHA intake, and EPA+DHA obtained from 
(fatty) fish with plasma phospholipid EPA+DHA. This is in line with a study among adult Swedish women 
showing comparable strong correlations between dietary intake of EPA+DHA and EPA+DHA plasma 
phospholipids [39]. Only three women in our study (5%) used a supplement containing EPA+DHA, 
which is similar to the data of the DNFCS 2007-2010 [34] and to a cohort in Australia where 9% of the 
women used a fish oil supplement during the three months prior to conception [29]. The women in 
our study who took EPA+DHA containing supplements had higher plasma phospholipid EPA+DHA 
plasma levels, adjusted for dietary EPA+DHA intake, than the women who did not take a supplement, 
indicating that for women who cannot or do not want to consume fish, EPA+DHA containing 
supplements can be helpful to achieve recommended intakes and increase EPA+DHA levels.   
Supplement use 
As demonstrated in our study, supplementation can help in achieving adequate intake levels and 
consequently achieve adequate blood levels of folate and vitamin D. However, some considerations 
should be taken into account regarding supplement use. Women who take prenatal supplements are 
often women with a higher educational level, who, in general, already achieve higher intakes of 
micronutrients [40, 41]. Health policies encouraging supplement use might not reach the women with 
the lowest intake levels, but increase supplement consumption in health-conscious women with 
already adequate intake levels, who are consequently at risk of overconsumption [31]. This might 
especially occur in countries with mandatory fortification of bread, for example, with folate, such as in 
the United States, United Kingdom and Australia. It should also be noted that the WHO advises against 
using supplements, other than folic acid, vitamin D and iron in the preconception period or during 
pregnancy when not deficient, including multivitamins as there has been no proven additional benefit 
of other supplements and may lead to overconsumption of specific micronutrients [42]. 
Study limitations and strengths  
Before heading to the conclusion, some limitations and strengths of this study need to be discussed. 
First of all, the sample size of this study was relatively small (n=66). However, significant correlations 
and associations were observed suggesting that study power does not seem to be an important 
limitation. Besides that, median (IQR) vitamin D intake from dietary sources was in line with the values 
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described in the study of Vaes (2016) (n=595), indicating that our sample size was large enough to 
provide robust vitamin D intake estimates. Secondly, our FFQ was not validated for vitamin D and the 
n-3 fatty acids EPA and DHA, but was an updated version of an FFQ which was validated for dietary 
intake of energy, macronutrients, and B-vitamins in Dutch women of reproductive age [20-22]. 
However, the FFQ was designed to capture energy intake (i.e. an extensive FFQ including a large variety 
of food items) and included food items covering the most important dietary sources of vitamin D and 
EPA+DHA (e.g. fat and oils, fish, meat, and dairy). Nevertheless, measurement errors resulting from 
aggregation of food-items in an FFQ, under- or over reporting, recall bias, seasonal influence and thus 
biased estimates associated with self-report methods cannot be excluded [21]. Thirdly, our study 
population consisted of mostly highly educated women with a Western ethnicity, with an oversampling 
of women with a high risk of GDM. Our results may therefore be limited in generalizability to other 
study populations with respect to reported dietary intake estimates and prevalence of inadequacy. 
However, intake-status associations are less likely to be influenced by education and were adjusted for 
both educational level and BMI (most important GDM risk factor). 
Major strengths of this study include availability of blood samples of women in the preconception 
period and information on women’s total nutrient intake, including both diet and supplement use, 
enabling us to examine intake-status associations. Because the FFQ covered dietary intake of the 
previous month, appropriate blood biomarkers were used, as plasma folate, serum 25(OH)D, and 
plasma phospholipid EPA+DHA levels were considered indicators of recent dietary intake [35, 43, 44]. 
Furthermore, potential relevant covariates appropriate to specific nutrient intakes were used in 
statistical analyses to reduce the risk of confounding.   
Conclusions 
Results of our study showed that even among highly educated women who wanted to become 
pregnant a large proportion did not meet recommendations regarding folate, vitamin D and EPA+DHA 
intake. Significant associations were found between total folate, total vitamin D and total EPA+DHA 
intake and their blood levels. Women with modest inadequate vitamin D and EPA+DHA intake may 
obtain an adequate intake by an increased consumption of fats and oils and fish. In this population, 
supplement use contributed substantially to total folate and vitamin D intake and status levels. 
Promotion of fish intake and folic acid and vitamin D supplement use of for women wish to become 
pregnant is necessary, since intake of the top-5 dietary sources, covering at least 80% of dietary intakes 
of these micronutrients, cannot suffice the nutritional requirements in most women to obtain an 
adequate nutritional status in the preconception period. Results of our study contribute to the current 
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scientific evidence as data on intake of folate, vitamin D, and EPA+DHA from different sources and data 
on nutrient status is very limited, especially among women who wish to become pregnant.   
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The main aim of this thesis was to provide more insight in dietary intake and nutrient status before 
and during pregnancy and the association with development of gestational diabetes (GDM). In 
addition, we studied adverse pregnancy outcomes in women who received treatment after diagnosis 
of GDM and addressed two methodological topics important in nutrition research: assessment of diet 
quality, and bias in diet-disease associations due to measurement error.  
The findings of these studies are summarized in Table 9.1. To be able to assess adherence to the Dutch 
dietary guidelines of 2015 the Dutch Healthy Diet 2015 (DHD15) index score was developed, which 
appeared to be a good marker of diet quality (chapter 2). Combining FFQ and 24-hour recall (24hR) 
dietary intake estimates was done using regression calibration and enhanced regression calibration 
and was found to reduce bias in diet-disease associations (chapter 3). Using data from medical file 
records, it was observed that women who were diagnosed with GDM and subsequently received 
treatment had higher risk of laceration but not of other adverse pregnancy outcomes than women 
with normal glucose tolerance during pregnancy; highest risks were observed for women with 
borderline gestational diabetes (BGDM) (chapter 4). Pre-pregnancy dietary intake was associated with 
GDM development in a large Australian population-based cohort study, with a low carbohydrate diet 
and higher cereal intake being associated with a higher risk of GDM (chapter 5), and with a higher 
fibre, fruit and fruit juice intake (chapter 5) and micronutrient adequacy (chapter 6) being associated 
with a lower risk of GDM. No clear associations between diet quality, micronutrient intake and 
micronutrient status levels, measured throughout pregnancy with fasting glucose, 2-hour glucose and 
HbA1c levels were observed in a small-scale study of Dutch women (chapter 7). In this study consisting 
predominantly of highly educated women, a high percentage of inadequate intake of folate, vitamin D 
and n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) was observed in the 
preconception period, as well as inadequate folate and vitamin D status (chapter 8).  
In chapters 2-8, methodological considerations specific for the respective chapters have been 
addressed. The following paragraphs will discuss overarching methodological considerations  and how 
the main findings of this thesis fit with the existing literature. First, a reflection is given on issues related 
to GDM diagnosis and dietary assessment, followed by a discussion regarding different aspects of the 
design of the studies used. Finally, suggestions for further research, implications for public health and 
clinical practice, and an overall conclusion will be presented. 
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GDM assessment 
One of the major challenges in GDM research is the lack of uniform diagnostic criteria. In this thesis 
data was used from different studies from two countries that used different criteria. In the GLIMP 
(chapter 4) and GLIMP2 study (chapter 7) results from the oral glucose tolerance test (OGTT) were 
available, making it possible to recalculate prevalences based on different sets of diagnostic criteria or 
work with continuous glucose values. In the ALSWH study (chapter 5, 6), however, only GDM diagnosis 
(yes/no) was reported, and thus based on one specific set of diagnostic criteria used in Australia at that 
time [1]. There has been a call for uniform diagnostic criteria [2-4]. In 2010, the International 
Association of Diabetes and Pregnancy Study Group (IADPSG) has proposed criteria based on the 
results of the landmark Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) study [5]. These 
criteria have been adopted by several important institutions, including the World Health Organization 
(WHO) and American Diabetes Association, but not all, e.g. American College of Obstetricians and 
Gynaecologist [6]. Therefore, not every country has endorsed and implemented the new guidelines. 
GDM diagnostic criteria and adverse pregnancy outcomes 
An important aspect in the discussion on GDM diagnosis and its treatment is the increased risk of 
adverse pregnancy outcomes when GDM stays unrecognized. In chapter 4, risk of common adverse 
pregnancy outcomes including Caesarean section, assisted vaginal delivery, laceration, shoulder 
dystocia and post-partum haemorrhage were compared between three groups based on glucose 
tolerance status: women diagnosed with GDM (fasting glucose ≥6.1 mmol/l and/or 2-hour glucose ≥7.8 
mmol/l after 75g OGTT) who received treatment, women with BGDM (1-hour glucose ≥7.8 mmol/l 
after 50g glucose challenge test (GCT) and normal 75g OGTT result) who did not receive treatment and 
women with normal glucose tolerance (normal 50g GCT result) during pregnancy. This study used 
medical file data from women who underwent GDM screening and delivered in hospital Gelderse Vallei 
Ede in 2010-2014. Hospital Gelderse Vallei Ede used a two-step universal screening strategy during the 
study period, which allowed us to define a group of women with BGDM that based on a one-step 
approach would have been included in the normal glucose tolerance group. Furthermore, as all women 
included in the study underwent GDM testing, regardless of whether they were at high risk, i.e. 
universal screening, all cases of GDM were identified. In this study the WHO criteria from 1999 [7] 
were used, which has the lowest 2-hour glucose cut-off value.  
In our study, most women were diagnosed with GDM based on an abnormal 2-hour post-glucose load 
level. Few studies have investigated whether abnormal fasting glucose or abnormal 2-hour post-
glucose load levels are more indicative of adverse pregnancy outcomes [8, 9]. In the study of Koning 
et al. women with abnormal fasting glucose levels were at higher risk of gestational hypertension, 
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induction of labour, planned Caesarean section, Apgar score <7 and admission to neonatology, 
whereas women with normal fasting glucose (<5.1 mmol/L) and abnormal 2-hour glucose level (≥7.8 
mmol/l) were not at increased risk compared to the normal glucose tolerance group [9]. However, 
these women with abnormal 2-hour glucose levels received treatment whereas the abnormal fasting 
glucose group did not. The study of Black et al., in which women received no treatment, observed that 
women with an elevated fasting but normal 2-hour glucose level had a higher risk of large for 
gestational age infants, but not for other adverse pregnancy outcomes compared to women with 
normal glucose tolerance [8]. In contrast, women in this study with abnormal 2-hour post-glucose level 
and normal fasting glucose had higher risk of preterm delivery, shoulder dystocia, gestational 
hypertension and hyperbilirubinemia compared to women with normal glucose tolerance [8]. These 
studies raise the question whether or not to keep the lower 2-hour glucose level of 7.8 mmol/l for 
diagnosis of GDM rather than the 8.5 mmol/l cut-off suggested in the 2010 International Association 
of Diabetes and Pregnancy Study Group (IADPSG) criteria [5], endorsed by the WHO and the American 
Diabetes Association (ADA) [10, 11].  
The results of our study go even further and indicate that women with an abnormal 50 grams glucose 
challenge test (1-hour glucose ≥7.8 mmol/l), but normal 75 grams OGTT (fasting glucose <6.1 mmol/l 
and 2-hour glucose <7.8 mmol/l) had an increased risk of several common adverse pregnancy 
outcomes including macrosomia (i.e. birth weight >4000g), laceration and (unscheduled) Caesarean 
section. However, a two-step universal screening approach is necessary to identify these women at 
risk. Main arguments of critics opposing to lower diagnostic criteria for GDM (i.e. implementation of 
IADPSG criteria) are the resulting steep increase in GDM cases and subsequent treatment costs [12, 
13]. In addition, more cases of GDM will generate a greater workload for obstetrician, endocrinologist, 
and dietician services. For two hospital units in Australia it was estimated that overall workload would 
increase by 20-60%, which might require a structural change in health care services [14]. 
 
Dietary assessment 
Complexity of diet 
Diet consists of different nutrients of which some exert beneficial health effects and others exert 
detrimental effects, and combinations present in foods and dietary patterns might have synergistic or 
antagonistic effects. In this thesis, several aspects of the diet, including dietary patterns (chapter 5, 7), 
foods (chapter 5) and micronutrients (chapter 6,7) in relation to GDM development have been studied.   
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Dietary patterns 
People do not consume single nutrients or foods, but combinations of foods. These combinations of 
foods may be interactive and synergistic and can be captured with dietary pattern analysis [15-18]. 
Dietary guidelines represent the current state of scientific knowledge regarding the effect of nutrients 
and foods on the development of chronic diseases [19]. In chapter 2, we developed and evaluated the 
Dutch Healthy Diet 2015 (DHD15) index score assessing adherence to the Dutch dietary guidelines 
2015. The DHD15 index score proved to be a good measure of diet quality as it was associated with 
nutrient density. Furthermore, another study observed that higher adherence to the DHD15 index was 
associated with lower rates of mortality [20]. The DHD15 index is an a priori index score as it has 
predefined components and cut-off values. The advantage of a priori dietary patterns is that the 
predefined set of components and cut-off values can be applied in different study populations, which 
allows comparisons across different studies and populations [15]. However, the DHD15 index is 
designed for the Dutch population as it is based on the Dutch dietary guidelines 2015 [21]. 
Recommended intakes of these dietary guidelines were set taken the consumption pattern of the 
Dutch population into account, but might not be applicable to populations with on average higher or 
lower food group intakes. It is thus important to use diet scores appropriate to the study population. 
In this thesis, two dietary pattern scores were used in relation to GDM development: the DHD15 index 
score used in chapter 7 and the low-carbohydrate diet (LCD) score used in chapter 5. The LCD score 
has been used in one other study investigating its association with GDM development [22]. The LCD 
score is a measure of macronutrient composition and both we (chapter 5) and Bao et al. observed a 
higher risk of GDM with a higher LCD score, reflecting a relative low carbohydrate intake and a relative 
high fat and protein intake [22]. We were the first to study the newly developed DHD15 index score in 
relation to glucose tolerance during pregnancy. We did not observe a significant association between 
the DHD15 index score and fasting glucose, 2-hour glucose and HbA1c levels during pregnancy in the 
total study population, but the DHD15-index was inversely associated with fasting glucose in a 
sensitivity analysis, in which participants with only one measurement were excluded (chapter 7). Other 
dietary patterns investigated in relation to GDM development are: Mediterranean Diet Score (MDS) 
[23-25], Healthy Eating Index (HEI) [25, 26], Dietary Approaches to Stop Hypertension (DASH) [23, 25], 
the Healthy Food Intake Index (HFII) which assesses adherence to the Nordic Nutrition 
Recommendations [27], and Western and prudent dietary patterns obtained with a posteriori dietary 
patterns [26, 28-33]. Except for the LCD score and the Western dietary pattern score, the MDS, HEI, 
DASH, and HFII reflect a healthier diet with higher adherence; and higher adherence to any of these 
scores was associated with a significantly lower risk of GDM, except for the HFII. The Western dietary 
pattern was associated with a higher risk of GDM [43-47]. Although these dietary patterns have been 
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derived in different ways, several food groups are included in the majority of these “healthier diet” 
patterns and are summarized in Table 9.2. Based on the results from these observational studies it is 
probable that a dietary pattern characterized by high intakes of fruit, vegetables, legumes, fish, nuts, 
whole grains and low intakes of red and processed meat, snacks, and added sugar lowers the risk of 
developing GDM.  
Table 9.2. Components of dietary pattern scores reflecting a healthier diet that are associated with lower risk 
of gestational diabetes. 
 A priori  A posteriori 
 MDS DASH HEI HFII DHD15  Prudent 
Higher intake is encouraged        
Fruit X X X X X  X 
Vegetables X X X X X  X 
Nuts X X X  X  X 
Legumes X X X  X  X 
White: red meat ratio   X    X 
Fish and seafood X   X X  X 
Whole grains X X   X   
Whole grains: refined grains    X X  X 
Cereal fibre   X     
Low-fat dairy  X  X   X 
MUFA or PUFA:SFA X  X X X   
        
Low/moderate intake is encouraged        
Trans fat   X     
Red and processed meats X X   X   
Sweetened beverages  X  X X  X 
Alcohol X  X  X  X 
Sodium  X   X   
Added sugar    X    
MDS, Mediterranean diet score; DASH, dietary approaches to stop hypertension; HEI, healthy eating index; HFII, healthy 
food intake index; DHD15, Dutch healthy diet index 2015; MUFA, mono-unsaturated fatty acids; PUFA, poly-unsaturated 
fatty acids; SFA, saturated fatty acids;  
 
Foods 
A better understanding of single foods and nutrients driving the association between diet and GDM as 
observed with dietary patterns can support dietary intervention development and nutritional 
counselling. Thus, analysis of individual foods and nutrients can complement dietary pattern analysis 
[15]. In chapter 5, the intake of several carbohydrate-rich food groups in relation to GDM development 
was investigated, and we observed that a higher intake of fruit and fruit juice was associated with a 
lower risk of GDM, whereas a higher cereal intake was associated with a higher risk of GDM. The 
number of studies investigating individual foods in relation to GDM development are limited (see Table 
1.1 (chapter 1) for an overview of reported associations). Most statistically significant associations 
were reported in studies using the Nurses’ Health Study II data; a positive association was observed 
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for consumption of potatoes, red meat, processed meat, fried foods and sugar-sweetened cola [32, 
34-36], whereas higher intake of nuts and cereal and fruit fibre were associated with lower risk of GDM 
[37-39]. The study of Karamanos using data of 1000 pregnant women from 10 Mediterranean countries 
reported a lower risk of GDM with higher intakes of potatoes, cereal and a higher risk with higher 
intakes of olive oil and cheese [24]. The discrepancy in results for single food items, for example, cereal 
intake, might be due to other products consumed with these specific foods, i.e. lack of context or 
differences in preparation methods. For example in the US, potatoes are more commonly consumed 
by women with a lower socioeconomic status who have in general a less healthy lifestyle and potatoes 
are often fried or baked [40], whereas in Mediterranean countries potatoes are considered a vegetable 
and higher intakes might be indicative of women with a higher overall vegetable intake and a more 
healthy lifestyle in general. For other foods, the nutrient content might be important to take into 
account. For example, cereal can contain high amounts of cereal fibre, but can also be a source of 
added sugar. However, up to date the evidence is too limited to make specific food recommendations 
for the prevention of GDM other than the dietary guidelines for the general population.  
Macronutrients 
The first studies investigating the relationship between diet and GDM paid most attention to 
macronutrient intake and composition. In general, total fat and saturated fat were associated with an 
increased risk of GDM, whereas results for polyunsaturated fat, protein and carbohydrates were mixed 
and thus inconclusive. Most conclusive evidence was observed in studies that took the correlation 
between and substitution of macronutrients into account, which is comparable to the LCD score used 
in chapter 5. Our results and those of others [22, 41] indicate that a lower carbohydrate intake in 
combination with a higher fat and protein intake is associated with higher risk of GDM, and especially 
saturated fat and protein from animal origin were found to be detrimental [22, 37, 42].   
Fibre and glycaemic index (GI) 
Another dietary factor that has received ample attention in relation with GDM development is fibre, 
as epidemiological evidence relates high fibre and whole grain intake with a lower risk of type 2 
diabetes [43]. Several, but not all, studies have observed a lower risk of GDM with a higher fibre 
consumption [39, 44-52]. In chapter 5, we also report a lower risk of GDM with higher fibre 
consumption, however adjustment for BMI attenuated the association. Dietary fibre can be divided 
into two groups based on water solubility. Whole grain products mainly contain insoluble fibre [53], 
which has been associated with intestinal transit time [54] and may modulate the composition and 
metabolism of gut microbiota, which can impact glucose homeostasis via several mechanisms [55]. On 
the other hand, fruit and vegetables contain more soluble fibres [53]. Soluble fibres can create a gel-
like substance in the stomach, which can delay gastric emptying and thus slow glucose absorption [56-
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58]. In our study (chapter 5), we observed a lower risk of GDM with higher fruit consumption, but not 
cereal, whereas in the study of Zhang et al. both fruit and cereal fibre, but not vegetable fibre, were 
associated with lower GDM risk [39]. Therefore, it might be important to take the type of fibre into 
account. Furthermore, a high fibre diet often coincides with a low GI diet [59].  There is substantial 
evidence that low GI diets may reduce insulin resistance and hyperlipidaemia [60, 61]. However, only 
few studies have been done on a low GI diet in pregnancy. Results of these studies suggest that 
pregnant women could benefit from low GI diets to lower maternal glycosylated haemoglobin, plasma 
glucose, birth weight, and reduce insulin requirements of women with GDM [62-64]. 
Micronutrients 
Micronutrients are involved in a vast array of physiological processes such as enzyme activity, signal 
transduction and transcription pathways, biological functions and oxidative stress [65]. Recent reviews 
have shown that there is a relation between diet and the development of glucose intolerance [56, 66, 
67]; however, data regarding the impact of specific micronutrients on glucose homeostasis and GDM 
are just beginning to emerge [56]. Vitamin A, D, K, C and E, calcium, magnesium, zinc, chromium, and 
sodium are suggested to have a positive effect on glucose homeostasis, but underlying mechanisms 
are not yet established, or need further confirmation [66, 67]. Higher intakes of iron, on the other 
hand, are suggested to have a detrimental effect on glucose homeostasis, as excess iron can induce 
oxidative stress that can damage beta cell function [68, 69].  
In chapter 6, we investigated prevalence of micronutrient deficiency and association of micronutrient 
adequacy and risk of GDM development. We did not observe an association between a single nutrient 
deficiency and risk of GDM, but overall micronutrient adequacy, i.e. meeting intake recommendations 
for 13 micronutrients, was associated with a lower risk of GDM. This might suggest that although 
individual micronutrients have a distinct role in glucose homeostasis, the effect of one single 
micronutrient on glucose homeostasis and consequently GDM development might be too small to be 
detected. A limitation of the ALSWH study used in chapter 6, was the absence of nutrient status 
markers. Nutrient status markers could provide more information on underlying physiology and 
mechanisms, as intake does not necessarily reflect the amount of nutrient available to the body [70]. 
Nutrient status is the link between intake and health effects. In the GLIMP2 study, chapter 7 and 8, 
both intake and status markers of folate, vitamin B6, B12, D, and iron were available. We observed no 
significant associations of micronutrient intake and status with markers of glucose tolerance (chapter 
7), except for a weakly inverse association between folate intake and 2-hour glucose levels and a 
weakly positive association between iron status and 2-hour glucose levels. Thus, no clear associations 
could be drawn regarding the role of micronutrients in relation to GDM development. A limitation of 
the GLIMP2 study is that we investigated only five micronutrients and the study might have been 
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underpowered. The few studies that included both intake and status [71-73], in general, observed 
stronger associations between nutrient status and GDM risk than between nutrient intake and GDM 
risk, advocating the inclusion of nutrient status markers in future studies investigating micronutrients 
and GDM risk.   
In chapter 7, we also described changes in nutrient status during pregnancy. We observed that all 
status markers significantly changed during pregnancy, and that this was not always related to intake. 
Furthermore, status markers were more often associated with supplement intake than dietary intake. 
Thus, both gestational age and supplement use are important to take into account when status 
markers during pregnancy are used, for example to determine prevalence of deficiency. Although diet 
is linked to development of GDM, the role of micronutrients remains unclear and more research 
including both intake and status markers is needed to unravel the potential mechanisms by which diet 
can affect GDM development and the specific (micro)nutrients involved. 
Measurement error 
Dietary intake assessment is prone to measurement error, which can lead to biased diet-disease 
associations and prevalence estimates. In chapter 3, we observed that combining dietary intake data 
from 24hR and FFQ with regression calibration (RC) and enhanced regression calibration (ERC) reduced 
bias in diet-disease associations. An advantage of these methods is that the statistical method is quite 
simple and most nutrition researchers should be able to apply them, in contrast to more advanced 
approaches such as the NCI-method [74, 75], which requires advanced statistical computations. 
Disadvantages of regression calibration have a more practical nature. The development of web-based 
24hR have reduced costs and burden for the researcher [76], but still requires additional time from 
participants. Furthermore, multiple dietary assessments might reduce willingness to participate or 
increase dropout, which could affect representativeness of the study population. This is especially of 
concern, when participants with a low educational level or low socioeconomic status, which are 
already underrepresented in most nutrition research studies, are the most affected. However, 
obtaining unbiased diet-disease associations is of the utmost importance as well. The development of 
new technological dietary assessment tools using smartphone apps might provide part of the solution 
[82].   
In chapter 7, we were able to use ERC to estimate micronutrient intake estimates as we had dietary 
estimates from both FFQ and two 24hR at each measurement moment. However, in chapter 8, we did 
not use ERC, although we had both the FFQ and two 24hR available. The reason was that the sample 
size for this study was limited to 66 women. In the ALSWH study, used in chapter 5 and 6, dietary 
intake was assessed with only a FFQ, thus ERC and RC were not possible. Although the FFQ was 
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validated for a wide range of macro- and micronutrients (correlation coefficients ranging from 0.28 for 
vitamin A to 0.78 for carbohydrates) [77], bias due to measurement error is likely to have occurred, 
and affected observed diet-disease associations to some extent [78].  
Lifestyle clustering 
The main focus of this thesis is the association of diet with GDM. However, diet is just one part of a 
larger set of lifestyle behaviours. Other lifestyle factors include physical activity, smoking, alcohol 
intake and sleep. These behaviours tend to cluster, e.g. people with unhealthy dietary habits, are more 
often physically inactive, smoke more often and are more likely to consume more alcohol, and vice-
versa [79-81]. Two recent studies have investigated the association between a healthy lifestyle, 
including a healthy diet, and development of GDM. They observed that adherence to a healthy lifestyle 
was associated with a significant 75-80% decrease in risk of developing GDM compared to women with 
an unhealthy lifestyle [82, 83], but only few women were in the extremes, i.e. adhering to all healthy 
or all unhealthy lifestyle behaviours. These studies demonstrate the importance of taking other 
lifestyle factors into account when investigating diet in relation to GDM development. If other lifestyle 
factors are not accounted for, the observed effect might be due to these unmeasured factors instead 
of dietary intake, i.e. residual confounding. In both the ALSWH and GLIMP2 studies several other 
lifestyle factors, including physical activity, smoking and alcohol intake were assessed and results 
presented in chapter 5-8 are adjusted for these factors. However, inaccurate measurements, e.g. 
physical activity, and unmeasured factors, e.g. sleep, might still have led to residual confounding.   
 
Study design 
There are several study design aspects that need to be discussed in order to be able to place the 
emerging body of evidence regarding the association of diet with the development of GDM, including 
results presented in this thesis (chapters 5-7) into context. These include study population, time frame, 
effect size and type of study (i.e. observational vs. intervention) and will be discussed below.  
Study population 
In this thesis, two different study populations have been used to investigate the role of diet in the 
development of GDM. In chapters 5 and 6 data from the ALSWH study, a large population-based 
prospective cohort study was used. The advantage of a population-based cohort study is the high 
external validity. However, as prevalence of GDM is around 5% in Caucasian populations [2], the 
number of cases is still rather low. An alternative to ensure enough cases and thus enough statistical 
power is studying high-risk populations with GDM prevalence up to 50% [84, 85]. This was done in the 
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GLIMP2 study, which oversampled women with a history of GDM, a previous macrosomic infant, 
polycystic ovarian syndrome (PCOS), and overweight. Oversampling of women at high risk of GDM in 
the GLIMP2 study resulted in a GDM incidence of 10%. A consequence of selecting a high-risk study 
population is that the degree of gradually developed, underlying, subclinical insulin resistance in the 
years before pregnancy (see figure 9.1) might be too severe for dietary factors to have any beneficial 
effect [51, 86, 87], thus potentially limiting the ability to detect an effect of diet. Furthermore, BMI can 
also act as a mediator in the association between diet and GDM [88], and should be considered when 
selecting only obese women, as is done in some other studies [89-93]. In addition to having a higher 
risk of GDM, the GLIMP2 study population consisted of women who were mostly highly educated and 
with an interest in health, and thus more likely to be more health conscious than the general 
population. This may not only have reduced external generalizability, but potentially may also have 
limited variation in dietary intake and thus the ability to detect an association with GDM.  
 
Figure 9.1: A schematic overview of how dietary intake might vary over time and can be influenced by specific 
events in relation to insulin resistance/GDM development. 
 
Time frame 
Diet is a lifelong exposure and it is important to take the timing of dietary assessment into account 
when studying diet-disease associations, especially since chronic disease development does not 
happen overnight, but develops over time. To avoid reverse causation, dietary assessment should be 
done before disease diagnosis, in this case before GDM diagnosis, as is done in the ALSWH and GLIMP2 
studies (chapters 5-7). Furthermore, depending on the method used, dietary intake may reflect intake 
at a certain point in time, which is not necessarily representative of habitual intake. For example, 
seasonal variation might influence dietary intake. Pregnancy is a major life event that can influence 
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dietary intake. For example, food safety recommendations are given to ensure avoidance of 
contaminants, but also pregnancy-induced food aversions, nausea and vomiting can affect dietary 
intake. Therefore, diet measured several years before pregnancy (e.g. ALSWH) may not reflect the diet 
consumed during pregnancy, and vice versa, diet assessed during pregnancy might not reflect habitual 
pre-pregnancy diet, whereas both can have an effect on the development of insulin resistance (see 
figure 9.1). In the ALSWH study, two FFQs were administered six years apart and sensitivity analyses 
in which data from both were combined as long-term dietary intake showed similar associations as 
those based on the FFQ closest to the pregnancy (chapter 5, 6). In theory, multiple measurements 
both in the preconception and pregnancy period are necessary to accurately capture dietary intake 
and changes over time. In chapter 7, we assessed diet quality and micronutrient intake in the 
preconception period, on average 13 weeks before conception, and twice during pregnancy. We 
observed that dietary intake remained stable over this time frame. Combined with results obtained 
from others [94-96], it is likely that, although total intake and intake of specific foods may change in 
the year before the pregnancy, the effect on diet quality and micronutrient intake is limited. 
Furthermore, in the GLIMP2 study, we did not observe a significant effect of nausea and vomiting on 
dietary intake estimates.  
Observational versus intervention studies 
Results presented in this thesis with respect to the association between diet and GDM development 
(chapters 5-7) are based on observational data, as are the majority of results of other studies. 
However, randomized controlled trials (RCTs) are needed to prove causality. A recent systematic 
review and meta-analysis summarized results from 23 RCTs investigating combined diet and exercise 
interventions to prevent GDM compared to no intervention and concluded that there was a possible 
reduced risk of GDM (average risk ratio 0.85, 95% confidence interval 0.71 to 1.01; 6633 women; 19 
RCTs), but that the quality of the evidence was moderate [97]. Furthermore, there was large 
heterogeneity observed in the type of dietary intervention given, so effective dietary components are 
difficult to disentangle.  
Another limitation of RCTs is that they often start during pregnancy, due to feasibility reasons, and 
thus have only a short time window (e.g. from 12 weeks of gestation at inclusion to 24-28 weeks of 
gestation for GDM testing) to change dietary intake and for this change in diet to have an effect on 
insulin resistance and glucose homeostasis. Therefore, new trials aim to start already in the 
preconception period. One of these trials is the recently started large multicentre, multi-ethnic 
randomized “Nutritional intervention Preconception and during Pregnancy to maintain healthy 
glucose metabolism and offspring health (NiPPeR)” trial investigating the effect of an optimized 
nutritional drink with myo-inositol, micronutrients and probiotics on glucose tolerance that starts with 
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the intervention in the preconception phase [98]. A major challenge of this study, however, is the large 
number of women needed, n=1800, to be able to study the aimed 600 pregnancies, as not all women 
will conceive and anticipating dropout. 
 
Diet during pregnancy in a broader perspective 
A high prevalence of inadequate pre-pregnancy dietary intake of folate, calcium, magnesium, 
potassium and vitamin E was observed in an Australian population (chapter 6) and a large proportion 
of Dutch women who wished to become pregnant did not meet recommendations for folate, vitamin 
D and n-3 fatty acids intake (chapter 8). These suboptimal prepregnancy intakes were also observed 
in other populations [99-102], and although more prevalent among lower educated women [102, 103], 
our results indicate that even in highly educated women recommendations are not met. In chapter 7, 
we observed that diet quality, not considering supplement use, did not change in women from 
preconception to the end of the second trimester. This is in line with other studies observing that, 
although energy intake increased, diet quality and micronutrient intake did not change [101, 104, 105]. 
This is of concern, as pregnancy is a potential window of opportunity to improve diet quality [106-108]. 
More and more focus has been placed on starting interventions already in the preconception period, 
when maternal diet and nutrient status can be improved to provide an optimal intrauterine 
environment before foetal development starts. However, preconception care is not a standardized 
part of general health care [109] and awareness of preconception health among women and health 
professionals is low, and responsibility for providing preconception care is unclear [106]. 
Improving diet quality during pregnancy and ideally in the preconception period may not only lead to 
a lower risk of developing GDM. By providing an optimal intrauterine environment, chronic disease 
risk in childhood and adulthood may be reduced as postulated by the developmental origins of health 
and disease (DOHaD) hypothesis [110, 111]. In addition, improving diet quality in the preconception 
period might reduce subfertility rates [112-114], gestational weigh gain [115], gestational 
hypertension [116], preeclampsia [117], intrauterine growth retardation [118], preterm delivery [119], 
risk of Caesarean section [115] and potentially many others [120].  
As demonstrated in chapters 7 and 8, supplementation can help in meeting micronutrient intake 
recommendations and improving micronutrient status. However, some considerations should be 
taken into account regarding supplement use. Women who take prenatal supplements are often 
women with a higher educational level, who, in general, already achieve higher intakes of 
micronutrients [121, 122]. Health policies encouraging supplement use might not reach the women 
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with the lowest intake levels, but increase supplement consumption in health-conscious women with 
partly already adequate intake levels, who are consequently at risk of excess intake above the upper 
level of intake [101]. This might especially occur in countries with mandatory fortification of bread, for 
example, with folate, such as in the United States, United Kingdom and Australia. In the GLIMP2 study 
(chapter 7) 14% of the women consumed folate above the upper level of intake. For other 
micronutrients, we observed no intake above upper levels. Intake of micronutrients above the 
recommended upper level can cause medical complaints such as nerve damage with long-term 
excessive intake of vitamin B6 [123, 124]. Furthermore, little is known about whether high doses of 
micronutrients might affect development of the unborn child, but in light of the DOHaD hypothesis, 
this seems plausible. A recent study has found a link between high doses of folic acid during pregnancy 
(>5 mg/d) and impaired psychomotor development at 12-23 months of age [125]. More research is 
needed to unravel the adverse effects of excess micronutrient intake, especially for potential adverse 
effects in the offspring.  
Thus, adequate dietary intake is important and a supplement can help in achieving recommended 
intakes, but caution is warranted with respect to the doses and should not exceed the recommended 
daily allowance.  
 
Recommendations for future research 
Current scientific evidence suggests a beneficial role of a healthy diet in GDM prevention, especially 
when a healthy diet is achieved before pregnancy. However, more research is needed to further 
understand the role of diet in the development of GDM and defining the foods and nutrients driving 
observed associations, as well as potential underlying mechanisms. This information can be used for 
tailoring dietary interventions to prevent GDM.  
As outlined above, current intervention studies may be limited by a short time frame for dietary 
changes to exert an effect on glucose homeostasis and insulin resistance. Starting in the preconception 
period is thus a logical next step. Recruitment of women in the preconception period was the biggest 
challenge in our small-scale GLIMP2 study. The currently ongoing NiPPeR trial [98] will not only provide 
information on the effect of a nutritional drink on GDM development, but also provide vital 
information on feasibility and practicality of research in the preconception period on a large scale.   
Furthermore, research should include both intake and status markers, as these complement each 
other and together they provide a more complete picture than either one alone. Our observations of 
changes in micronutrient intake, supplement use and status markers warrant additional research in a 
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larger study sample. Multiple measurements throughout the pregnancy are preferable, especially 
regarding status markers. As supplement use can significantly influence status markers, detailed 
assessment of supplemental intake is desirable.   
Prevention of GDM is preferred above treatment, but identification of women with GDM as well as 
timely treatment is essential. Although the IADSPG guidelines are endorsed by several leading 
organizations such as the WHO and ADA, the debate regarding screening and diagnostic criteria 
continues, especially in light of increasing prevalence and health care burden. It is important that 
future research will identify those at risk of adverse pregnancy outcomes and those who might benefit 
from treatment. Cost-effectiveness studies will give more insight in treatment and health care costs 
versus benefits from preventing adverse pregnancy outcomes.  
Finally, efforts to optimize and improve dietary assessment methods to minimize bias should not be 
forgotten, as dietary intake estimates are the key stone in nutrition research.  
 
Implications for clinical and public health practice 
In the Netherlands, GDM screening is recommended [126], but there are no strict recommendations 
with regard to screening and diagnostic criteria. Results from this thesis underline the importance of 
timely screening and start of treatment, as women with (borderline) GDM have an increased risk of 
common adverse pregnancy outcomes. Furthermore, risk of GDM can potentially be reduced, by 
providing women with dietary counselling to improve diet quality. The discussion of potential food 
hazards is a common routine at the first prenatal visit, and dietary counselling could be amended to 
this. This requires proper informing and training of obstetricians, GPs, midwives and others involved. 
Dietary counselling at the first prenatal visit might not only reduce risk of GDM development, but could 
beneficially impact a number of pregnancy outcomes and potentially long term health of the foetus.  
Ideally, dietary counselling is already provided in the preconception stage, to ensure an adequate 
nutrient status upon conception. Although the Health Council of the Netherlands already called upon 
the provision of proper and adequate preconception care a decade ago [127], results of this thesis 
indicate that more action is needed to improve intake and status of essential micronutrients in the 
preconception period. This might be partly due to the fact that it is unclear who is responsible for 
offering preconception care and that women are not aware of the possibility of preconception advice 
from health care providers [106]. A first step for reaching women in the preconception stage could be 
fertility clinics. As obesity is associated with reduced fertility [128], this might provide a high-risk group 
that could benefit from dietary counselling.  
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Dietary counselling should include information regarding the importance of meeting dietary 
recommendations, how to improve diet quality, the potential benefit of supplement use, but also 
information regarding the correct dose and use of supplements and risk of excessive intake.  
 
Conclusions 
Based on the results described in this thesis as well as existing literature, it is probable that a healthy 
diet can reduce risk of developing gestational diabetes. Most convincing evidence is observed for diet 
in the pre-pregnancy period. In both an Australian and a Dutch population, diet in the pre-pregnancy 
period was considered suboptimal and intake of several vital micronutrients, including folate, was 
below recommended intakes for a large proportion of women. The pre-pregnancy period thus is an 
ideal situation for improving dietary intakes. Supplements can help bridging the gap between dietary 
intake and recommended intake, but caution regarding excessive intake is warranted. Furthermore, 
borderline gestational diabetes was associated with higher risk of common adverse pregnancy 
outcomes, stressing the urgency of gestational diabetes diagnosis and timely treatment.  
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Gestational diabetes mellitus (GDM) is one of the most common metabolic complications during 
pregnancy and prevalence has continued to increase worldwide. As BMI is one of the most important 
risk factors for development of GDM, prevention of GDM has focused on modifiable factors including 
diet. A range of dietary factors has been investigated, but results per dietary factor are limited and 
inconclusive (chapter 1). This thesis aims to provide more insight into dietary intake and nutrient status 
before and during pregnancy and into the association of dietary intake and nutrient status with risk of 
GDM. In addition, two methodological topics are addressed: the development of an index reflecting 
adherence to the Dutch dietary guidelines of 2015 and the effect of combining food frequency 
questionnaire (FFQ) and 24-hour recall (24hR) data on bias in diet-disease associations.  
In chapter 2, the development and evaluation of the Dutch Healthy Diet 2015 (DHD15) index score is 
described. The DHD15 index score assesses adherence to the Dutch dietary guidelines of 2015 and 
consists of 15 components representing the 15 food-based dietary guidelines. Per component the 
score ranges between zero and ten, resulting in a total score between zero (no adherence) and 150 
(complete adherence). We evaluated the DHD15 index based on data from two 24hR and one FFQ 
from 885 men and women, aged 20-70 years, participating in the longitudinal NQplus study. A higher 
DHD15 index score was inversely associated with BMI, smoking, and intakes of energy, total fat, and 
saturated fat and positively associated with energy-adjusted micronutrient intakes. We concluded that 
the DHD15 index is a good marker of diet quality.  
Measurement error in dietary intakes leads to biased diet-disease associations. If dietary intake is 
assessed with a second method, regression calibration (RC) or enhanced regression calibration (ERC) 
can be used to combine dietary intakes. This could result in less biased associations. In chapter 3, we 
investigated the effect of combining dietary intakes obtained with two methods (24hR and FFQ) on 
diet-disease associations using data from 236 participants of the NQplus study. We observed that 
combining FFQ and 24hR data with RC and ERC for protein and potassium resulted in empirical 
attenuation factors approaching 1, indicating less biased diet-disease associations. 
In chapter 4, the prevalence of common delivery-related adverse pregnancy outcomes was compared 
between women with normal glucose tolerance during pregnancy (NGT), women with treated GDM 
and women with untreated borderline GDM (BGDM). BGDM was defined as women with an abnormal 
50-grams glucose challenge test and a normal 75-grams oral glucose tolerance test. Medical file data 
were used from 1049 women who had undergone GDM screening and had given birth in hospital 
Gelderse Vallei Ede in the period 2010-2014. Women with treated GDM had a higher risk of laceration 
and women with untreated BGDM had a higher risk of laceration and (unscheduled) Caesarean section 
as compared to women with NGT. Furthermore, we observed that associations between glucose 
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tolerance and adverse pregnancy outcomes were not mediated by macrosomia (birth weight >4000 
gram).  
In chapter 5, the associations between pre-pregnancy dietary carbohydrate quantity and quality with 
risk of GDM were investigated in women of reproductive age in an Australian cohort. A total of 3,607 
women aged 25-30 years were followed-up for self-reported GDM development from 2003 till 2015. 
Pre-pregnancy dietary intake was assessed with a FFQ in 2003 and 2009. Carbohydrate quantity was 
assessed based on total carbohydrate intake and the low-carbohydrate diet (LCD) score. Carbohydrate 
quality was assessed by studying fibre intake, total sugar intake, glycaemic index, glycaemic load and 
intake of carbohydrate-rich food groups. A relatively low carbohydrate and high fat and protein intake 
as expressed by the LCD score and a higher cereal intake were significantly associated with higher risk 
of GDM, whereas higher fibre, fruit and fruit juice intakes were associated with lower risk of GDM.  
Chapter 6 describes the prevalence of inadequate micronutrient intakes and the association of pre-
pregnancy micronutrient adequacy with risk of GDM in the same Australian cohort of women of 
reproductive age. We used a summary measure of adequate micronutrient intake across 13 
micronutrients, i.e. the mean adequacy ratio (MAR). Prevalence of inadequate dietary micronutrient 
intake was more than 50% for the micronutrients calcium, potassium, magnesium, vitamin E and 
folate, indicating suboptimal pre-pregnancy micronutrient intakes. A higher overall micronutrient 
adequacy (i.e. MAR) was associated with a lower risk of developing GDM.   
In chapter 7, changes in folate, vitamin B6, vitamin B12, vitamin D and iron intake, their status markers 
and diet quality from preconception to the second trimester of pregnancy are described. In addition, 
associations of these micronutrient intakes, their status markers and diet quality with glucose 
tolerance during pregnancy were examined. Data from 91 Dutch women at increased risk of GDM, 
aged 18-40 years, and with either a wish to get pregnant or less than 24 weeks pregnant was collected 
longitudinally. Data was collected at preconception (n=67), 12 weeks of pregnancy (n=47) and 24 
weeks of pregnancy (n=55). At each time point women underwent a fasting venipuncture and a 75-
grams oral glucose tolerance test. Dietary intake was assessed at each time point with a validated FFQ 
and two non-consecutive 24hR. We observed significant changes in total micronutrient intakes 
throughout pregnancy, due to changes in supplemental intakes, whereas dietary micronutrient intakes 
and diet quality remained stable. Nutrient status levels changed significantly from preconception to 
the second trimester of pregnancy. For folate, vitamin B6 and vitamin D this could be partly explained 
by changes in intake. In general, no associations between fasting and 2-hour glucose levels and HbA1c 
levels with diet quality, micronutrient intake or status levels were observed; except for a weak inverse 
association of folate intake with 2-hour glucose levels, and a weak positive association between ferritin 
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and 2-hour glucose levels.  Diet quality was inversely associated with fasting glucose in a sensitivity 
analysis, excluding data from participants with only one measurement. 
Using data from the same study collected at preconception from the same study (n=66), main dietary 
sources of folate, vitamin D, and the n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA) were determined in chapter 8. Additionally, associations of these intakes with their blood 
levels were examined. A large proportion of women did not meet the Dutch recommended intakes of 
folate (50%), vitamin D (67%), and EPA+DHA (52%). Vegetables were the main contributor of dietary 
folate intake (25%), oils and fats of dietary vitamin D intake (39%), and fish of dietary EPA and DHA 
intake (69%). Fourteen percent had an inadequate folate status and 23% an inadequate vitamin D 
status. Supplemental folate intake, supplemental and dietary vitamin D intake and dietary EPA+DHA 
intake were significantly associated with their blood levels. 
In chapter 9, the main findings of this thesis were summarized and a reflection on methodological 
aspects was given. Considering results described in this thesis and associations reported by other 
studies, it is probable that a healthy diet can reduce risk of developing GDM. Most convincing evidence 
was observed for diet in the pre-pregnancy period. More research is needed to understand which 
foods and nutrients drive diet-GDM associations, and to unravel underlying mechanisms. Diet in the 
pre-pregnancy period was considered suboptimal and intakes of several vital micronutrients, including 
folate, were below recommended intakes for a large proportion of women in two different studies. 
Although the Health Council of the Netherlands already called upon the provision of proper and 
adequate preconception care a decade ago, more action is needed to improve intake and status of 
essential micronutrients in the preconception period. 
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Diabetes gravidarum (ook wel zwangerschapsdiabetes of gestational diabetes genoemd) is één van de 
meest voorkomende metabole complicaties die tijdens de zwangerschap kan optreden. We spreken 
van diabetes gravidarum (GDM) als er sprake is van koolhydratenintolerantie of een hoge bloedsuiker 
(glucose) spiegel tijdens de zwangerschap. Het hebben van overgewicht of obesitas is één van de 
grootste risicofactoren voor het krijgen van GDM. Daarom richt de preventie van GDM zich op 
risicofactoren van obesitas die we kunnen veranderen, zoals de voedingsinname. In Hoofdstuk 1 wordt 
een overzicht gegeven van onderzoek naar voedingsinname en GDM. Helaas zijn de resultaten beperkt 
en niet altijd eenduidig. Het doel van dit proefschrift is om meer inzicht te krijgen in de voedingsinname 
en nutriëntstatus van vrouwen voor en tijdens hun zwangerschap en de associatie tussen 
voedingsinname, nutriëntstatus en het risico op het krijgen van GDM. Daarnaast bekijken we twee 
methodologische aspecten van het meten van voedingsinname: 1) het ontwikkelen van een score die 
weergeeft hoe goed iemand eet volgens de Nederlandse voedingsrichtlijnen van 2015 en 2) het 
combineren van voedingsinnamegegevens verzameld met een voedselfrequentievragenlijst (FFQ) met 
voedingsinnamegegevens verzameld met een 24-uursnavraag (24hR) en effect daarvan op voedings-
ziekte associaties. 
In Hoofdstuk 2 wordt de ontwikkeling en evaluatie van de Dutch Healthy Diet 2015 (DHD15) index 
score beschreven. Deze DHD15 index score geeft weer in welke mate iemand voldoet aan de 
Nederlandse voedingsrichtlijnen van 2015. De index score bestaat uit 15 componenten, 1 voor elke 
richtlijn. Voor elke component kan een score tussen de 0 en 10 punten behaald worden. Deze 
componentscores worden bij elkaar opgeteld, wat resulteert in de totaalscore. De laagste totaalscore 
van 0 punten geeft aan dat iemand helemaal niet voldoet aan de richtlijnen en de hoogste totaalscore 
van 150 score wordt gegeven als iemand voldoet aan alle richtlijnen. Om de DHD15 index score te 
evalueren hebben we de gegevens gebruikt van 885 mannen en vrouwen van tussen de 20 en 70 jaar 
oud die hebben meegedaan aan de longitudinale NQplus studie en twee 24hR en één FFQ hebben 
ingevuld. We zagen dat een hogere DHD15 index score negatief geassocieerd was met BMI, roken en 
energie-, vet-, en verzadigd vetinname en positief geassocieerd was met micronutriëntinnames nadat 
deze gecorrigeerd waren voor energie-inname. We concluderen hieruit dat de DHD15 index een goede 
graadmeter is voor het bepalen van de kwaliteit van de voeding.  
Meetfouten in voedingsinnamegegevens kan leiden tot systematische fouten in gerapporteerde 
voedings-ziekte associaties. Indien de voedingsinname met een tweede methode wordt gemeten, kan 
de regressiecalibratie (RC) of uitgebreide regressiecalibratie (ERC) techniek gebruikt worden om de 
voedingsinnamegegevens van de twee verschillende methodes te combineren. Het combineren van 
voedingsinnamegegevens van twee verschillende methoden kan leiden tot minder fouten in voedings-
ziekte associaties. In Hoofdstuk 3 onderzoeken we wat het effect is van het combineren van 
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voedingsinnamegegevens verzameld met twee verschillende methodes (24hR en FFQ) op de 
systematische fout in voedings-ziekte associaties. Hiervoor gebruikten we gegevens van 236 
deelnemers van de NQplus studie. We zagen dat het combineren (met behulp van de RC en ERC 
technieken) van FFQ en 24hR innamegegevens van eiwit en kalium leidde tot attenuatiefactoren 
dichtbij 1. Dit geeft aan dat het combineren van FFQ en 24hR gegevens kan leiden tot minder 
systematische fout in gerapporteerde voedings-ziekte associaties.  
In Hoofdstuk 4 hebben we veelvoorkomende bevallingscomplicaties vergeleken tussen vrouwen met 
normale glucosetolerantie (NGT) tijdens de zwangerschap, vrouwen met GDM die behandeld werden 
en vrouwen met licht afwijkende glucose-intolerantie, maar die geen behandeling ondergingen 
(BGDM). Voor dit onderzoek hebben we medische gegevens van 1049 vrouwen gebruikt. Deze 
vrouwen waren getest op GDM en zijn bevallen in ziekenhuis Gelderse Vallei tussen 2010 en 2014. 
Vrouwen met behandelde GDM hadden een hoger risico op een ruptuur, terwijl vrouwen met 
onbehandelde BGDM een hoger risico hadden op een ruptuur en (ongeplande) keizersnede vergeleken 
met vrouwen met NGT. Verder zagen we dat de associaties tussen glucosetolerantie en 
bevallingscomplicaties niet gemedieerd werden door macrosomie (geboortegewicht >4000g).   
In Hoofdstuk 5 bekeken we of de hoeveelheid en kwaliteit van de koolhydraten in de voeding voor de 
zwangerschap geassocieerd was met het risico op het krijgen van GDM. Hiervoor gebruikten we 
gegevens van 3607 Australische vrouwen tussen de 25 en 30 jaar oud die 12 jaar lang (2003-2015) 
gevolgd werden om te kijken of ze GDM kregen. Voedingsinname voor de zwangerschap werd in 2003 
en 2009 gemeten met een FFQ. De koolhydratenhoeveelheid werd gemeten aan de hand van totaal 
gegeten koolhydraten en de low-carbohydate diet (LCD) score. Koolhydratenkwaliteit werd bekeken 
met behulp van de totale hoeveelheid vezelinname, suikerinname, glycemische index, glycemische 
load en inname van koolhydraatrijke voedselgroepen. Een relatief lage koolhydrateninname en hoge 
vet en eiwitinname (weergegeven met de LCD-score) en een hoge inname van ontbijtgranen was 
geassocieerd met een hoger risico op het ontwikkelen van GDM, terwijl een hoge vezelinname, 
fruitinname en vruchtensapinname geassocieerd waren met een lager risico op het krijgen van GDM.  
In Hoofdstuk 6 beschrijven we de prevalentie van inadequate micronutriëntinname en de associatie 
met het krijgen van zwangerschapsdiabetes. Hiervoor gebruikten we de gegevens van dezelfde 3607 
Australische vrouwen. We gebruiken de mean adequacy ratio (MAR) om weer te geven of de 
micronutriëntinname van 13 verschillende micronutriënten adequaat is. Meer dan 50% van de 
vrouwen had onvoldoende inname van calcium, kalium, magnesium, vitamine E en foliumzuur. 
Vrouwen met een meer adequate micronutriëntinname (weergegeven met de MAR), hadden een lager 
risico om GDM te ontwikkelen.  
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In Hoofdstuk 7 wordt beschreven hoe de inname van foliumzuur, vitamine B6, vitamine B12, vitamine 
D en ijzer, hun statusmarkers en kwaliteit van de voeding veranderen van de preconceptiefase tot het 
tweede trimester van de zwangerschap. Daarnaast worden de associaties van deze 
micronutriëntinnames, statusmarkers en kwaliteit van de voeding met glucosetolerantie tijdens de 
zwangerschap beschreven. Hiervoor gebruikten we longitudinale gegevens van 91 Nederlandse 
vrouwen (18-40 jaar oud) met een verhoogd risico op GDM die of een zwangerschapswens hadden of 
minder dan 24 weken zwanger waren. Gegevens werden verzameld voor de zwangerschap (n=67), bij 
12 weken zwangerschap (n=47) en bij 24 weken zwangerschap (n=55). Op elk meetmoment was er een 
nuchtere bloedafname en een 75grams glucosetolerantie test. Voedingsinname werd op elk 
meetmoment gemeten met een gevalideerde FFQ en 24hR op twee willekeurige, niet-opeenvolgende 
dagen. We zagen dat de micronutriëntinnames significant veranderden tijdens de zwangerschap door 
veranderingen in supplementinname. Micronutriëntinnames uit de voeding bleef gelijk. Ook de 
nutriëntstatus veranderde significant tijdens de zwangerschap. De veranderingen in nutriëntstatus van 
foliumzuur, vitamine B6 en vitamine D konden gedeeltelijk verklaard worden door veranderingen in 
de inname. Over het algemeen zagen we geen associatie tussen nuchtere glucose, 2-uurs glucose en 
HbA1c waardes met kwaliteit van de voeding, micronutriëntinname of micronutriëntstatus. De enige 
uitzonderingen waren een zwakke negatieve associatie tussen foliumzuur en 2-uurs glucose en een 
zwakke positieve associatie tussen ijzerstatus en 2-uurs glucosewaardes. Kwaliteit van de voeding was 
negatief geassocieerd met nuchtere glucosewaardes in een sensitiviteitsanalyse, waarin de gegevens 
van deelnemers die maar één meting hadden gedaan niet mee werden genomen.  
Met de gegevens van dezelfde studie hebben we in Hoofdstuk 8 gekeken naar de belangrijkste 
voedingsbronnen van foliumzuur, vitamine D en de omega-3-vetzuren EPA en DHA in de 
preconceptiefase (n=66). Daarnaast hebben we gekeken of deze micronutriëntinnames geassocieerd 
waren met micronutriëntbloedwaardes. Een groot deel van de vrouwen kreeg minder binnen dan de 
aanbevolen hoeveelheden voor foliumzuur (50%), vitamine D (67%) en EPA+DHA (52%). Groenten 
waren de belangrijkste voedingsbron van foliumzuurinname (25%), oliën en vetten van vitamine D 
(39%) en vis van EPA en DHA (69%). Veertien procent van de vrouwen had een inadequate 
foliumzuurstatus en 23% had een inadequate vitamine D-status. Foliumzuurinname uit supplementen, 
vitamine D-inname uit zowel de voeding als supplementen en EPA+DHA-inname uit de voeding waren 
significant geassocieerd met bloedwaardes van deze micronutriënten.  
In Hoofdstuk 9 worden de belangrijkste bevindingen van dit proefschrift samengevat en worden de 
belangrijkste methodologische aspecten besproken. Wanneer we zowel de resultaten van dit 
promotieonderzoek als de resultaten van overige onderzoeken beschouwen, kan er geconcludeerd 
worden dat gezonde voeding het risico op het ontwikkelen van GDM waarschijnlijk kan verminderen. 
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Het meest overtuigende bewijs daarvoor komt uit onderzoeken die hebben gekeken naar 
voedingsinname voor de zwangerschap. Er is meer onderzoek nodig om te begrijpen welke 
voedingsmiddelen en nutriënten ten grondslag liggen aan deze waargenomen associaties en welke 
mechanismes hierbij een rol spelen. De voedingsinname in de periode voor de zwangerschap bleek 
suboptimaal en de innames van verschillende micronutriënten, waaronder foliumzuur, bleken voor 
een groot deel van de vrouwen uit twee verschillende studies lager te zijn dan de aanbevolen dagelijkse 
hoeveelheid. Hoewel de Gezondheidsraad al meer dan 10 jaar geleden opriep tot een betere 
preconceptiezorg, is er nog steeds veel te verbeteren wat betreft de inname en nutriëntstatus van 
essentiële micronutriënten in de preconceptiefase.   
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Propositions  
1. Gestational diabetes prevention should focus on 
improving diet quality before as well as during pregnancy 
(this thesis) 
2. Despite public health campaigns, micronutrient intakes 
of women in the preconception period remain 
inadequate  
(this thesis) 
3. Nonceliac gluten sensitivity can be explained by a nocebo 
effect i.e. induction or worsening of symptoms due to 
negative expectations 
4. Risk avoidance is a favourable personality trait 
5. Small is beautiful also applies to research 
6. Coffee breaks are essential for a PhD student 
7. Every thinker needs a doer, and vice-versa 
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